
<html lang="en"     class="pb-page"  data-request-id="a87cf6a5-8a9f-42bb-8ab2-3d11705bab87"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm900159g;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2009.52.issue-15;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Small Molecule Chloropyramine Hydrochloride (C4) Targets the Binding Site of Focal Adhesion Kinase and Vascular Endothelial Growth Factor Receptor 3 and Suppresses Breast Cancer Growth in Vivo" /></meta><meta name="dc.Creator" content="Elena V.  Kurenova" /></meta><meta name="dc.Creator" content="Darell L.  Hunt" /></meta><meta name="dc.Creator" content="Dihua  He" /></meta><meta name="dc.Creator" content="Andrew T.  Magis" /></meta><meta name="dc.Creator" content="David A.  Ostrov" /></meta><meta name="dc.Creator" content="William G.  Cance" /></meta><meta name="dc.Description" content="FAK is a tyrosine kinase that functions as a key orchestrator of signals leading to invasion and metastasis. Since FAK interacts directly with a number of critical proteins involved in survival sig..." /></meta><meta name="Description" content="FAK is a tyrosine kinase that functions as a key orchestrator of signals leading to invasion and metastasis. Since FAK interacts directly with a number of critical proteins involved in survival sig..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 17, 2009" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm900159g" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2009 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm900159g" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm900159g" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm900159g" /></link>
        
    
    

<title>Small Molecule Chloropyramine Hydrochloride (C4) Targets the Binding Site of Focal Adhesion Kinase and Vascular Endothelial Growth Factor Receptor 3 and Suppresses Breast Cancer Growth in Vivo | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm900159g" /></meta><meta property="og:title" content="Small Molecule Chloropyramine Hydrochloride (C4) Targets the Binding Site of Focal Adhesion Kinase and Vascular Endothelial Growth Factor Receptor 3 and Suppresses Breast Cancer Growth in Vivo" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/large/jm-2009-00159g_0007.jpeg" /></meta><meta property="og:description" content="FAK is a tyrosine kinase that functions as a key orchestrator of signals leading to invasion and metastasis. Since FAK interacts directly with a number of critical proteins involved in survival signaling in tumor cells, we hypothesized that targeting a key protein−protein interface with druglike small molecules was a feasible strategy for inhibiting tumor growth. In this study, we targeted the protein−protein interface between FAK and VEGFR-3 and identified compound C4 (chloropyramine hydrochloride) as a drug capable of (1) inhibiting the biochemical function of VEGFR-3 and FAK, (2) inhibiting proliferation of a diverse set of cancer cell types in vitro, and (3) reducing tumor growth in vivo. Chloropyramine hydrochloride reduced tumor growth as a single agent, while concomitant administration with doxorubicin had a pronounced synergistic effect. Our data demonstrate that the FAK−VEGFR-3 interaction can be targeted by small druglike molecules and this interaction can provide the basis for highly specific novel cancer therapeutics." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm900159g"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm900159g">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm900159g&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm900159g&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm900159g&amp;href=/doi/10.1021/jm900159g" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2009</span><span class="cit-fg-volume">, 52</span><span class="cit-fg-issue">, 15</span><span class="cit-fg-pageRange">, 4716-4724</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/52/15" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm900259h" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm9002654" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Small Molecule Chloropyramine Hydrochloride (C4) Targets the Binding Site of Focal Adhesion Kinase and Vascular Endothelial Growth Factor Receptor 3 and Suppresses Breast Cancer Growth in Vivo</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elena+V.++Kurenova">Elena V. Kurenova</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Darell+L.++Hunt">Darell L. Hunt</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dihua++He">Dihua He</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+T.++Magis">Andrew T. Magis</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+A.++Ostrov">David A. Ostrov</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William+G.++Cance">William G. Cance</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, New York 14263</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Surgery</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Department of Pathology</span></div><div class="aff-info" id="ufl"><span class="aff-text">Immunology and Laboratory Medicine, University of Florida, College of Medicine, Gainesville, Florida 32610</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: 716-845-8204. Fax: 716-845-3434. E-mail: <a href="/cdn-cgi/l/email-protection#b6e1dfdadadfd7db98f5d7d8d5d3f6c4d9c5c1d3dadac6d7c4dd98d9c4d1"><span class="__cf_email__" data-cfemail="cd9aa4a1a1a4aca0e38eaca3aea88dbfa2bebaa8a1a1bdacbfa6e3a2bfaa">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm900159g&amp;href=/doi/10.1021%2Fjm900159g" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2009</span></span><span class="cit-volume">, 52</span><span class="cit-issue">, 15</span><span class="cit-pageRange">, 4716–4724</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 17, 2009</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>6 February 2009</li><li><span class="item_label"><b>Published</b> online</span>17 July 2009</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 August 2009</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm900159g" title="DOI URL">https://doi.org/10.1021/jm900159g</a></div><div class="article_header-article-copyright"><strong>Copyright © 2009 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4716%26pageCount%3D9%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DElena%2BV.%2BKurenova%252C%2BDarell%2BL.%2BHunt%252C%2BDihua%2BHe%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D52%26issueNum%3D15%26contentID%3Djm900159g%26title%3DSmall%2BMolecule%2BChloropyramine%2BHydrochloride%2B%2528C4%2529%2BTargets%2Bthe%2BBinding%2BSite%2Bof%2BFocal%2BAdhesion%2BKinase%2Band%2BVascular%2BEndothelial%2BGrowth%2BFactor%2BReceptor%2B3%2Band%2BSuppresses%2BBreast%2BCancer%2BGrowth%2Bin%2BVivo%26numPages%3D9%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4724%26publicationDate%3DAugust%2B2009">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm900159g"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2051</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">43</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm900159g" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Small Molecule Chloropyramine Hydrochloride (C4) Targets the Binding Site of Focal Adhesion Kinase and Vascular Endothelial Growth Factor Receptor 3 and Suppresses Breast Cancer Growth in Vivo&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Elena&quot;,&quot;last_name&quot;:&quot;V. Kurenova&quot;},{&quot;first_name&quot;:&quot;Darell&quot;,&quot;last_name&quot;:&quot;L. Hunt&quot;},{&quot;first_name&quot;:&quot;Dihua&quot;,&quot;last_name&quot;:&quot;He&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;T. Magis&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;A. Ostrov&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;G. Cance&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2009&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;17&quot;,&quot;issue&quot;:&quot;15&quot;,&quot;volume&quot;:&quot;52&quot;,&quot;pages&quot;:&quot;4716-4724&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm900159g&quot;},&quot;abstract&quot;:&quot;FAK is a tyrosine kinase that functions as a key orchestrator of signals leading to invasion and metastasis. Since FAK interacts directly with a number of critical proteins involved in survival signaling in tumor cells, we hypothesized that targeting a key protein−protein interface with druglike small molecules was a feasible strategy for inhibiting tumor growth. In this study, we targeted the protein−protein interface between FAK and VEGFR-3 and identified compound C4 (chloropyramine hydrochloride) as a drug capable of (1) inhibiting the biochemical function of VEGFR-3 and FAK, (2) inhibiting proliferation of a diverse set of cancer cell types in vitro, and (3) reducing tumor growth in vivo. Chloropyramine hydrochloride reduced tumor growth as a single agent, while concomitant administration with doxorubicin had a pronounced synergistic effect. Our data demonstrate that the FAK−VEGFR-3 interaction can be targeted by small druglike molecules and this interaction can provide the basis for highly specific novel&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900159g&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900159g" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900159g&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900159g" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900159g&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900159g" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm900159g&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900159g&amp;href=/doi/10.1021/jm900159g" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm900159g" /></input><a href="/doi/pdf/10.1021/jm900159g" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm900159g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm900159g%26sid%3Dliteratum%253Aachs%26pmid%3D19610651%26genre%3Darticle%26aulast%3DKurenova%26date%3D2009%26atitle%3DSmall%2BMolecule%2BChloropyramine%2BHydrochloride%2B%2528C4%2529%2BTargets%2Bthe%2BBinding%2BSite%2Bof%2BFocal%2BAdhesion%2BKinase%2Band%2BVascular%2BEndothelial%2BGrowth%2BFactor%2BReceptor%2B3%2Band%2BSuppresses%2BBreast%2BCancer%2BGrowth%2Bin%2BVivo%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D52%26issue%3D15%26spage%3D4716%26epage%3D4724%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292276" title="Small molecules">Small molecules</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=290682" title="Post-translational modification">Post-translational modification</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/52/15" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/medium/jm-2009-00159g_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/large/jm-2009-00159g_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900159g&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">FAK is a tyrosine kinase that functions as a key orchestrator of signals leading to invasion and metastasis. Since FAK interacts directly with a number of critical proteins involved in survival signaling in tumor cells, we hypothesized that targeting a key protein−protein interface with druglike small molecules was a feasible strategy for inhibiting tumor growth. In this study, we targeted the protein−protein interface between FAK and VEGFR-3 and identified compound C4 (chloropyramine hydrochloride) as a drug capable of (1) inhibiting the biochemical function of VEGFR-3 and FAK, (2) inhibiting proliferation of a diverse set of cancer cell types in vitro, and (3) reducing tumor growth in vivo. Chloropyramine hydrochloride reduced tumor growth as a single agent, while concomitant administration with doxorubicin had a pronounced synergistic effect. Our data demonstrate that the FAK−VEGFR-3 interaction can be targeted by small druglike molecules and this interaction can provide the basis for highly specific novel cancer therapeutics.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85064" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85064" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Tumor cell survival requires that tumor cells acquire the ability to survive the apoptotic stimuli associated with invasion and metastasis. Focal adhesion kinase (FAK<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a>) <div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: FAK, focal adhesion kinase; FAT, focal adhesion targeting domain; VEGFR-3, vascular endothelial growth factor receptor 3; ECM, extracellular matrix; MTS, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2<i>H</i>-tetrazolium.</p></div> and vascular endothelial growth factor receptor 3 (VEGFR-3) are tyrosine kinases that have been identified as critical signaling molecules for these host−tumor interactions.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> FAK is a protein tyrosine kinase that is localized at contact points between cells and extracellular matrix (ECM) and is a point of convergence of a number of signaling pathways associated with cell adhesion, invasion, motility, and angiogenesis.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3-5)</a> This signaling requires both FAK kinase activity and its ability to form multiple protein complexes.<a onclick="showRef(event, 'ref6 ref7 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8 ref9 ref10">(6-10)</a> Targeting of FAK by anti-FAK antibody,<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> FAK dominant negative FAK-CD,<a onclick="showRef(event, 'ref9 ref13'); return false;" href="javascript:void(0);" class="ref ref9 ref13">(9, 13)</a> antisense oligonucleotides,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> or siRNA<a onclick="showRef(event, 'ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17">(15-17)</a> results in cell rounding, detachment, and apoptosis. FAK is emerging as an attractive target for the treatment of cancer because it has been shown that FAK is up-regulated in a broad range of solid tumors and is expressed at very low levels in normal tissues, creating an optimal setting for FAK-targeted cancer therapeutics.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> Indeed, control of FAK signaling has been suggested as a potential anticancer therapy<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20, 21)</a> and several FAK kinase inhibitors recently have been developed.<a onclick="showRef(event, 'ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24">(22-24)</a></div><div class="NLM_p">VEGFR-3 or Flt4 is a receptor tyrosine kinase playing a major role in lymphangiogenesis, angiogenesis and has also been linked to tumorigenesis.<a onclick="showRef(event, 'ref2 ref25'); return false;" href="javascript:void(0);" class="ref ref2 ref25">(2, 25)</a> VEGFR-3 is activated by its specific ligands, VEGF-C and VEGF-D, which promote cancer progression.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The VEGF-C/VEGFR-3 axis is expressed in a variety of human tumor cells, and its activation has been shown to promote metastasis.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Importantly, it has been shown that inhibition of VEGFR-3 signaling leads to both regression of the lymphatic network and suppression of tumor lymph node metastasis.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> VEGFR-3 is up-regulated in the microvasculature of tumors and wounds,<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a> and recently, blocking VEGFR-3 has been shown to suppress angiogenic sprouting in tumors.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> While there is some controversy regarding the levels of expression of VEGFR-3 in tumor cells,<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a> VEGFR-3 remains an attractive target for cancer therapy.</div><div class="NLM_p last">Previously we have shown that VEGFR-3 and FAK physically interact in cancer cells, and this provides a survival advantage for the tumor cells.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Thus, we have sought to develop novel molecular therapeutics by targeting the VEGFR-3−FAK site of interaction and disrupting their survival function. In the current study we utilized the crystal structure of the FAK focal adhesion targeting (FAT) domain for molecular docking of small molecules that target the VEGFR-3 binding site on FAK. We identified a small molecule compound C4<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a>(chloropyramine hydrochloride, a histamine receptor H1 antagonist, <b>1</b>) that disrupted VEGFR-3−FAK binding and abrogated the phosphorylation of VEGFR-3 while reducing the phosphorylation of FAK. In vitro testing of this compound resulted in the selective growth inhibition and induction of apoptosis in many cancer cell lines, especially those that overexpressed VEGFR-3. In vivo, <b>1</b> showed a marked reduction of tumor growth and was synergistic with doxorubicin chemotherapy in breast cancer xenograft models. These results have demonstrated that targeting the FAK−VEGFR-3 interaction with a small molecule compound can disrupt the survival function of these two tyrosine kinases, representing a unique approach for molecular-targeted cancer therapeutics.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51653" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51653" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Structure-Based Development of Small Molecules That Targeted the Binding of FAK and VEGFR-3</h3><div class="NLM_p">We previously demonstrated binding of the 12 amino acid peptide of VEGFR-3 to the C-terminal, focal adhesion targeting (FAT) domain of FAK.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Nuclear magnetic resonance analysis (NMR) of the FAT/VEGFR-3 peptide complex localized chemical shift of residue histidine 1025 on the FAT domain (Prutzman and Campbell, unpublished data), so we hypothesized that a small molecule binding to this site could disrupt the FAK−VEGFR-3 interaction. Therefore, we used the crystal structure of the FAT domain of FAK<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> to dock small molecules from the NCI/DTP database to the binding region in silico (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A,B). We selected compounds with the highest binding affinities to FAK for functional testing and selected compound <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B, C) for its profound inhibitory effect on cell growth. Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B illustrates the binding mode of <b>1</b> with the FAK FAT domain. In a panel of breast, colon, lung, osteosarcoma, melanoma, and pancreas cancer cells, the IC<sub>50</sub> of <b>1</b> varied between 1 and 20 μΜ (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>D). Because <b>1</b> was an orally bioavailable antihistamine that inhibited cell survival, we selected it for further mechanistic analyses, focusing on human breast cancer.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/medium/jm-2009-00159g_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/large/jm-2009-00159g_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure-based development of small molecules that targeted the binding of FAK and VEGFR-3. (A) Site selection for high throughout virtual screening of druglike compounds to develop small molecule FAK inhibitors. The crystal structure of the focal adhesion targeting (FAT) domain of FAK was obtained from the Protein Data Bank (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1K04">1K04</a>) and prepared for computational docking. The 140 000 small molecules from the NCI’s Development Therapeutics Program were each positioned in the structural pocket and scored for electrostatic and van der Waals interactions as implemented in DOCKv5.2 package9 (UCSF). The crystal structure is shown in cyan and salmon, and residues that undergo shifts upon peptide binding in NMR studies are shown in magenta. The catalytic tyrosine is shown in green. Red spheres indicate the site defined by the program SPHGEN (UCSF) with chemical and geometric features appropriate for specific small molecule binding. Gray bars demarcate the scoring grid utilized to calculate interactions between potential ligands and the targeted structural pocket. (B) Predicted binding site of <b>1</b> to focal adhesion targeting domain of FAK. Histidine 1025 shown in magenta with surrounding residues. Black dashed lines indicate hydrogen bonds between proline 906 and <b>1</b> N2, aspartic acid 1030 hydroxyl group and <b>1</b> N1, and also hydroxyl group of threonin1022 and Cl of <b>1</b>. (C) Compound <b>1</b> (chlorpyramin hydrochloride) structure. (D) <b>1</b> treatment decreased the viability of a diverse set of cancer cell types. MTS assay was performed on selected cell lines. Cells were treated with the increased concentration of <b>1</b> for 72 h and analyzed with Cell Titer Proliferation Assay. Error bars represent ± SEM, <i>P < </i>0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/large/jm-2009-00159g_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900159g&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> <b>1</b> specifically decreased the viability and proliferation and caused apoptosis in breast cancer cells that expressed VEGFR-3</h3><div class="NLM_p">To further characterize small molecule <b>1</b> and its specificity, we used two model systems of breast cancer: BT474 breast cancer cells with high endogenous expression of VEGFR-3 that we previously used to assess the FAK−VEGFR-3 interaction<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and MCF7 breast cancer cells with undetectable endogenous VEGFR-3 expression that were engineered to overexpress VEGFR-3 (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Figure S1). Cells were treated with increasing concentrations of <b>1</b>, and viability was measured with MTS assay. BT474 cells were highly sensitive to <b>1</b> treatment, whereby 1 μM concentration caused a 40% reduction of viability after 48 h of treatment (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A). In addition, we found that the effect of <b>1</b> was more pronounced in the BT474 breast cancer cells compared to MCF10A “normal” breast epithelial cells (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Figure S2A). Next, we tested the specificity of small molecule <b>1</b> in the MCF7−VEGFR-3 overexpressing cells. We found that at 1 μM concentration of <b>1</b>, viability of control MCF7−pcDNA3 cells was significantly higher than the viability of MCF7−VEGFR-3 cells (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A, <i>P</i> < 0.01) and at 10 μM concentration this difference reached 2-fold (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A, <i>P</i> < 0.001). This demonstrated that cells expressing low levels of VEGFR-3 were less sensitive to <b>1</b> inhibition than those that overexpressed this protein. Taken together, these data suggested that <b>1</b> specifically inhibited the viability of cells overexpressing VEGFR-3.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/medium/jm-2009-00159g_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/large/jm-2009-00159g_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. <b>1</b> specifically decreased the viability and proliferation and caused apoptosis in breast cancer cells that expressed VEGFR-3. BT474 breast cancer cells with endogenous high VEGFR-3 expression and stable clones of MCF7 breast cancer cells with undetectable VEGFR-3 expression, transfected with either control vector pcDNA3 or VEGFR-3, were treated with the marked concentration of <b>1</b>. (A) <b>1</b> caused a dose-dependent cytotoxicity of VEGFR-3 expressing cells. The viability was measured in MTS assays after 48 h of treatment: (∗) <i>P</i> < 0.01; (∗∗) <i>P</i> < 0.001. (B) <b>1</b> caused a dose-dependent and a time-dependent decrease in proliferation of VEGFR-3 expressing cells: BrdU incorporation assay, (∗) <i>P</i> < 0.05, (∗∗) <i>P</i> < 0.001. (C) <b>1</b> treatment caused dose-dependent apoptosis, and proapoptotic effect of <b>1</b> is specific for cells expressing VEGFR3: TUNEL assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/large/jm-2009-00159g_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900159g&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Proliferation assays have shown similar results. MCF7−pcDNA control cells did not show any decrease in proliferation even after 48 h of treatment with 10 μM <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B, gray bars). In contrast, MCF7−VEGFR-3 cells not only proliferated much more quickly than vector controls but were also sensitive to <b>1</b> treatment. In these VEGFR-3-overexpressing cells, a similar concentration of <b>1</b> for 48 h reduced proliferation approximately 50%, demonstrating that the antiproliferative effect of <b>1</b> is VEGFR-3 specific (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B). We also confirmed that proliferation of normal MCF10A cells was not affected by small molecule <b>1</b> (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Figure S2B). Similarly, in the BT474 cells, treatment with <b>1</b> also led to a concentration-dependent decrease of cell proliferation (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B). We also found that there was no significant increase in BrdU incorporation in these cells exposed to 10 μM <b>1</b> for more than 12 h. We concluded that 10 μM <b>1</b> had a cytostatic effect on BT474 cells that might lead to apoptosis at later time points.</div><div class="NLM_p last">When treatment with <b>1</b> was continued for 48 h, the breast cancer cells that overexpressed VEGFR-3 underwent apoptosis. This effect was dose-dependent, with 10 μM <b>1</b> inducing apoptosis in more than 60% of BT474 cells (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>C). Furthermore, we found that apoptosis caused by <b>1</b> was related to the level of VEGFR-3 expression. In our model cell lines MCF7−pcDNA3 and MCF7−VEGFR-3, treatment with 10 μM <b>1</b> for 48 h led to a 4-fold increase in apoptotic cell death in the cell line that overexpressed VEGFR-3 (18% versus 76%, respectively) (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>C). We confirmed these results biochemically by measuring the cleavage of PARP and the activation of caspase 8 (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Figure S3). From these experiments, we concluded that <b>1</b> caused VEGFR-3-dependent apoptosis in breast cancer cells.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> <b>1</b> disrupted the FAK−VEGFR-3 complex</h3><div class="NLM_p">To determine the effects of <b>1</b> on the interaction of FAK and VEGFR-3, we analyzed the distribution of FAK and VEGFR-3 in the BT474 and MCF7−VEGFR-3 cells after treatment. As a control, we also tested a different focal adhesion protein, paxillin that bound to the FAT domain close to the VEGFR-3 binding site. Cells were dually immunostained for FAK in combination with either VEGFR-3 or paxillin, and confocal microscopy was used to calculate the degree of colocalization by scatter plot analysis. In untreated cells, stained for FAK and paxillin, we found that approximately 80% of the FAK and paxillin molecules were colocalized in BT474 cells and positioned predominantly in focal adhesions (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B, panels a, b, e). Similarly, the colocalization of VEGFR-3 with FAK was also high in untreated cells, with a rate of 80% for BT474 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A, panels a, b, e) and 50% for MCF7−VEGFR-3 cells (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>C, panels a, b, e), and occurring predominantly in the cytoplasm, as we have shown previously.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> When BT474 cells were treated with <b>1</b>, the FAK−paxillin localization was not affected (80% nontreated vs 76% treated, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B, panels c, d, e). In contrast, <b>1</b> treatment dramatically decreased the colocalization of FAK and VEGFR-3 in the cytoplasm of both BT474 and MCF7−VEGFR-3 cells, reducing it to 45% and 29% respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>C, panels c, d, e). This drop in colocalized FAK and VEGFR-3 molecules correlated with intracellular redistribution of these proteins after <b>1</b> treatment, revealed by confocal microscopy and 3D reconstruction of the confocal images. <b>1</b> treatment led to redistribution of FAK and VEGFR-3 inside the cells but did not affect the localization of paxillin (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Figure S4). We confirmed this effect on multiple samples of BT474 and MCF7−VEGFR-3 cells and with different FAK and VEGFR-3 antibody (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Figure S5A,B).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/medium/jm-2009-00159g_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/large/jm-2009-00159g_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. <b>1</b> treatment affected colocalization and led to redistribution and decrease of FAK−VEGFR-3 complexes. Cells were treated with DMSO (CTL, all panels a and b) or 10 μM <b>1</b> (all panels c and d) for 24 h, immunostained for FAK (green, Alexa Fluor 488) in combination with VEGFR-3 or paxillin (red, Alexa Fluor 546). Colocalization in treated and untreated cells was assessed by confocal microscopy and scatter plot analysis (e). (A) Treatment with small molecule <b>1</b> caused decrease in colocalization of FAK and VEGFR-3 in BT474 cells: (a) merged image, control cells; (b) colocalization, control cells; (c) merged image, <b>1</b> treated cells; (d) colocalization, <b>1</b> treated cells; (e) percentage of colocalized FAK and VEGFR-3 molecules in control and <b>1</b> treated cells. (B) FAK−paxillin complexes were not affected by treatment with small molecule <b>1</b>. (a−e) Percentage of colocalized FAK and paxillin molecules in control and <b>1</b> treated BT474 cells. (C) <b>1</b> caused decrease in colocalization of VEGFR-3 and FAK in MCF7 cells that overexpressed VEGFR-3. (a−e) Percentage of colocalized FAK and VEGFR-3 molecules in control and <b>1</b> treated MCF7−VEGFR-3 cells. (D) <b>1</b> disrupted binding of the FAK and VEGFR-3 proteins. Immunoprecipitation with VEGFR-3 antibody after treatment for 24 h with increasing concentrations of compound <b>1</b> revealed a decreased amount of FAK protein coprecipitated with VEGFR-3.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/large/jm-2009-00159g_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900159g&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Next, we used immunoprecipitation to confirm that <b>1</b> disrupted FAK and VEGFR-3 binding. BT474 cells were treated with an increasing concentration of <b>1</b>, and the proteins were coprecipitated with VEGFR-3 antibody. We found that treatment with 10 μM <b>1</b> for 24 h dramatically decreased the amount of FAK−VEGFR-3 associated molecules (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>D). Thus, small molecule <b>1</b> specifically targeted the FAK−VEGFR-3 interaction and disrupted the binding of these proteins in the breast cancer cells.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> <b>1</b> caused dose-dependent dephosphorylation of both VEGFR-3 and FAK</h3><div class="NLM_p">To further characterize the biochemical effects of <b>1</b> on VEGFR-3 and FAK, we treated cells with different concentrations of <b>1</b> and analyzed for the phosphorylation of Tyr1063/1068 in the activation loop of the VEGFR-3 kinase domain. We found that a 24 h treatment with 1 μM <b>1</b> caused a partial dephosphorylation of this site and 10 μM completely dephosphorylated this activation site of VEGFR-3 (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A,B). This effect was dose and time dependent and appeared to be specific for VEGFR-3 because it did not affect phosphorylation of other tyrosine kinases including Src, EGFR, PDGFR, and IGF-1R (data not shown). At the same time this effect was <b>1</b>-specific, as other small molecules, selected for the FAK−VEGFR-3 binding site, did not affect VEGFR-3 phosphorylation (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Figure S3C). Next, we assessed changes in the total phosphorylation of FAK. We found that 10 μM <b>1</b> treatment for 24 h decreased total FAK phosphorylation in both model cell lines (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>C,D). Taken together, these results show that <b>1</b> reduces the phosphorylation of both VEGFR-3 and FAK. Since dephosphorylation of FAK has been shown to result in disruption of FAK from its position in the focal adhesions and lead to apoptosis,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> these biochemical results are consistent with our findings that <b>1</b> treatment caused apoptosis in the tumor cells.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/medium/jm-2009-00159g_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/large/jm-2009-00159g_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. <b>1</b> treatment caused dose-dependent dephosphorylation of VEGFR-3 and decreased phosphorylation of FAK. (A, B) Western blot analysis of MCF7−VEGFR-3 breast cancer cells and BT474 breast cancer cells after 24 h of treatment with increasing doses of <b>1</b>. VEGFR-3 phosphorylation was analyzed. (C, D) Immunoprecipitation of FAK and Western blot analysis with antiphosphotyrosine antibody 4G10 of MCF7−VEGFR-3 and BT474 cells treated for 24 h with 10 μM or 1 μM <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/large/jm-2009-00159g_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900159g&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> <b>1</b> decreased tumor growth in vivo and sensitized the tumors to chemotherapy</h3><div class="NLM_p">To further validate the activity of small molecule <b>1</b>, we employed a tumor xenograft mouse model. Female nude mice were subcutaneously inoculated with either the BT474 breast cancer cells or the MCF7 breast cancer cells that stably overexpressed VEGFR-3. Treatment with small molecule <b>1</b> (60 mg/kg) was started the day after injection of the cells and given for a total of 21 days. <b>1</b> caused a dramatic reduction of tumor growth in both model systems whereby the tumor size in the treated groups was approximately 20% of the tumor size in vehicle control groups (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Figure S6A,B). Similarly, the weights of the tumors in the treated group were approximately 4 times less than in the untreated groups (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Figure S6C). These results demonstrated significant in vivo efficacy of <b>1</b>.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/medium/jm-2009-00159g_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/large/jm-2009-00159g_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. <b>1</b> reduced tumor growth in mouse xenograft models. BT474 (A) or MCF7−VEGFR-3 (B) cells were inoculated into mice subcutaneously. Treatment with 60 mg/kg <b>1</b> or vehicle (PBS) was started the day after cell inoculation. Mice were sacrificed 21 days later, and tumors were measured for size and weight (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Figure S6). BT474 and MCF7−VEGFR-3 <b>1</b>-treated tumor volumes were significantly smaller than vehicle treated tumors after day 14: (∗) <i>P</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/large/jm-2009-00159g_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900159g&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We also compared <b>1</b> with a different histamine receptor H1 antagonist <b>2</b> (diphenhydramine) and found that it did not have any effect on tumor growth when <b>1</b> reduced tumor growth more than 75% (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>A). Thus, we concluded that the antitumor efficacy of <b>1</b> is not related to its antihistamine properties.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/medium/jm-2009-00159g_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/large/jm-2009-00159g_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. The <b>1</b> antitumor effect is not related to its antihistamine properties, and it sensitizes tumors to chemotherapy treatment with doxorubicin at low concentration. (A) MCF7−VEGFR-3 cells were inoculated into mice subcutaneously. Treatment with 60 mg/kg <b>1</b>, 30 mg/kg <b>2</b> (diphenhydramine), or vehicle (PBS) daily was started the next day. (B) BT474 cells were inoculated into mice subcutaneously. Treatment with 10 mg/kg <b>1</b> daily or doxorubicin 0.3 mg/kg weekly or the combination of both drugs was started the next day after cell inoculation. Experiments were terminated after 14 days when tumor size of single treatment reached protocol end point. Statistically significant difference (∗, <i>P</i> < 0.01) with vehicle treated tumors was seen from day 9.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/large/jm-2009-00159g_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900159g&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Next, we tested the efficacy of the combination of <b>1</b> with standard chemotherapy for breast cancer, because our in vitro experiments have shown that <b>1</b> sensitized breast cancer cells to doxorubicin treatment (data not shown). We tested this combination approach in vivo by concomitant administration of lower dose <b>1</b> (10 mg/kg daily) and low-dose of doxorubicin (0.3 mg/kg/week) in mice bearing BT474 xenografts. Doxorubicin administered at 3 mg/kg caused approximately 60% reduction of tumor growth but had no effect on tumor growth at 0.3 mg/kg (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>B, triangles). In contrast, there was a modest effect of <b>1</b> alone (50% reduction of tumor growth, Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>B, rectangles). However, the low-dose combination of <b>1</b> and doxorubicin had a prolonged antitumor effect (85% reduction of tumor growth) that was greater than either drug alone (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>B, dots). These data demonstrated a synergistic effect of the combination of <b>1</b> with standard chemotherapy for breast cancer.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05381" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05381" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In this report, we have demonstrated a unique approach to cancer treatment by inhibiting FAK and VEGFR-3 through targeting the site of their protein−protein interaction. This study has demonstrated that we can inhibit the function of these tyrosine kinases by targeting their binding site. Moreover, our computational approach for molecular docking has identified a small molecule that not only decreased activity of both VEGFR-3 and FAK but had antitumor effects that were synergistic with chemotherapy in vivo.</div><div class="NLM_p">We selected the VEGFR-3 binding site on the FAT domain of FAK as a template for our in silico studies because of the importance of both of these kinases in cancer cell survival and tumor progression. We virtually docked potential small molecules and identified compound <b>1</b> (chloropyramine hydrochloride). It was functionally equivalent to the FAK-inhibiting peptide from the VEGFR-3,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> decreased cell proliferation, and caused apoptosis in breast cancer cells. To prove that this small molecule affects interaction of VEGFR-3 with FAK, we analyzed FAK−VEGFR-3 colocalization and coprecipitation in immunohistochemical and biochemical experiments. We have shown that treatment with <b>1</b> decreased colocalization and FAK−VEGFR-3 complex formation. Thus, in silico modeling demonstrated that peptide binding sites of FAK are appropriate targets for non-peptide small druglike molecule binding.</div><div class="NLM_p">Studies with peptide inhibitors already have indicated that blockade of specific protein−protein interactions have therapeutic promise for treating a variety of human cancers.<a onclick="showRef(event, 'ref35 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37">(35-37)</a> The major advantage of protein−protein inhibitors is their high selectivity. For example, the nutlins inhibitors of the p53-MDM2 interaction activated apoptosis in cells expressing wild-type p53 and showed a 10- to 20-fold selectivity for cells with active versus mutated p53.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> In the present study, targeting the site of FAK−VEGFR-3 protein−protein interaction represents a novel approach to targeting tyrosine kinases that can potentially be used to disrupt their “interactome” and inhibit specific downstream signaling. Until now, the main approach to target FAK was to inhibit the catalytic activity of the tyrosine kinase by interfering with the binding of ATP. Three such inhibitors have been reported by Novartis<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and Pfizer.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a> All of them inhibit FAK kinase activity but have varying degrees of cross-reactivity with other tyrosine kinases.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Similarly, the only known inhibitor for VEGFR-3 is MAZ-51, which suppressed mammary tumor growth in rats,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> but not having a broad clinical utility. Clinically, broad range tyrosine kinase inhibitors are being used to target the VEGFR family in addition to other receptor tyrosine kinases with varying degrees of success.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> In this study, we have shown the specificity of <b>1</b> for FAK and VEGFR-3 whereby it changed the phosphorylation and activation status of VEGFR-3 and FAK by disrupting their interaction and did not have a demonstrable effect on the activity of other receptor and nonreceptor protein kinases.</div><div class="NLM_p">The small molecule <b>1</b> that targeted the FAK−VEGFR-3 binding site was chloropyramine hydrochloride, belonging to the class of antagonists of histamine receptor H1. This small molecule was analyzed in mouse ascites tumor experiments of Honti and Puntoky over 40 years ago<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> when the hypothesis that histamine might be involved in carcinogenesis was proposed,<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> but the results were inconclusive. In our experiments, we have shown a unique biological specificity of this drug for the FAK−VEGFR-3 interaction. In our breast cancer xenograft models, we have shown that treatment with <b>1</b> reduced tumor burden more than 80%, and this effect was not related to its antihistamine properties when compared to the histamine blocker <b>2</b>.</div><div class="NLM_p">One of the most significant aspects of our findings relates to the ability of <b>1</b> to sensitize breast cancer cells to chemotherapy. When <b>1</b> was administered with the standard chemotherapeutic for breast cancer, doxorubicin, we saw a pronounced synergistic effect, and this effect was still significant when we reduced the dose of both drugs. Because FAK is a survival signal and has been directly implicated in chemoresistance,<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> we hypothesize that the decreased phosphorylation of FAK and VEGFR-3 caused by <b>1</b> results in a greater sensitivity of the cancer cells to chemotherapy.</div><div class="NLM_p last">In summary, our data suggest that the FAK−VEGFR-3 protein−protein interaction is an excellent site to develop small molecule inhibitors to provide the basis for highly specific novel cancer therapeutic agents. When this interaction is targeted, survival signaling in the tumors can be interrupted, and this may provide a useful method of augmenting the effects of chemotherapy in breast cancer.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47052" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47052" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Virtual Screening</h3><div class="NLM_p last">The DOCKv5.2 package9 was used for in silico screening of approximately 140 000 compounds available from the National Cancer Institute Developmental Therapeutics Program. This small molecule database was prepared with the DOCK accessory software SF2MOL2 (University of California—San Francisco) and Sybyl (Tripos, Inc.) as described previously.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> The crystal structure for focal adhesion kinase (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1K04">1K04</a><a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a>) was obtained from the Protein Data Bank. All heteroatoms and water molecules were removed, and a single chain was isolated in the coordinate file. The program DMS was used to generate a molecular surface.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> SPHGEN was used to generate spheres on the surface of the protein, and a subset of these spheres within 5 Å of the target pocket was selected to constrain the search space (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A). Molecular mechanics force field grids were generated using the program GRID, using the standard 6−12 Lennard-Jones function to approximate the van der Waals forces. Finally, DOCK 5.2 was executed using the prepared files and the small molecule database. Each compound was docked as a rigid body in up to 100 different orientations. The orientations were filtered by default bump filter parameters to exclude compounds with pronounced steric clashes. The top compounds predicted to interact with the target site were subsequently obtained from the National Cancer Institute.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Cell Lines</h3><div class="NLM_p last">MCF7, MDA-MB-231, T47D, A549, SAOS-2, A375, C8161, PANC1, MiaPaCa-2, HT29, and Colo205 cells were purchased from ATCC (Rockville, MD). The BT474 cells are a subclone of the original cell line that does not express the receptor tyrosine kinase Her-2/neu. BT474 cells were maintained in RPMI-1640 with 10% fetal bovine serum and insulin, 250 μg/mL. MCF7−pcDNA3 and MCF7−VEGFR-3 stable clones of the MCF7 breast cancer cell line were produced as described (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Figure S1). All cells are maintained in correspondence with ATCC recommendations.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Antibodies and Reagents</h3><div class="NLM_p">Antihuman VEGFR-3 antibodies were purchased from Chemicon (MAB3757, clone 9D9F9, Temecula, CA) and from Santa Cruz Biotechnology (sc-321), phospho-specific VEGFR-3 antibody (pc460) was from Calbiochem (San Diego, CA), FAK antibody 4.47 was from Upstate and sc-558 from Santa Cruz Biotechnology, phospho-specific Y-397 antibody MAB1144 was from Chemicon, and phosphotyrosine specific antibody 4G10 (no. 05-321) was from Upstate. The following were from Cell Signaling Technology (Danvers, MA): procaspase-8 (no. 9746), Erk 1,2 (no. 9102), p-Erk (no. 4377S), Akt (no. 9272), p-Akt (no. 9271), PARP (no. 9542), and paxillin antibody no. 610051 from BD Biosciences.</div><div class="NLM_p last">Compound <b>1</b> was obtained as chlorpyramin hydrochloride (Sigma, no. 1915), solution for injection 20 mg/mL (EGIS, Hungary), 60 μL/injection, 60 mg/kg. Also obtained was diphenhydramine (solution for injections 10 mg/mL), 60 μL/injection, 30 mg/kg. Doxorubicin hydrochloride injection, USP, is a sterile, isotonic solution, 2 mg/mL, and was used as 30 μL/injection, 3 mg/kg, and 10× dilution, 0.2 mg/mL, 30 μL/injection, 0.3 mg/kg. All chemicals were of the highest purity commercially available.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Immunocytochemistry</h3><div class="NLM_p last">Cells were incubated in presence or absence of <b>1</b> and stained with anti-FAK antibody 4.47 or in combination with paxillin or VEGFR-3 as previously described<a onclick="showRef(event, 'ref7 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref9">(7, 9)</a> and described in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. Detection was done with Alexa Fluor 546 secondary antibody, and for dual staining the combination of Alexa Fluor 488 and Alexa Fluor 546 secondary antibody were used (Invitrogen, Carlsbad, CA). The slides were observed on a Leica confocal microscope (Leica TCS SP5) running Leica LAS-AF software for instrument control and image analysis.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Assays of Cell Viability</h3><div class="NLM_p">Cell survival was assayed in MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2<i>H</i>-tetrazolium) assay by measuring mitochondrial dehydrogenase activity of metabolically active cells with Cell Titer 96 AQueous One Solution Cell Proliferation Assay (Promega, Madison, WI). The 5.0 × 10<sup>3</sup> (100 μL) cells were plated in 96-well plates and were allowed to attach overnight. Then 100 μL of fresh medium with or without <b>1</b> was added to each well. Cells were treated for the designated amount of time. MTS assay was performed according to the manufacturer's protocol.</div><div class="NLM_p last">Detection of apoptosis was performed by TUNEL assay with the APO-DIRECT kit (Pharmingen, BD Biosciences, San Diego, CA) according to the manufacturer’s recommendations and analyzed by flow cytometry. Quantitative analysis of apoptosis was performed using the FlowJo program (Tree Star, Ashland, OR).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Immunoprecipitation and Western Blot Analysis</h3><div class="NLM_p last">Appropriately treated or nontreated cells were allowed to grow until they were 80−85% confluent or until treatment was completed. Cells were lysed and used for Western blot or immunoprecipitation as previously described.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> BrdU Incorporation Assay</h3><div class="NLM_p last">BrdU incorporation was performed using BrdU Cell Proliferation Assay, HTS (Calbiochem, San Diego, CA). The 2.5 × 10<sup>3</sup> cells were plated into a 96-well plate and allowed to attach overnight. Then 100 μL of fresh growth medium or growth medium with treatment was added to each well followed by 20 μL of BrdU labeling. Cells were incubated for the appropriate time and treated according to the manufacturer’s protocol.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Animal Models</h3><div class="NLM_p last">BT474 and MCF7−VEGFR-3 cells at a concentration of (2−5) × 10<sup>6</sup> cells per 200 μL were subcutaneously injected into the right flank of the 5−6 week old hsd:athymic nude-<i>foxn1nu</i> mice (Harlan), five in each group, in accordance with the University of Florida IACUC approved protocol. Treatment with compound <b>1</b> was started the next day after cell injection via intraperitoneal injection (ip) once a day. Tumor size was measured thrice weekly, and volume was calculated using the formula length × width<sup>2</sup> × 0.5. Animals were sacrificed after 21 days of treatment or when tumor size reached protocol end point. Tumor was excised, measured and preserved for protein and RNA preparation and cytochemistry.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Statistical Analysis</h3><div class="NLM_p last">Data are represented as the mean ± SEM of three or more independent experiments. For in vitro and in vivo experiments comparison between groups were made using a two-tailed two-sample Student’s <i>t</i> test. Differences for which the <i>P</i> value was less than 0.05 were considered statistically significant.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20"><a href="/doi/suppl/10.1021/jm900159g">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06630" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06630" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Experimental procedures and additional biochemical evaluation of compound <b>1</b> effect in vitro and in vivo. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm900159g/suppl_file/jm900159g_si_001.pdf">jm900159g_si_001.pdf (1.69 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm900159g" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87128" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87128" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William G. Cance</span> - <span class="hlFld-Affiliation affiliation">Department of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, New York 14263</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#cd9aa4a1a1a4aca0e38eaca3aea88dbfa2bebaa8a1a1bdacbfa6e3a2bfaa"><span class="__cf_email__" data-cfemail="aff8c6c3c3c6cec281eccec1cccaefddc0dcd8cac3c3dfceddc481c0ddc8">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elena V. Kurenova</span> - <span class="hlFld-Affiliation affiliation">Department of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, New York 14263</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Darell L. Hunt</span> - <span class="hlFld-Affiliation affiliation">Department of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, New York 14263</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Surgery</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Pathology</span>; 
    <span class="hlFld-Affiliation affiliation">Immunology and Laboratory Medicine, University of Florida, College of Medicine, Gainesville, Florida 32610</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dihua He</span> - <span class="hlFld-Affiliation affiliation">Department of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, New York 14263</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Surgery</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Pathology</span>; 
    <span class="hlFld-Affiliation affiliation">Immunology and Laboratory Medicine, University of Florida, College of Medicine, Gainesville, Florida 32610</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew T. Magis</span> - <span class="hlFld-Affiliation affiliation">Department of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, New York 14263</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Surgery</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Pathology</span>; 
    <span class="hlFld-Affiliation affiliation">Immunology and Laboratory Medicine, University of Florida, College of Medicine, Gainesville, Florida 32610</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David A. Ostrov</span> - <span class="hlFld-Affiliation affiliation">Department of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, New York 14263</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Surgery</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Pathology</span>; 
    <span class="hlFld-Affiliation affiliation">Immunology and Laboratory Medicine, University of Florida, College of Medicine, Gainesville, Florida 32610</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01353" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01353" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank members of the Flow Cytometry Core Laboratory at the Interdisciplinary Center for Biotechnology Research, University of Florida, and especially Steve McClellan, for technical assistance with confocal microscopy and FACS analysis. The Leica TCS SP5 was obtained through a shared instrument grant from the State of Florida Bankhead-Cooley Cancer Research fund. This work was supported by National Cancer Institute Grant CA-65910 (W.G.C.) and Ruth L. Kirschtein National Research Service Award 5 T32 CA106493-02 (D.L.H.).</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74236" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74236" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 46 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Chatzizacharias, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouraklis, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theocharis, S. E.</span><span> </span><span class="NLM_article-title">Focal adhesion kinase: a promising target for anticancer therapy</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1315</span><span class="NLM_x">–</span> <span class="NLM_lpage">1328</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1517%2F14728222.11.10.1315" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=17907961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSgsbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=1315-1328&author=N.+A.+Chatzizachariasauthor=G.+P.+Kouraklisauthor=S.+E.+Theocharis&title=Focal+adhesion+kinase%3A+a+promising+target+for+anticancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Focal adhesion kinase: a promising target for anticancer therapy</span></div><div class="casAuthors">Chatzizacharias, Nikolaos A.; Kouraklis, Gregory P.; Theocharis, Stamatios E.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1315-1328</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Focal adhesion kinase (FAK) is a protein tyrosine kinase acting as an early modulator of the integrin signalling cascade, thus regulating various basic cellular functions.  In transformed cells, upregulation of FAK protein expression and uncontroled signalling were held responsible for the promotion of malignant phenotypic characteristics, as well as resistance to chemotherapy and radiotherapy.  Direct FAK targeting resulted in the inhibition of the malignant phenotype of cancer cells, whereas increased apoptotic rates of cancer cells, either used alone or in combination with conventional chemotherapeutic agents, radiotherapy or hormonal therapy.  Furthermore, drugs used in cancer chemotherapy, besides their basic mode of action, were also shown to act through altering FAK signalling.  Finally, pos. results were noted by the transfection of cancer cells with fak mutants or genes that suppress FAK expression or activity, such as phosphatase and tensin homolog deleted on chromosome Ten (PTEN), ribonucleotide reductase M1 polypeptide (RRM1) and melanoma differentiation-assocd. gene-7 (mda-7).  The purpose of this article is a comprehensive review of the existing data on the possible use of FAK targeting in anticancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGOvqvFdDrFrVg90H21EOLACvtfcHk0lgSpMhNyRoOYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSgsbvE&md5=d875e2641fa7f0e622d2b764c2233c7b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1517%2F14728222.11.10.1315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.11.10.1315%26sid%3Dliteratum%253Aachs%26aulast%3DChatzizacharias%26aufirst%3DN.%2BA.%26aulast%3DKouraklis%26aufirst%3DG.%2BP.%26aulast%3DTheocharis%26aufirst%3DS.%2BE.%26atitle%3DFocal%2520adhesion%2520kinase%253A%2520a%2520promising%2520target%2520for%2520anticancer%2520therapy%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2007%26volume%3D11%26spage%3D1315%26epage%3D1328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Tammela, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarkada, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallgard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murtomaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suchting, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirzenius, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waltari, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellstrom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schomber, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peltonen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freitas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duarte, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isoniemi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laakkonen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christofori, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yla-Herttuala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibuya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pytowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eichmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betsholtz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alitalo, K.</span><span> </span><span class="NLM_article-title">Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">454</span><span class="NLM_x">, </span> <span class="NLM_fpage">656</span><span class="NLM_x">–</span> <span class="NLM_lpage">660</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=454&publication_year=2008&pages=656-660&author=T.+Tammelaauthor=G.+Zarkadaauthor=E.+Wallgardauthor=A.+Murtomakiauthor=S.+Suchtingauthor=M.+Wirzeniusauthor=M.+Waltariauthor=M.+Hellstromauthor=T.+Schomberauthor=R.+Peltonenauthor=C.+Freitasauthor=A.+Duarteauthor=H.+Isoniemiauthor=P.+Laakkonenauthor=G.+Christoforiauthor=S.+Yla-Herttualaauthor=M.+Shibuyaauthor=B.+Pytowskiauthor=A.+Eichmannauthor=C.+Betsholtzauthor=K.+Alitalo&title=Blocking+VEGFR-3+suppresses+angiogenic+sprouting+and+vascular+network+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTammela%26aufirst%3DT.%26aulast%3DZarkada%26aufirst%3DG.%26aulast%3DWallgard%26aufirst%3DE.%26aulast%3DMurtomaki%26aufirst%3DA.%26aulast%3DSuchting%26aufirst%3DS.%26aulast%3DWirzenius%26aufirst%3DM.%26aulast%3DWaltari%26aufirst%3DM.%26aulast%3DHellstrom%26aufirst%3DM.%26aulast%3DSchomber%26aufirst%3DT.%26aulast%3DPeltonen%26aufirst%3DR.%26aulast%3DFreitas%26aufirst%3DC.%26aulast%3DDuarte%26aufirst%3DA.%26aulast%3DIsoniemi%26aufirst%3DH.%26aulast%3DLaakkonen%26aufirst%3DP.%26aulast%3DChristofori%26aufirst%3DG.%26aulast%3DYla-Herttuala%26aufirst%3DS.%26aulast%3DShibuya%26aufirst%3DM.%26aulast%3DPytowski%26aufirst%3DB.%26aulast%3DEichmann%26aufirst%3DA.%26aulast%3DBetsholtz%26aufirst%3DC.%26aulast%3DAlitalo%26aufirst%3DK.%26atitle%3DBlocking%2520VEGFR-3%2520suppresses%2520angiogenic%2520sprouting%2520and%2520vascular%2520network%2520formation%26jtitle%3DNature%26date%3D2008%26volume%3D454%26spage%3D656%26epage%3D660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Cox, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natarajan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stettner, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gladson, C. L.</span><span> </span><span class="NLM_article-title">New concepts regarding focal adhesion kinase promotion of cell migration and proliferation</span> <span class="citation_source-journal">J. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1002%2Fjcb.20956" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=16823799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A280%3ADC%252BD28rhtFGgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2006&pages=35-52&author=B.+D.+Coxauthor=M.+Natarajanauthor=M.+R.+Stettnerauthor=C.+L.+Gladson&title=New+concepts+regarding+focal+adhesion+kinase+promotion+of+cell+migration+and+proliferation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">New concepts regarding focal adhesion kinase promotion of cell migration and proliferation</span></div><div class="casAuthors">Cox Braden D; Natarajan Meera; Stettner Michelle R; Gladson Candece L</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cellular biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-52</span>
        ISSN:<span class="NLM_cas:issn">0730-2312</span>.
    </div><div class="casAbstract">Focal adhesion kinase (FAK) is a non-receptor cytoplasmic tyrosine kinase that plays a key role in the regulation of proliferation and migration of normal and tumor cells.  FAK associates with integrin receptors and recruits other molecules to the site of this interaction thus forming a signaling complex that transmits signals from the extracellular matrix to the cell cytoskeleton.  Crk-associated substrate (CAS) family members appear to play a pivotal role in FAK regulation of cell migration.  Cellular Src bound to FAK phosphorylates CAS proteins leading to the recruitment of a Crk family adaptor molecule and activation of a small GTPase and c-Jun N-terminal kinase (JNK) promoting membrane protrusion and cell migration.  The relocalization of CAS and signaling through specific CAS family members appears to determine the outcome of this pathway.  FAK also plays an important role in regulating cell cycle progression through transcriptional control of the cyclin D1 promoter by the Ets B and Kruppel-like factor 8 (KLF8) transcription factors.  FAK regulation of cell cycle progression in tumor cells requires Erk activity, cyclin D1 transcription, and the cyclin-dependent kinase (cdk) inhibitor p27Kip1.  The ability of FAK to integrate integrin and growth factor signals resulting in synergistic promotion of cell migration and proliferation, and its potential regulation by nuclear factor kappa B (NFkappaB) and p53 and a ubiquitously expressed inhibitory protein, suggest that it is remarkable in its capacity to integrate multiple extracellular and intracellular stimuli.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTJXl7Nm0CVcjAEfvC7EH1LfW6udTcc2ebviP0a_s1Bgrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28rhtFGgug%253D%253D&md5=418bfd01c7dacb9607c4c591973b30b5</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fjcb.20956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.20956%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DB.%2BD.%26aulast%3DNatarajan%26aufirst%3DM.%26aulast%3DStettner%26aufirst%3DM.%2BR.%26aulast%3DGladson%26aufirst%3DC.%2BL.%26atitle%3DNew%2520concepts%2520regarding%2520focal%2520adhesion%2520kinase%2520promotion%2520of%2520cell%2520migration%2520and%2520proliferation%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2006%26volume%3D99%26spage%3D35%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Frisch, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruoslahti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan-Hui, P. Y.</span><span> </span><span class="NLM_article-title">Control of adhesion-dependent cell survival by focal adhesion kinase</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">793</span><span class="NLM_x">–</span> <span class="NLM_lpage">799</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=1996&pages=793-799&author=S.+M.+Frischauthor=K.+Vuoriauthor=E.+Ruoslahtiauthor=P.+Y.+Chan-Hui&title=Control+of+adhesion-dependent+cell+survival+by+focal+adhesion+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrisch%26aufirst%3DS.%2BM.%26aulast%3DVuori%26aufirst%3DK.%26aulast%3DRuoslahti%26aufirst%3DE.%26aulast%3DChan-Hui%26aufirst%3DP.%2BY.%26atitle%3DControl%2520of%2520adhesion-dependent%2520cell%2520survival%2520by%2520focal%2520adhesion%2520kinase%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D1996%26volume%3D134%26spage%3D793%26epage%3D799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Schlaepfer, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitra, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ilic, D.</span><span> </span><span class="NLM_article-title">Control of motile and invasive cell phenotypes by focal adhesion kinase</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1692</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1692&publication_year=2004&pages=77-102&author=D.+D.+Schlaepferauthor=S.+K.+Mitraauthor=D.+Ilic&title=Control+of+motile+and+invasive+cell+phenotypes+by+focal+adhesion+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchlaepfer%26aufirst%3DD.%2BD.%26aulast%3DMitra%26aufirst%3DS.%2BK.%26aulast%3DIlic%26aufirst%3DD.%26atitle%3DControl%2520of%2520motile%2520and%2520invasive%2520cell%2520phenotypes%2520by%2520focal%2520adhesion%2520kinase%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2004%26volume%3D1692%26spage%3D77%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Chen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y.</span><span> </span><span class="NLM_article-title">Regulation of the PH-domain-containing tyrosine kinase Etk by focal adhesion kinase through the FERM domain</span> <span class="citation_source-journal">Nat. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">444</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1038%2F35074500" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=11331870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjsFClu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2001&pages=439-444&author=R.+Chenauthor=O.+Kimauthor=M.+Liauthor=X.+Xiongauthor=J.+L.+Guanauthor=H.+J.+Kungauthor=H.+Chenauthor=Y.+Shimizuauthor=Y.+Qiu&title=Regulation+of+the+PH-domain-containing+tyrosine+kinase+Etk+by+focal+adhesion+kinase+through+the+FERM+domain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of the PH-domain-containing tyrosine kinase Etk by focal adhesion kinase through the FERM domain</span></div><div class="casAuthors">Chen, Riyan; Kim, Oekyung; Li, Ming; Xiong, Xinsheng; Guan, Jun-Lin; Kung, Hsing-Jien; Chen, Hegang; Shimizu, Yoji; Qiu, Yun</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">439-444</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Etk/BMX, a member of the Btk family of tyrosine kinases, is highly expressed in cells with great migratory potential, including endothelial cells and metastatic carcinoma cell lines.  Here, we present evidence that Etk is involved in integrin signalling and promotes cell migration.  The activation of Etk by extracellular matrix proteins is regulated by focal adhesion kinase (FAK) through an interaction between the PH domain of Etk and the FERM domain of FAK.  The lack of Etk activation by extracellular matrix in FAK-null cells could be restored by co-transfection with wild-type FAK.  Disrupting the interaction between Etk and FAK diminished the cell migration promoted by either kinase.  Furthermore, inhibiting Etk expression in metastatic carcinoma cell lines with an antisense oligonucleotide blocks integrin-mediated migration of these cells.  Taken together, our data indicate the essential role of the interaction of the PH domain of Etk and the FERM domain of FAK in integrin signalling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXbI88x44Jo7Vg90H21EOLACvtfcHk0lhej9ZpYZl-0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjsFClu7c%253D&md5=937a54d06ef57978840f8a16100b0058</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2F35074500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35074500%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DO.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DXiong%26aufirst%3DX.%26aulast%3DGuan%26aufirst%3DJ.%2BL.%26aulast%3DKung%26aufirst%3DH.%2BJ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DShimizu%26aufirst%3DY.%26aulast%3DQiu%26aufirst%3DY.%26atitle%3DRegulation%2520of%2520the%2520PH-domain-containing%2520tyrosine%2520kinase%2520Etk%2520by%2520focal%2520adhesion%2520kinase%2520through%2520the%2520FERM%2520domain%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2001%26volume%3D3%26spage%3D439%26epage%3D444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Garces, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurenova, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golubovskaya, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cance, W. G.</span><span> </span><span class="NLM_article-title">Vascular endothelial growth factor receptor-3 and focal adhesion kinase bind and suppress apoptosis in breast cancer cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">1446</span><span class="NLM_x">–</span> <span class="NLM_lpage">1454</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1158%2F0008-5472.CAN-05-1661" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=16452200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsVehug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=1446-1454&author=C.+A.+Garcesauthor=E.+V.+Kurenovaauthor=V.+M.+Golubovskayaauthor=W.+G.+Cance&title=Vascular+endothelial+growth+factor+receptor-3+and+focal+adhesion+kinase+bind+and+suppress+apoptosis+in+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular Endothelial Growth Factor Receptor-3 and Focal Adhesion Kinase Bind and Suppress Apoptosis in Breast Cancer Cells</span></div><div class="casAuthors">Garces, Christopher A.; Kurenova, Elena V.; Golubovskaya, Vita M.; Cance, William G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1446-1454</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Focal adhesion kinase (FAK) and vascular endothelial growth factor receptor-3 (VEGFR-3) are protein tyrosine kinases that are overexpressed in human cancer and play an important role in survival signaling.  In addn. to its involvement with cell survival, VEGFR-3 is a primary factor in lymphatic angiogenesis.  Because FAK function is regulated by its COOH terminus (FAK-CD), we used FAK-CD as a target to identify binding partners.  We isolated a peptide from a phage library that bound to FAK-CD, specifically the focal adhesion targeting domain of FAK and was homologous to VEGFR-3, suggesting these two tyrosine kinases phys. interact.  We have also shown that VEGFR-3 is overexpressed in human breast tumors and cancer cell lines.  For the first time, we have shown the phys. assocn. of FAK and VEGFR-3.  The assocn. between the NH2 terminus of VEGFR-3, contg. the peptide identified by phage display, and the COOH terminus of FAK was detected by in vitro and in vivo binding studies.  We then coupled a 12-amino-acid VEGFR-3 peptide, AV3, to a TAT cellular penetration sequence and showed that AV3 and not control-scrambled peptide caused specific displacement of FAK from the focal adhesions and affected colocalization of FAK and VEGFR-3.  In addn., AV3 peptide decreased proliferation and caused cell detachment and apoptosis in breast cancer cell lines but not in normal breast cells.  Thus, the FAK/VEGFR-3 interaction may have a potential use to develop novel mol. therapeutics to target the signaling between FAK and VEGFR-3 in human tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod9mUYmoenhrVg90H21EOLACvtfcHk0lhej9ZpYZl-0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsVehug%253D%253D&md5=889ef9ed6935fe6ebe4b1ec6933369b6</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-1661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-1661%26sid%3Dliteratum%253Aachs%26aulast%3DGarces%26aufirst%3DC.%2BA.%26aulast%3DKurenova%26aufirst%3DE.%2BV.%26aulast%3DGolubovskaya%26aufirst%3DV.%2BM.%26aulast%3DCance%26aufirst%3DW.%2BG.%26atitle%3DVascular%2520endothelial%2520growth%2520factor%2520receptor-3%2520and%2520focal%2520adhesion%2520kinase%2520bind%2520and%2520suppress%2520apoptosis%2520in%2520breast%2520cancer%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D1446%26epage%3D1454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Mamali, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapodistria, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lampropoulou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marmaras, V. J.</span><span> </span><span class="NLM_article-title">Elk-1 is a novel protein-binding partner for FAK, regulating phagocytosis in medfly hemocytes</span> <span class="citation_source-journal">J. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">1895</span><span class="NLM_x">–</span> <span class="NLM_lpage">1911</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2008&pages=1895-1911&author=I.+Mamaliauthor=K.+Kapodistriaauthor=M.+Lampropoulouauthor=V.+J.+Marmaras&title=Elk-1+is+a+novel+protein-binding+partner+for+FAK%2C+regulating+phagocytosis+in+medfly+hemocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMamali%26aufirst%3DI.%26aulast%3DKapodistria%26aufirst%3DK.%26aulast%3DLampropoulou%26aufirst%3DM.%26aulast%3DMarmaras%26aufirst%3DV.%2BJ.%26atitle%3DElk-1%2520is%2520a%2520novel%2520protein-binding%2520partner%2520for%2520FAK%252C%2520regulating%2520phagocytosis%2520in%2520medfly%2520hemocytes%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2008%26volume%3D103%26spage%3D1895%26epage%3D1911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Kurenova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, A. S., ,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craven, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanks, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.-g.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cance, W. G.</span><span> </span><span class="NLM_article-title">Focal adhesion kinase suppresses apoptosis by binding to the death domain of receptor-interacting protein</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">4361</span><span class="NLM_x">–</span> <span class="NLM_lpage">4371</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1128%2FMCB.24.10.4361-4371.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=15121855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvFChtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=4361-4371&author=E.+Kurenovaauthor=L.-H.+Xuauthor=X.+Yangauthor=A.+S.%2C++Baldwinauthor=R.+J.+Cravenauthor=S.+K.+Hanksauthor=Z.-g.+Liuauthor=W.+G.+Cance&title=Focal+adhesion+kinase+suppresses+apoptosis+by+binding+to+the+death+domain+of+receptor-interacting+protein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Focal adhesion kinase suppresses apoptosis by binding to the death domain of receptor-interacting protein</span></div><div class="casAuthors">Kurenova, Elena; Xu, Li-Hui; Yang, Xihui; Baldwin, Albert S., Jr.; Craven, Rolf J.; Hanks, Steven K.; Liu, Zheng-gang; Cance, William G.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4361-4371</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Tumor cells resist the apoptotic stimuli assocd. with invasion and metastasis by activating survival signals that suppress apoptosis.  Focal adhesion kinase (FAK), a tyrosine kinase that is overexpressed in a variety of human tumors, mediates one of these survival signals.  Attenuation of FAK expression in tumor cells results in apoptosis that is mediated by caspase 8- and FADD-dependent pathways, suggesting that death receptor pathways are involved in the process.  Here, we report a functional link between FAK and death receptors.  We have demonstrated that FAK binds to the death domain of kinase receptor-interacting protein (RIP).  RIP is a major component of the death receptor complex and has been shown to interact with Fas and tumor necrosis factor receptor 1 through its binding to adapter proteins.  We have shown that RIP provides proapoptotic signals that are suppressed by its binding to FAK.  We thus propose that FAK overexpression in human tumors provides a survival signal function by binding to RIP and inhibiting its interaction with the death receptor complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1a2jd8fnDFLVg90H21EOLACvtfcHk0ljW47CWmRyZZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvFChtLs%253D&md5=5ab911dd0a17eb990cda9806b6ef054b</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1128%2FMCB.24.10.4361-4371.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.24.10.4361-4371.2004%26sid%3Dliteratum%253Aachs%26aulast%3DKurenova%26aufirst%3DE.%26aulast%3DXu%26aufirst%3DL.-H.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DBaldwin%26aufirst%3DA.%2BS.%252C%26aulast%3DCraven%26aufirst%3DR.%2BJ.%26aulast%3DHanks%26aufirst%3DS.%2BK.%26aulast%3DLiu%26aufirst%3DZ.-g.%26aulast%3DCance%26aufirst%3DW.%2BG.%26atitle%3DFocal%2520adhesion%2520kinase%2520suppresses%2520apoptosis%2520by%2520binding%2520to%2520the%2520death%2520domain%2520of%2520receptor-interacting%2520protein%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2004%26volume%3D24%26spage%3D4361%26epage%3D4371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Golubovskaya, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cance, W. G.</span><span> </span><span class="NLM_article-title">Focal adhesion kinase and p53 signaling in cancer cells</span> <span class="citation_source-journal">Int. Rev. Cytol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">263</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">153</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1016%2FS0074-7696%2807%2963003-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=17725966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1ajt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=263&publication_year=2007&pages=103-153&author=V.+M.+Golubovskayaauthor=W.+G.+Cance&title=Focal+adhesion+kinase+and+p53+signaling+in+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Focal adhesion kinase and p53 signaling in cancer cells</span></div><div class="casAuthors">Golubovskaya, Vita M.; Cance, William G.</div><div class="citationInfo"><span class="NLM_cas:title">International Review of Cytology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">263</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103-153</span>CODEN:
                <span class="NLM_cas:coden">IRCYAJ</span>;
        ISSN:<span class="NLM_cas:issn">0074-7696</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The progression of human cancer is characterized by a process of tumor cell motility, invasion, and metastasis to distant sites, requiring the cancer cells to be able to survive the apoptotic pressures of anchorage-independent conditions.  One of the crit. tyrosine kinases linked to these processes of tumor invasion and survival is the focal adhesion kinase (FAK).  FAK was first isolated from human tumors, and FAK mRNA was found to be upregulated in invasive and metastatic human breast and colon cancer samples.  Recently, the FAK promoter was cloned, and it has been found to contain p53-binding sites.  P53 inhibits FAK transcription, and recent data show direct binding of FAK and P53 proteins in vitro and in vivo.  The structure of FAK and P53, proteins interacting with FAK, and the role of FAK in tumorigenesis and FAK-p53-related therapy are reviewed.  This review focuses on FAK signal transduction pathways, particularly on FAK and P53 signaling, revealing a new paradigm in cell biol., linking signaling from the extracellular matrix to the nucleus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY7XzbcgJKfrVg90H21EOLACvtfcHk0ljW47CWmRyZZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1ajt70%253D&md5=a16ab3013b215e4f74ef16b4187cdca4</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0074-7696%2807%2963003-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0074-7696%252807%252963003-4%26sid%3Dliteratum%253Aachs%26aulast%3DGolubovskaya%26aufirst%3DV.%2BM.%26aulast%3DCance%26aufirst%3DW.%2BG.%26atitle%3DFocal%2520adhesion%2520kinase%2520and%2520p53%2520signaling%2520in%2520cancer%2520cells%26jtitle%3DInt.%2520Rev.%2520Cytol.%26date%3D2007%26volume%3D263%26spage%3D103%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Hungerford, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Compton, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matter, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffstrom, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otey, C. A.</span><span> </span><span class="NLM_article-title">Inhibition of pp125FAK in cultured fibroblasts results in apoptosis</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">1383</span><span class="NLM_x">–</span> <span class="NLM_lpage">1390</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=1996&pages=1383-1390&author=J.+E.+Hungerfordauthor=M.+T.+Comptonauthor=M.+L.+Matterauthor=B.+G.+Hoffstromauthor=C.+A.+Otey&title=Inhibition+of+pp125FAK+in+cultured+fibroblasts+results+in+apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHungerford%26aufirst%3DJ.%2BE.%26aulast%3DCompton%26aufirst%3DM.%2BT.%26aulast%3DMatter%26aufirst%3DM.%2BL.%26aulast%3DHoffstrom%26aufirst%3DB.%2BG.%26aulast%3DOtey%26aufirst%3DC.%2BA.%26atitle%3DInhibition%2520of%2520pp125FAK%2520in%2520cultured%2520fibroblasts%2520results%2520in%2520apoptosis%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D1996%26volume%3D135%26spage%3D1383%26epage%3D1390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Liu, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiang, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. P.</span><span> </span><span class="NLM_article-title">Apoptosis of rat hepatic stellate cells induced by anti-focal adhesion kinase antibody</span> <span class="citation_source-journal">World J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">734</span><span class="NLM_x">–</span> <span class="NLM_lpage">738</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=12174388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD38XntFeqt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=734-738&author=X.+J.+Liuauthor=L.+Yangauthor=H.+B.+Wuauthor=O.+Qiangauthor=M.+H.+Huangauthor=Y.+P.+Wang&title=Apoptosis+of+rat+hepatic+stellate+cells+induced+by+anti-focal+adhesion+kinase+antibody"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis of rat hepatic stellate cells induced by anti-focal adhesion kinase antibody</span></div><div class="casAuthors">Liu, Xiao-Jing; Yang, Li; Wu, Hong-Bin; Ou, Qiang; Huang, Ming-Hui; Wang, Ying-Ping</div><div class="citationInfo"><span class="NLM_cas:title">World Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">734-738</span>CODEN:
                <span class="NLM_cas:coden">WJGAF2</span>;
        ISSN:<span class="NLM_cas:issn">1007-9327</span>.
    
            (<span class="NLM_cas:orgname">World Journal of Gastroenterology</span>)
        </div><div class="casAbstract">AIM: To explore the role of focal adhesion kinase (FAK) in the apoptosis in culture-activated rat hepatic stellate cells (HSCs) using a specific anti-FAK antibody.  METHODS: Rat HSCs were prepd. from Wistar rats by in situ perfusion of collagenase and pronase and single-step d. Nycodenze gradient.  Culture-activated HSCs were serum-starved and treated with the anti-FAK antibodies for 24, 48 or 72 h.  The apoptosis of HSC was detected by DNA-fragment assay, flow cytometry and caspase-3 activity detn.  The expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) mRNA was assessed by reverse transcription polymerase chain reaction (RT-PCR).  RESULTS: The expt. showed that anti-FAK antibodies induced apoptosis of culture-activated rat HSCs.  This phenomenon displayed the classical features of apoptotic cell death (DNA fragmentation, cell cycle anal.) after treated with 30 mg·L-1 FAK antibody for 72 h, and accompanied by a significant increase of caspase-3 activity (1208+76) vs (309±28) nmol·min-1·g-1, t=208.5, P<0.05.  Meanwhile, treatment with the FAK antibody in HSCs could markedly decrease the TIMP-1 mRNA expression (0.07±0.01 vs 0.38±0.03, t = 2.72, P<0.05).  CONCLUSION: FAK plays an important role in the survival of HSCs and the specific anti-FAK antibody could induce the apoptosis in rat HSCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj2rTZ3910OrVg90H21EOLACvtfcHk0lj13tX3wpe0Fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntFeqt7Y%253D&md5=93c9ec709fa5443896b4fd110407ab76</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%2BJ.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DH.%2BB.%26aulast%3DQiang%26aufirst%3DO.%26aulast%3DHuang%26aufirst%3DM.%2BH.%26aulast%3DWang%26aufirst%3DY.%2BP.%26atitle%3DApoptosis%2520of%2520rat%2520hepatic%2520stellate%2520cells%2520induced%2520by%2520anti-focal%2520adhesion%2520kinase%2520antibody%26jtitle%3DWorld%2520J.%2520Gastroenterol.%26date%3D2002%26volume%3D8%26spage%3D734%26epage%3D738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Heidkamp, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayer, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalina, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eble, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samarel, A. M.</span><span> </span><span class="NLM_article-title">GFP-FRNK disrupts focal adhesions and induces anoikis in neonatal rat ventricular myocytes</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">1282</span><span class="NLM_x">–</span> <span class="NLM_lpage">1289</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2002&pages=1282-1289&author=M.+C.+Heidkampauthor=A.+L.+Bayerauthor=J.+A.+Kalinaauthor=D.+M.+Ebleauthor=A.+M.+Samarel&title=GFP-FRNK+disrupts+focal+adhesions+and+induces+anoikis+in+neonatal+rat+ventricular+myocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeidkamp%26aufirst%3DM.%2BC.%26aulast%3DBayer%26aufirst%3DA.%2BL.%26aulast%3DKalina%26aufirst%3DJ.%2BA.%26aulast%3DEble%26aufirst%3DD.%2BM.%26aulast%3DSamarel%26aufirst%3DA.%2BM.%26atitle%3DGFP-FRNK%2520disrupts%2520focal%2520adhesions%2520and%2520induces%2520anoikis%2520in%2520neonatal%2520rat%2520ventricular%2520myocytes%26jtitle%3DCirc.%2520Res.%26date%3D2002%26volume%3D90%26spage%3D1282%26epage%3D1289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Xu, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturge, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craven, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cance, W. G.</span><span> </span><span class="NLM_article-title">Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells</span> <span class="citation_source-journal">Cell Growth Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">418</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=9052982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADyaK28XitFegt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1996&pages=413-418&author=L.+H.+Xuauthor=L.+V.+Owensauthor=G.+C.+Sturgeauthor=X.+Yangauthor=E.+T.+Liuauthor=R.+J.+Cravenauthor=W.+G.+Cance&title=Attenuation+of+the+expression+of+the+focal+adhesion+kinase+induces+apoptosis+in+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells</span></div><div class="casAuthors">Xu, Li-hui; Owens, Lewis V.; Sturge, Glenn C.; Yang, Xihui; Liu, Edison T.; Craven, Rolf J.; Cance, William G.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Growth & Differentiation</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">413-18</span>CODEN:
                <span class="NLM_cas:coden">CGDIE7</span>;
        ISSN:<span class="NLM_cas:issn">1044-9523</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The focal adhesion kinase (FAK) is a non-receptor protein tyrosine kinase implicated in integrin-mediated signal transduction pathways, oncogenic transformation by v-src, and the invasion of human tumors.  The overexpression of p125FAK in a variety of human tumors and tumor cell lines in comparison to their non-transformed counterparts suggested that attenuation of p125FaK expression might have an effect on tumor cell proliferation.  In this study, the authors have treated tumor cell lines that expressed high levels of p125FAK with different antisense oligonucleotides to FAK, and have specifically attenuated p125FAK expression.  The cells treated with antisense oligonucleotides not only lost their attachment, but also underwent apoptosis.  Extensive control oligonucleotide expts. suggested that this attenuation was highly FAK specific.  Furthermore, normal human fibroblasts, which did not express high levels of p125FaK, did not lose their attachment or become apoptotic with FAK antisense treatment.  These results suggested that FAK is involved in adhesion-mediated growth in tumor cells and that FAK may be a rational gene-directed target for disrupting tumor cell growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGYz8mKAEF_LVg90H21EOLACvtfcHk0lj13tX3wpe0Fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XitFegt78%253D&md5=ea65ebdce50a369ce454259f072a320d</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DL.%2BH.%26aulast%3DOwens%26aufirst%3DL.%2BV.%26aulast%3DSturge%26aufirst%3DG.%2BC.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DE.%2BT.%26aulast%3DCraven%26aufirst%3DR.%2BJ.%26aulast%3DCance%26aufirst%3DW.%2BG.%26atitle%3DAttenuation%2520of%2520the%2520expression%2520of%2520the%2520focal%2520adhesion%2520kinase%2520induces%2520apoptosis%2520in%2520tumor%2520cells%26jtitle%3DCell%2520Growth%2520Differ.%26date%3D1996%26volume%3D7%26spage%3D413%26epage%3D418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Halder, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamat, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landen, C. N., ,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutgendorf, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merritt, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavez-Reyes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gershenson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmandt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Berestein, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sood, A. K.</span><span> </span><span class="NLM_article-title">Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">4916</span><span class="NLM_x">–</span> <span class="NLM_lpage">4924</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1158%2F1078-0432.CCR-06-0021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=16914580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD28XotFKgt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=4916-4924&author=J.+Halderauthor=A.+A.+Kamatauthor=C.+N.%2C++Landenauthor=L.+Y.+Hanauthor=S.+K.+Lutgendorfauthor=Y.+G.+Linauthor=W.+M.+Merrittauthor=N.+B.+Jenningsauthor=A.+Chavez-Reyesauthor=R.+L.+Colemanauthor=D.+M.+Gershensonauthor=R.+Schmandtauthor=S.+W.+Coleauthor=G.+Lopez-Beresteinauthor=A.+K.+Sood&title=Focal+adhesion+kinase+targeting+using+in+vivo+short+interfering+RNA+delivery+in+neutral+liposomes+for+ovarian+carcinoma+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Focal Adhesion Kinase Targeting Using In vivo Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma Therapy</span></div><div class="casAuthors">Halder, Jyotsnabaran; Kamat, Aparna A.; Landen, Charles N., Jr.; Han, Liz Y.; Lutgendorf, Susan K.; Lin, Yvonne G.; Merritt, William M.; Jennings, Nicholas B.; Chavez-Reyes, Arturo; Coleman, Robert L.; Gershenson, David M.; Schmandt, Rosemarie; Cole, Steven W.; Lopez-Berestein, Gabriel; Sood, Anil K.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4916-4924</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Focal adhesion kinase (FAK) plays a crit. role in ovarian cancer cell survival and in various steps in the metastatic cascade.  Based on encouraging in vitro results with FAK silencing, the authors examd. the in vivo therapeutic potential of this approach using short interfering RNA (siRNA) in the neutral liposome 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine (DOPC).  Exptl. Design: Therapy expts. of FAK siRNA with or without docetaxel were done using human ovarian cancer cell lines SKOV3i.p.1, HeyA8, and HeyA8MDR in nude mice.  Addnl. expts. with a cisplatin-resistant cell line (A2780-CP20) were also done.  Assessments of angiogenesis (CD31), cell proliferation (proliferating cell nuclear antigen), and apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling) were done using immunohistochem. anal.  RESULTS: A single dose of FAK siRNA-DOPC was highly effective in reducing in vivo FAK expression for up to 4 days as assayed by Western blot and immunohistochem. anal.  Therapy expts. were started 1 wk after injection of the ovarian cancer cells.  Treatment with FAK siRNA-DOPC (150 μg/kg twice weekly) reduced mean tumor wt. by 44% to 72% in the three cell lines compared with the control group (Ps < 0.05 for HeyA8, A2780-CP20, and SKOV3i.p.1).  When FAK siRNA-DOPC was combined with docetaxel, there was even greater redn. in mean tumor wt. in all models (all Ps < 0.05).  Similar results were obsd. in combination with cisplatin.  Treatment with FAK siRNA-DOPC plus docetaxel resulted in decreased microvessel d., decreased expression of vascular endothelial growth factor and matrix metalloproteinase-9, and increased apoptosis of tumor-assocd. endothelial cells and tumor cells.  CONCLUSIONS: Taken together, these findings suggest that FAK siRNA-DOPC plus docetaxel or platinum might be a novel therapeutic approach against ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-vlGdBWWR07Vg90H21EOLACvtfcHk0lj13tX3wpe0Fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotFKgt7Y%253D&md5=5792171e4e7d89bb4ce2c3f9d3697b5e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-0021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-0021%26sid%3Dliteratum%253Aachs%26aulast%3DHalder%26aufirst%3DJ.%26aulast%3DKamat%26aufirst%3DA.%2BA.%26aulast%3DLanden%26aufirst%3DC.%2BN.%252C%26aulast%3DHan%26aufirst%3DL.%2BY.%26aulast%3DLutgendorf%26aufirst%3DS.%2BK.%26aulast%3DLin%26aufirst%3DY.%2BG.%26aulast%3DMerritt%26aufirst%3DW.%2BM.%26aulast%3DJennings%26aufirst%3DN.%2BB.%26aulast%3DChavez-Reyes%26aufirst%3DA.%26aulast%3DColeman%26aufirst%3DR.%2BL.%26aulast%3DGershenson%26aufirst%3DD.%2BM.%26aulast%3DSchmandt%26aufirst%3DR.%26aulast%3DCole%26aufirst%3DS.%2BW.%26aulast%3DLopez-Berestein%26aufirst%3DG.%26aulast%3DSood%26aufirst%3DA.%2BK.%26atitle%3DFocal%2520adhesion%2520kinase%2520targeting%2520using%2520in%2520vivo%2520short%2520interfering%2520RNA%2520delivery%2520in%2520neutral%2520liposomes%2520for%2520ovarian%2520carcinoma%2520therapy%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2006%26volume%3D12%26spage%3D4916%26epage%3D4924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Jin, Y.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jindra, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rozengurt, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, E. F.</span><span> </span><span class="NLM_article-title">RNA interference elucidates the role of focal adhesion kinase in HLA class I-mediated focal adhesion complex formation and proliferation in human endothelial cells</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">178</span><span class="NLM_x">, </span> <span class="NLM_fpage">7911</span><span class="NLM_x">–</span> <span class="NLM_lpage">7922</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2007&pages=7911-7922&author=Y.-P.+Jinauthor=Y.+Korinauthor=X.+Zhangauthor=P.+T.+Jindraauthor=E.+Rozengurtauthor=E.+F.+Reed&title=RNA+interference+elucidates+the+role+of+focal+adhesion+kinase+in+HLA+class+I-mediated+focal+adhesion+complex+formation+and+proliferation+in+human+endothelial+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DY.-P.%26aulast%3DKorin%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DJindra%26aufirst%3DP.%2BT.%26aulast%3DRozengurt%26aufirst%3DE.%26aulast%3DReed%26aufirst%3DE.%2BF.%26atitle%3DRNA%2520interference%2520elucidates%2520the%2520role%2520of%2520focal%2520adhesion%2520kinase%2520in%2520HLA%2520class%2520I-mediated%2520focal%2520adhesion%2520complex%2520formation%2520and%2520proliferation%2520in%2520human%2520endothelial%2520cells%26jtitle%3DJ.%2520Immunol.%26date%3D2007%26volume%3D178%26spage%3D7911%26epage%3D7922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Huang, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. T.</span><span> </span><span class="NLM_article-title">Targeting of focal adhesion kinase by flavonoids and small-interfering RNAs reduces tumor cell migration ability</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">2017</span><span class="NLM_x">–</span> <span class="NLM_lpage">2025</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=16158939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtl2htLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=2017-2025&author=Y.+T.+Huangauthor=L.+T.+Leeauthor=P.+P.+Leeauthor=Y.+S.+Linauthor=M.+T.+Lee&title=Targeting+of+focal+adhesion+kinase+by+flavonoids+and+small-interfering+RNAs+reduces+tumor+cell+migration+ability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting of focal adhesion kinase by flavonoids and small-interfering RNAs reduces tumor cell migration ability</span></div><div class="casAuthors">Huang, Ying-Tang; Lee, Lung-Ta; Lee, Ping-Ping; Lin, Yung-Sheng; Lee, Ming-Ting</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3B</span>),
    <span class="NLM_cas:pages">2017-2025</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Focal adhesion kinase (FAK), a member of a growing family of structurally distinct protein tyrosine kinases (PTK), has been linked to specific phosphorylation events, and the elevation of FAK activity in human carcinoma cells is assocd. with increased invasive potential.  In the present study, therefore, we developed two expts. to test the hypothesis that FAK is a determinant of, and plays an important role in, regulating tumor cell migration.  In the first, the biol. functions of FAK were examd. using flavonoid inhibition.  MiaPaCa-2 cells, treated with luteolin (Lu) and quercetin (Qu), were used to dampen FAK phosphorylation and protein expression by parallel suppression of cell migration ability.  The second expt. involved suppression of FAK expression using small-interfering RNAs (siRNA) specific to FAK.  While not affecting cellular proliferation or apoptosis, the siRNA targeting FAK almost completely inhibited FAK protein expression in MiaPaCa-2 cells and potently blocked the cell migration mediated by FAK.  Our results show that FAK functions as a key regulator of cell migration, and that FAK activity can be suppressed by specific FAK siRNA, and by luteolin and quercetin.  It appears reasonable to conclude, therefore, that suppression of FAK protein has a significant impact on tumor cell invasiveness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc-mkf_c_XXbVg90H21EOLACvtfcHk0lh-RwWrQeV0sA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtl2htLk%253D&md5=ac103b157e667456af301a8bcab91476</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%2BT.%26aulast%3DLee%26aufirst%3DL.%2BT.%26aulast%3DLee%26aufirst%3DP.%2BP.%26aulast%3DLin%26aufirst%3DY.%2BS.%26aulast%3DLee%26aufirst%3DM.%2BT.%26atitle%3DTargeting%2520of%2520focal%2520adhesion%2520kinase%2520by%2520flavonoids%2520and%2520small-interfering%2520RNAs%2520reduces%2520tumor%2520cell%2520migration%2520ability%26jtitle%3DAnticancer%2520Res.%26date%3D2005%26volume%3D25%26spage%3D2017%26epage%3D2025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Cance, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iacocca, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roche, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simkins, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span> </span><span class="NLM_article-title">Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">2417</span><span class="NLM_x">–</span> <span class="NLM_lpage">2423</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=10873094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD3cXksVGhsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=2417-2423&author=W.+G.+Canceauthor=J.+E.+Harrisauthor=M.+V.+Iacoccaauthor=E.+Rocheauthor=X.+Yangauthor=J.+Changauthor=S.+Simkinsauthor=L.+Xu&title=Immunohistochemical+analyses+of+focal+adhesion+kinase+expression+in+benign+and+malignant+human+breast+and+colon+tissues%3A+correlation+with+preinvasive+and+invasive+phenotypes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues. Correlation with preinvasive and invasive phenotypes</span></div><div class="casAuthors">Cance, William G.; Harris, Janet E.; Iacocca, Mary V.; Roche, Elizabeth; Yang, XiHui; Chang, Jinli; Simkins, Stephen; Xu, LiHui</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2417-2423</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The focal adhesion kinase (FAK) is a protein Tyr kinase linked to signaling events between cells and the extracellular matrix.  Studies at the Western blot level have demonstrated up-regulation of FAK expression in invasive breast and colon cancers.  To assess p125FAK expression at the cellular level, the authors developed monoclonal antibodies that specifically detected FAK in formalin-fixed, paraffin-embedded tissue sections and analyzed the levels of FAK expression in human breast and colon tissues.  Monoclonal antibody 4.47 demonstrated FAK-specific focal adhesion staining by immunofluorescence assays on BT-474 breast cancer cells and detected a Mr 125,000 protein by both Western blotting and immunopptn. analyses.  Using immunohistochem. techniques, the expression of p125FAK was analyzed in 36 normal and 43 preinvasive or invasive human breast and colon tissues from individual patients.  FAK was weakly expressed in most benign breast epithelium but was up-regulated at moderate or strong levels in 14 of 18 invasive breast carcinomas.  In 7 samples of ductal carcinoma-in situ, FAK was overexpressed.  Borderline-to-weak expression of FAK was detected in the normal colonic epithelium.  In the invasive colon cancers, FAK was overexpressed at moderate or strong levels in 13 of 15 tumors.  Furthermore, FAK expression was up-regulated in areas of dysplastic, premalignant colon epithelium.  These results provide the 1st evidence at the cellular level that FAK expression is variably overexpressed in breast and colon cancer and suggest that up-regulation occurs at an early stage of tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2hXSzIeZTIrVg90H21EOLACvtfcHk0lh-RwWrQeV0sA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXksVGhsLY%253D&md5=832dfa56cb894eadd8835c82d7d39f46</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCance%26aufirst%3DW.%2BG.%26aulast%3DHarris%26aufirst%3DJ.%2BE.%26aulast%3DIacocca%26aufirst%3DM.%2BV.%26aulast%3DRoche%26aufirst%3DE.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DSimkins%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DL.%26atitle%3DImmunohistochemical%2520analyses%2520of%2520focal%2520adhesion%2520kinase%2520expression%2520in%2520benign%2520and%2520malignant%2520human%2520breast%2520and%2520colon%2520tissues%253A%2520correlation%2520with%2520preinvasive%2520and%2520invasive%2520phenotypes%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2000%26volume%3D6%26spage%3D2417%26epage%3D2423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Carelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zadra, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaira, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falleni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottiglieri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nosotti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Giulio, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosari, S.</span><span> </span><span class="NLM_article-title">Up-regulation of focal adhesion kinase in non-small cell lung cancer</span> <span class="citation_source-journal">Lung Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">271</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2006&pages=263-271&author=S.+Carelliauthor=G.+Zadraauthor=V.+Vairaauthor=M.+Falleniauthor=L.+Bottiglieriauthor=M.+Nosottiauthor=A.+M.+Di+Giulioauthor=A.+Gorioauthor=S.+Bosari&title=Up-regulation+of+focal+adhesion+kinase+in+non-small+cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarelli%26aufirst%3DS.%26aulast%3DZadra%26aufirst%3DG.%26aulast%3DVaira%26aufirst%3DV.%26aulast%3DFalleni%26aufirst%3DM.%26aulast%3DBottiglieri%26aufirst%3DL.%26aulast%3DNosotti%26aufirst%3DM.%26aulast%3DDi%2BGiulio%26aufirst%3DA.%2BM.%26aulast%3DGorio%26aufirst%3DA.%26aulast%3DBosari%26aufirst%3DS.%26atitle%3DUp-regulation%2520of%2520focal%2520adhesion%2520kinase%2520in%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DLung%2520Cancer%26date%3D2006%26volume%3D53%26spage%3D263%26epage%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">McLean, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carragher, N. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avizienyte, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunton, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frame, M. C.</span><span> </span><span class="NLM_article-title">The role of focal-adhesion kinase in cancer—a new therapeutic opportunity</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">505</span><span class="NLM_x">–</span> <span class="NLM_lpage">515</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1038%2Fnrc1647" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=16069815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtFOns7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=505-515&author=G.+W.+McLeanauthor=N.+O.+Carragherauthor=E.+Avizienyteauthor=J.+Evansauthor=V.+G.+Bruntonauthor=M.+C.+Frame&title=The+role+of+focal-adhesion+kinase+in+cancer%E2%80%94a+new+therapeutic+opportunity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The role of focal-adhesion kinase in cancer - A new therapeutic opportunity</span></div><div class="casAuthors">McLean, Gordon W.; Carragher, Neil O.; Avizienyte, Egle; Evans, Jeff; Brunton, Valerie G.; Frame, Margaret C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">505-515</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  I Focal-adhesion kinase (FAK) is an important mediator of growth-factor signaling, cell proliferation, cell survival and cell migration.  Given that the development of malignancy is often assocd. with perturbations in these processes, it is not surprising that FAK activity is altered in cancer cells.  Mouse models have shown that FAK is involved in tumor formation and progression, and other studies showing that FAK expression is increased in human tumors make FAK a potentially important new therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplqluP90LTaLVg90H21EOLACvtfcHk0li60jpU0pEkXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtFOns7k%253D&md5=805ddeb142a8d73e111cf8211dbcdfa9</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnrc1647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1647%26sid%3Dliteratum%253Aachs%26aulast%3DMcLean%26aufirst%3DG.%2BW.%26aulast%3DCarragher%26aufirst%3DN.%2BO.%26aulast%3DAvizienyte%26aufirst%3DE.%26aulast%3DEvans%26aufirst%3DJ.%26aulast%3DBrunton%26aufirst%3DV.%2BG.%26aulast%3DFrame%26aufirst%3DM.%2BC.%26atitle%3DThe%2520role%2520of%2520focal-adhesion%2520kinase%2520in%2520cancer%25E2%2580%2594a%2520new%2520therapeutic%2520opportunity%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2005%26volume%3D5%26spage%3D505%26epage%3D515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">van Nimwegen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Water, B.</span><span> </span><span class="NLM_article-title">Focal adhesion kinase: a potential target in cancer therapy</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">609</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=597-609&author=M.+J.+van+Nimwegenauthor=B.+van+de+Water&title=Focal+adhesion+kinase%3A+a+potential+target+in+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BNimwegen%26aufirst%3DM.%2BJ.%26aulast%3Dvan%2Bde%2BWater%26aufirst%3DB.%26atitle%3DFocal%2520adhesion%2520kinase%253A%2520a%2520potential%2520target%2520in%2520cancer%2520therapy%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2006%26spage%3D597%26epage%3D609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Shi, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hjelmeland, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keir, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohmori, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigner, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, J. N.</span><span> </span><span class="NLM_article-title">A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth</span> <span class="citation_source-journal">Mol. Carcinog.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">488</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1002%2Fmc.20297" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=17219439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD2sXms1Olsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=488-496&author=Q.+Shiauthor=A.+B.+Hjelmelandauthor=S.+T.+Keirauthor=L.+Songauthor=S.+Wickmanauthor=D.+Jacksonauthor=O.+Ohmoriauthor=D.+D.+Bignerauthor=H.+S.+Friedmanauthor=J.+N.+Rich&title=A+novel+low-molecular+weight+inhibitor+of+focal+adhesion+kinase%2C+TAE226%2C+inhibits+glioma+growth"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth</span></div><div class="casAuthors">Shi, Qing; Hjelmeland, Anita B.; Keir, Stephen T.; Song, Linhua; Wickman, Sarah; Jackson, Dowdy; Ohmori, Osamu; Bigner, Darell D.; Friedman, Henry S.; Rich, Jeremy N.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Carcinogenesis</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">488-496</span>CODEN:
                <span class="NLM_cas:coden">MOCAE8</span>;
        ISSN:<span class="NLM_cas:issn">0899-1987</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Glioblastomas are highly lethal cancers that resist current therapies.  Novel therapies under development target mol. mechanisms that promote glioblastoma growth.  In glioblastoma patient specimens, the non-receptor tyrosine kinase focal adhesion kinase (FAK) is overexpressed.  Upon growth factor receptor stimulation or integrin engagement, FAK is activated by phosphorylation on crit. tyrosine residues.  Activated FAK initiates a signal transduction cascade which promotes glioma growth and invasion by increasing cellular adhesion, migration, invasion, and proliferation.  We find that human glioma cell lines express different levels of total FAK protein and activating phosphorylation of tyrosine residues Tyr397, Tyr861, and Tyr925.  As all glioma cell lines examd. expressed phosphorylated FAK, we examd. the efficacy of a novel low-mol. wt. inhibitor of FAK, TAE226, against human glioma cell lines.  TAE226 inhibited the phosphorylation of FAK as well as the downstream effectors AKT, extracellular signal-related kinase, and S6 ribosomal protein in multiple glioma cell lines.  TAE226 induced a concn.-dependent decrease in cellular proliferation with an assocd. G2 cell cycle arrest in every cell line and an increase in apoptosis in a cell-line-specific manner.  TAE226 also decreased glioma cell adhesion, migration, and invasion through an artificial extracellular matrix.  Together, these data demonstrate the potential benefit of TAE226 for glioma therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXL0wEDuHo9bVg90H21EOLACvtfcHk0li60jpU0pEkXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXms1Olsrg%253D&md5=83711a44fe2472eae4baf568ee4332a4</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fmc.20297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmc.20297%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DQ.%26aulast%3DHjelmeland%26aufirst%3DA.%2BB.%26aulast%3DKeir%26aufirst%3DS.%2BT.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DWickman%26aufirst%3DS.%26aulast%3DJackson%26aufirst%3DD.%26aulast%3DOhmori%26aufirst%3DO.%26aulast%3DBigner%26aufirst%3DD.%2BD.%26aulast%3DFriedman%26aufirst%3DH.%2BS.%26aulast%3DRich%26aufirst%3DJ.%2BN.%26atitle%3DA%2520novel%2520low-molecular%2520weight%2520inhibitor%2520of%2520focal%2520adhesion%2520kinase%252C%2520TAE226%252C%2520inhibits%2520glioma%2520growth%26jtitle%3DMol.%2520Carcinog.%26date%3D2007%26volume%3D46%26spage%3D488%26epage%3D496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Slack-Davis, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilghman, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwanicki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ung, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Autry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luzzio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kath, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, J. T.</span><span> </span><span class="NLM_article-title">Cellular characterization of a novel focal adhesion kinase inhibitor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">14845</span><span class="NLM_x">–</span> <span class="NLM_lpage">14852</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1074%2Fjbc.M606695200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=17395594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltFemtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=14845-14852&author=J.+K.+Slack-Davisauthor=K.+H.+Martinauthor=R.+W.+Tilghmanauthor=M.+Iwanickiauthor=E.+J.+Ungauthor=C.+Autryauthor=M.+J.+Luzzioauthor=B.+Cooperauthor=J.+C.+Kathauthor=W.+G.+Robertsauthor=J.+T.+Parsons&title=Cellular+characterization+of+a+novel+focal+adhesion+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular Characterization of a Novel Focal Adhesion Kinase Inhibitor</span></div><div class="casAuthors">Slack-Davis, Jill K.; Martin, Karen H.; Tilghman, Robert W.; Iwanicki, Marcin; Ung, Ethan J.; Autry, Christopher; Luzzio, Michael J.; Cooper, Beth; Kath, John C.; Roberts, W. Gregory; Parsons, J. Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">14845-14852</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Focal adhesion kinase (FAK) is a member of a family of non-receptor protein-tyrosine kinases that regulates integrin and growth factor signaling pathways involved in cell migration, proliferation, and survival.  FAK expression is increased in many cancers, including breast and prostate cancer.  Here we describe perturbation of adhesion-mediated signaling with a FAK inhibitor, PF-573,228.  In vitro, this compd. inhibited purified recombinant catalytic fragment of FAK with an IC50 of 4 nM.  In cultured cells, PF-573,228 inhibited FAK phosphorylation on Tyr397 with an IC50 of 30-100 nM.  Treatment of cells with concns. of PF-573,228 that significantly decreased FAK Tyr397 phosphorylation failed to inhibit cell growth or induce apoptosis.  In contrast, treatment with PF-573,228 inhibited both chemotactic and haptotactic migration concomitant with the inhibition of focal adhesion turnover.  These studies show that PF-573,228 serves as a useful tool to dissect the functions of FAK in integrin-dependent signaling pathways in normal and cancer cells and forms the basis for the generation of compds. amenable for preclin. and patient trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_48hzQ-vWhrVg90H21EOLACvtfcHk0li60jpU0pEkXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltFemtbY%253D&md5=38e97c67d37fbcbde006e6937ae4e360</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M606695200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M606695200%26sid%3Dliteratum%253Aachs%26aulast%3DSlack-Davis%26aufirst%3DJ.%2BK.%26aulast%3DMartin%26aufirst%3DK.%2BH.%26aulast%3DTilghman%26aufirst%3DR.%2BW.%26aulast%3DIwanicki%26aufirst%3DM.%26aulast%3DUng%26aufirst%3DE.%2BJ.%26aulast%3DAutry%26aufirst%3DC.%26aulast%3DLuzzio%26aufirst%3DM.%2BJ.%26aulast%3DCooper%26aufirst%3DB.%26aulast%3DKath%26aufirst%3DJ.%2BC.%26aulast%3DRoberts%26aufirst%3DW.%2BG.%26aulast%3DParsons%26aufirst%3DJ.%2BT.%26atitle%3DCellular%2520characterization%2520of%2520a%2520novel%2520focal%2520adhesion%2520kinase%2520inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D14845%26epage%3D14852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Roberts, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whalen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulford, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Autry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emerson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kath, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Alsina, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorenzen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berliner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luzzio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaGreca, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jani, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wessel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marr, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vajdos, F.</span><span> </span><span class="NLM_article-title">Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">1935</span><span class="NLM_x">–</span> <span class="NLM_lpage">1944</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=1935-1944&author=W.+G.+Robertsauthor=E.+Ungauthor=P.+Whalenauthor=B.+Cooperauthor=C.+Hulfordauthor=C.+Autryauthor=D.+Richterauthor=E.+Emersonauthor=J.+Linauthor=J.+Kathauthor=K.+Colemanauthor=L.+Yaoauthor=L.+Martinez-Alsinaauthor=M.+Lorenzenauthor=M.+Berlinerauthor=M.+Luzzioauthor=N.+Patelauthor=E.+Schmittauthor=S.+LaGrecaauthor=J.+Janiauthor=M.+Wesselauthor=E.+Marrauthor=M.+Grifforauthor=F.+Vajdos&title=Antitumor+activity+and+pharmacology+of+a+selective+focal+adhesion+kinase+inhibitor%2C+PF-562%2C271"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DW.%2BG.%26aulast%3DUng%26aufirst%3DE.%26aulast%3DWhalen%26aufirst%3DP.%26aulast%3DCooper%26aufirst%3DB.%26aulast%3DHulford%26aufirst%3DC.%26aulast%3DAutry%26aufirst%3DC.%26aulast%3DRichter%26aufirst%3DD.%26aulast%3DEmerson%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DKath%26aufirst%3DJ.%26aulast%3DColeman%26aufirst%3DK.%26aulast%3DYao%26aufirst%3DL.%26aulast%3DMartinez-Alsina%26aufirst%3DL.%26aulast%3DLorenzen%26aufirst%3DM.%26aulast%3DBerliner%26aufirst%3DM.%26aulast%3DLuzzio%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DN.%26aulast%3DSchmitt%26aufirst%3DE.%26aulast%3DLaGreca%26aufirst%3DS.%26aulast%3DJani%26aufirst%3DJ.%26aulast%3DWessel%26aufirst%3DM.%26aulast%3DMarr%26aufirst%3DE.%26aulast%3DGriffor%26aufirst%3DM.%26aulast%3DVajdos%26aufirst%3DF.%26atitle%3DAntitumor%2520activity%2520and%2520pharmacology%2520of%2520a%2520selective%2520focal%2520adhesion%2520kinase%2520inhibitor%252C%2520PF-562%252C271%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D1935%26epage%3D1944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Alitalo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmeliet, P.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of lymphangiogenesis in health and disease</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">227</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=219-227&author=K.+Alitaloauthor=P.+Carmeliet&title=Molecular+mechanisms+of+lymphangiogenesis+in+health+and+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlitalo%26aufirst%3DK.%26aulast%3DCarmeliet%26aufirst%3DP.%26atitle%3DMolecular%2520mechanisms%2520of%2520lymphangiogenesis%2520in%2520health%2520and%2520disease%26jtitle%3DCancer%2520Cell%26date%3D2002%26volume%3D1%26spage%3D219%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Skobe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawighorst, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prevo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janes, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velasco, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccardi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alitalo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claffey, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Detmar, M.</span><span> </span><span class="NLM_article-title">Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">192</span><span class="NLM_x">–</span> <span class="NLM_lpage">198</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1038%2F84643" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=11175850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhtVylu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=192-198&author=M.+Skobeauthor=T.+Hawighorstauthor=D.+G.+Jacksonauthor=R.+Prevoauthor=L.+Janesauthor=P.+Velascoauthor=L.+Riccardiauthor=K.+Alitaloauthor=K.+Claffeyauthor=M.+Detmar&title=Induction+of+tumor+lymphangiogenesis+by+VEGF-C+promotes+breast+cancer+metastasis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis</span></div><div class="casAuthors">Skobe, Mihaela; Hawighorsti, Thomas; Jackson, David G.; Prevo, Remko; Janes, Lauren; Velasco, Paula; Riccardii, Lucia; Alitalo, Kari; Claffey, Kevin; Detmar, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">192-198</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Metastasis of breast cancer occurs primarily through the lymphatic system, and the extent of lymph node involvement is a key prognostic factor for the disease.  Whereas the significance of angiogenesis for tumor progression has been well documented, the ability of tumor cells to induce the growth of lymphatic vessels (lymphangiogenesis) and the presence of intratumoral lymphatic vessels have been controversial.  Using a novel marker for lymphatic endothelium, LYVE-1, the authors demonstrate here the occurrence of intratumoral lymphangiogenesis within human breast cancers after orthotropic transplantation onto nude mice.  Vascular endothelial growth factor (VEGF)-C overexpression in breast cancer cells potently increased intratumoral lymphangiogenesis, resulting in significantly enhanced metastasis to regional lymph nodes and to lungs.  The degree of tumor lymphangiogenesis was highly correlated with the extent of lymph node and lung metastases.  These results establish the occurrence and biol. significance of intratumoral lymphangiogenesis in breast cancer and identify VEGF-C as a mol. link between tumor lymphangiogenesis and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgrUUm-FXuuLVg90H21EOLACvtfcHk0lj6IPskS7IrFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhtVylu7s%253D&md5=ecb4286d89dc5a32b8cee8a52396420b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2F84643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F84643%26sid%3Dliteratum%253Aachs%26aulast%3DSkobe%26aufirst%3DM.%26aulast%3DHawighorst%26aufirst%3DT.%26aulast%3DJackson%26aufirst%3DD.%2BG.%26aulast%3DPrevo%26aufirst%3DR.%26aulast%3DJanes%26aufirst%3DL.%26aulast%3DVelasco%26aufirst%3DP.%26aulast%3DRiccardi%26aufirst%3DL.%26aulast%3DAlitalo%26aufirst%3DK.%26aulast%3DClaffey%26aufirst%3DK.%26aulast%3DDetmar%26aufirst%3DM.%26atitle%3DInduction%2520of%2520tumor%2520lymphangiogenesis%2520by%2520VEGF-C%2520promotes%2520breast%2520cancer%2520metastasis%26jtitle%3DNat.%2520Med.%26date%3D2001%26volume%3D7%26spage%3D192%26epage%3D198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Su, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, L.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeng, Y.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, K.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, M.-L.</span><span> </span><span class="NLM_article-title">The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">223</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=209-223&author=J.-L.+Suauthor=P.-C.+Yangauthor=J.-Y.+Shihauthor=C.-Y.+Yangauthor=L.-H.+Weiauthor=C.-Y.+Hsiehauthor=C.-H.+Chouauthor=Y.-M.+Jengauthor=M.-Y.+Wangauthor=K.-J.+Changauthor=M.-C.+Hungauthor=M.-L.+Kuo&title=The+VEGF-C%2FFlt-4+axis+promotes+invasion+and+metastasis+of+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DJ.-L.%26aulast%3DYang%26aufirst%3DP.-C.%26aulast%3DShih%26aufirst%3DJ.-Y.%26aulast%3DYang%26aufirst%3DC.-Y.%26aulast%3DWei%26aufirst%3DL.-H.%26aulast%3DHsieh%26aufirst%3DC.-Y.%26aulast%3DChou%26aufirst%3DC.-H.%26aulast%3DJeng%26aufirst%3DY.-M.%26aulast%3DWang%26aufirst%3DM.-Y.%26aulast%3DChang%26aufirst%3DK.-J.%26aulast%3DHung%26aufirst%3DM.-C.%26aulast%3DKuo%26aufirst%3DM.-L.%26atitle%3DThe%2520VEGF-C%252FFlt-4%2520axis%2520promotes%2520invasion%2520and%2520metastasis%2520of%2520cancer%2520cells%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D9%26spage%3D209%26epage%3D223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Thiele, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sleeman, J. P.</span><span> </span><span class="NLM_article-title">Tumor-induced lymphangiogenesis: a target for cancer therapy?</span> <span class="citation_source-journal">J. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">224</span><span class="NLM_x">–</span> <span class="NLM_lpage">241</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1016%2Fj.jbiotec.2006.01.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=16497404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD28Xltl2isb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2006&pages=224-241&author=W.+Thieleauthor=J.+P.+Sleeman&title=Tumor-induced+lymphangiogenesis%3A+a+target+for+cancer+therapy%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor-induced lymphangiogenesis: A target for cancer therapy?</span></div><div class="casAuthors">Thiele, Wilko; Sleeman, Jonathan P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biotechnology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">224-241</span>CODEN:
                <span class="NLM_cas:coden">JBITD4</span>;
        ISSN:<span class="NLM_cas:issn">0168-1656</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Recent advances in understanding the biol. of lymphangiogenesis, the new growth of lymphatic vessels, have cast new light on the mol. basis of metastasis to regional lymph nodes.  The receptor tyrosine kinase VEGFR-3 is virtually exclusively expressed on lymphatic but not blood endothelium in the adult, and activation of VEGFR-3 by its ligands VEGF-C and VEGF-D is sufficient to induce lymphangiogenesis.  Correlative studies with human tumors and functional studies using animal tumor models show that increased levels of VEGF-C or VEGF-D in tumors lead to enhanced nos. of lymphatic vessels in the vicinity of tumors, which in turn promotes metastasis to regional lymph nodes by providing a greater no. of entry sites into the lymphatic system for invading tumor cells.  These findings have prompted studies to investigate whether inhibitors of VEGFR-3 activation might represent novel therapeutic agents for the suppression of metastasis.  However, a no. of points regarding the therapeutic potential of anti-lymphangiogenic treatments in the context of cancer remain to be addressed.  The spectrum and relative importance of mols. that induce lymphangiogenesis and the regulation of their expression during tumor progression, the reversibility of tumor-induced lymphangiogenesis, and possible side-effects of anti-lymphangiogenesis-based therapies all need to be investigated.  Most importantly, the extent to which lymph node metastases contribute to the formation of metastases in other organs remains to be elucidated.  These aspects are the focus of this review, and their investigation should serve as a roadmap to possible translational application.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9rMBypIU9KbVg90H21EOLACvtfcHk0lj6IPskS7IrFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xltl2isb8%253D&md5=57fcd518b694182b92295e8d3c2a2a8d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.jbiotec.2006.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jbiotec.2006.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DThiele%26aufirst%3DW.%26aulast%3DSleeman%26aufirst%3DJ.%2BP.%26atitle%3DTumor-induced%2520lymphangiogenesis%253A%2520a%2520target%2520for%2520cancer%2520therapy%253F%26jtitle%3DJ.%2520Biotechnol.%26date%3D2006%26volume%3D124%26spage%3D224%26epage%3D241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Valtola, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salven, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heikkila, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taipale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joensuu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rehn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pihlajaniemi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weich, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">deWaal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alitalo, K.</span><span> </span><span class="NLM_article-title">VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">1381</span><span class="NLM_x">–</span> <span class="NLM_lpage">1390</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=10329591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A280%3ADyaK1M3mtlektg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=1999&pages=1381-1390&author=R.+Valtolaauthor=P.+Salvenauthor=P.+Heikkilaauthor=J.+Taipaleauthor=H.+Joensuuauthor=M.+Rehnauthor=T.+Pihlajaniemiauthor=H.+Weichauthor=R.+deWaalauthor=K.+Alitalo&title=VEGFR-3+and+its+ligand+VEGF-C+are+associated+with+angiogenesis+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer</span></div><div class="casAuthors">Valtola R; Salven P; Heikkila P; Taipale J; Joensuu H; Rehn M; Pihlajaniemi T; Weich H; deWaal R; Alitalo K</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of pathology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1381-90</span>
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    </div><div class="casAbstract">Recently, monoclonal antibodies against the human vascular endothelial growth factor receptor VEGFR-3 were shown to provide a specific antigenic marker for lymphatic endothelium in various normal tissues.  In this study we have investigated the expression of VEGFR-3 and its ligand VEGF-C in normal breast tissue and in breast tumors by immunohistochemistry.  VEGFR-3 was weakly expressed in capillaries of normal breast tissue and in fibroadenomas.  In intraductal breast carcinomas, VEGFR-3 was prominent in the "necklace" vessels adjacent to the basal lamina of the tumor-filled ducts.  VEGF receptor 1 and 2 as well as blood vessel endothelial and basal lamina markers were colocalized with VEGFR-3 in many of these vessels.  Antibodies against smooth muscle alpha-actin gave a weak staining of the necklace vessels, suggesting that they were incompletely covered by pericytes/smooth muscle cells.  A highly elevated number of VEGFR-3 positive vessels was found in invasive breast cancer in comparison with histologically normal breast tissue (P < 0.0001, the Mann-Whitney test).  VEGF-C was located in the cytoplasm of intraductal and invasive cancer cells.  The results demonstrate that the expression of VEGFR-3 becomes up-regulated in the endothelium of angiogenic blood vessels in breast cancer.  The results also suggest that VEGF-C secreted by the intraductal carcinoma cells acts predominantly as an angiogenic growth factor for blood vessels, although this paracrine signaling network between the cancer cells and the endothelium may also be involved in modifying the permeabilities of both blood and lymphatic vessels and metastasis formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRqsKqXdODnb-98rul4nhSdfW6udTcc2eY8KHjP97hLc7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M3mtlektg%253D%253D&md5=de09976eb9f8045f4709956e03e34d60</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DValtola%26aufirst%3DR.%26aulast%3DSalven%26aufirst%3DP.%26aulast%3DHeikkila%26aufirst%3DP.%26aulast%3DTaipale%26aufirst%3DJ.%26aulast%3DJoensuu%26aufirst%3DH.%26aulast%3DRehn%26aufirst%3DM.%26aulast%3DPihlajaniemi%26aufirst%3DT.%26aulast%3DWeich%26aufirst%3DH.%26aulast%3DdeWaal%26aufirst%3DR.%26aulast%3DAlitalo%26aufirst%3DK.%26atitle%3DVEGFR-3%2520and%2520its%2520ligand%2520VEGF-C%2520are%2520associated%2520with%2520angiogenesis%2520in%2520breast%2520cancer%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D1999%26volume%3D154%26spage%3D1381%26epage%3D1390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Paavonen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puolakkainen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jussila, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jahkola, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alitalo, K.</span><span> </span><span class="NLM_article-title">Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">156</span><span class="NLM_x">, </span> <span class="NLM_fpage">1499</span><span class="NLM_x">–</span> <span class="NLM_lpage">1504</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1016%2FS0002-9440%2810%2965021-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=10793061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjslKltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2000&pages=1499-1504&author=K.+Paavonenauthor=P.+Puolakkainenauthor=L.+Jussilaauthor=T.+Jahkolaauthor=K.+Alitalo&title=Vascular+endothelial+growth+factor+receptor-3+in+lymphangiogenesis+in+wound+healing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing</span></div><div class="casAuthors">Paavonen, Karri; Puolakkainen, Pauli; Jussila, Lotta; Jahkola, Tiina; Alitalo, Kari</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1499-1504</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Vascular endothelial growth factor receptor-3 (VEGFR-3) is essential for embryonic cardiovascular development, but thereafter becomes confined to the lymphatic endothelium in adult tissues.  We have here studied VEGFR-3 expression in exptl. wounds of pigs and chronic inflammatory wounds of humans.  In healing incisional and punch biopsy wounds made in the dorsal skin of pigs, angiogenic blood vessels, identified by use of the blood vascular endothelial markers vWF and PAL-E and the basal lamina protein laminin, developed into the granulation tissue stroma from day 4 onward, being most abundant on days 5 and 6 and regressing thereafter.  VEGFR-3-pos. vessels were obsd. in the granulation tissue from day 5 onward.  These vessels were distinct from the PAL-E/laminin/vWF-pos. vessels and fewer in no., and they appeared to sprout from pre-existing VEGFR-3-pos. lymphatic vessels at the wound edge.  Unlike the blood vessels, very few VEGFR-3-pos. lymphatic vessels persisted on day 9 and none on day 14.  In chronic wounds such as ulcers and decubitus wounds of the lower extremity of humans, VEGFR-3 was also weakly expressed in the vascular endothelium.  Our results suggest that transient lymphangiogenesis occurs in parallel with angiogenesis in healing wounds and that VEGFR-3 becomes up-regulated in blood vessel endothelium in chronic inflammatory wounds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJqxyWjHM1-bVg90H21EOLACvtfcHk0lj8ZAGtNcK1FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjslKltL8%253D&md5=47ea2671a4261d08c45d7acd2adb749a</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2965021-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252965021-3%26sid%3Dliteratum%253Aachs%26aulast%3DPaavonen%26aufirst%3DK.%26aulast%3DPuolakkainen%26aufirst%3DP.%26aulast%3DJussila%26aufirst%3DL.%26aulast%3DJahkola%26aufirst%3DT.%26aulast%3DAlitalo%26aufirst%3DK.%26atitle%3DVascular%2520endothelial%2520growth%2520factor%2520receptor-3%2520in%2520lymphangiogenesis%2520in%2520wound%2520healing%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2000%26volume%3D156%26spage%3D1499%26epage%3D1504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Petrova, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bono, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holnthoner, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesnes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pytowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sihto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laakkonen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heikkilä, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joensuu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alitalo, K.</span><span> </span><span class="NLM_article-title">VEGFR-3 expression is restricted to blood and lymphatic vessels in solid tumors</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">554</span><span class="NLM_x">–</span> <span class="NLM_lpage">556</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=554-556&author=T.+V.+Petrovaauthor=P.+Bonoauthor=W.+Holnthonerauthor=J.+Chesnesauthor=B.+Pytowskiauthor=H.+Sihtoauthor=P.+Laakkonenauthor=P.+Heikkil%C3%A4author=H.+Joensuuauthor=K.+Alitalo&title=VEGFR-3+expression+is+restricted+to+blood+and+lymphatic+vessels+in+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPetrova%26aufirst%3DT.%2BV.%26aulast%3DBono%26aufirst%3DP.%26aulast%3DHolnthoner%26aufirst%3DW.%26aulast%3DChesnes%26aufirst%3DJ.%26aulast%3DPytowski%26aufirst%3DB.%26aulast%3DSihto%26aufirst%3DH.%26aulast%3DLaakkonen%26aufirst%3DP.%26aulast%3DHeikkil%25C3%25A4%26aufirst%3DP.%26aulast%3DJoensuu%26aufirst%3DH.%26aulast%3DAlitalo%26aufirst%3DK.%26atitle%3DVEGFR-3%2520expression%2520is%2520restricted%2520to%2520blood%2520and%2520lymphatic%2520vessels%2520in%2520solid%2520tumors%26jtitle%3DCancer%2520Cell%26date%3D2008%26volume%3D13%26spage%3D554%26epage%3D556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Su, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, M.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, M.-L.</span><span> </span><span class="NLM_article-title">Further evidence for expression and function of the VEGF-C/VEGFR-3 axis in cancer cells</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">557</span><span class="NLM_x">–</span> <span class="NLM_lpage">560</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=557-560&author=J.-L.+Suauthor=P.-S.+Chenauthor=M.-H.+Chienauthor=P.+B.+Chenauthor=Y.-H.+Chenauthor=C.-C.+Laiauthor=M.-C.+Hungauthor=M.-L.+Kuo&title=Further+evidence+for+expression+and+function+of+the+VEGF-C%2FVEGFR-3+axis+in+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DJ.-L.%26aulast%3DChen%26aufirst%3DP.-S.%26aulast%3DChien%26aufirst%3DM.-H.%26aulast%3DChen%26aufirst%3DP.%2BB.%26aulast%3DChen%26aufirst%3DY.-H.%26aulast%3DLai%26aufirst%3DC.-C.%26aulast%3DHung%26aufirst%3DM.-C.%26aulast%3DKuo%26aufirst%3DM.-L.%26atitle%3DFurther%2520evidence%2520for%2520expression%2520and%2520function%2520of%2520the%2520VEGF-C%252FVEGFR-3%2520axis%2520in%2520cancer%2520cells%26jtitle%3DCancer%2520Cell%26date%3D2008%26volume%3D13%26spage%3D557%26epage%3D560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Cance, W. G.; Golubovskaia, V. M.; Kurenova, E. V.; Ostrov, D. A.</span><span> </span><span class="NLM_article-title">Focal Adhesion Kinase Protein Binding Inhibitors</span>. Provisional Patent 61/192,192, September 15,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=W.+G.+Cance&author=V.+M.+Golubovskaia&author=E.+V.+Kurenova&author=D.+A.+Ostrov&title=Focal+Adhesion+Kinase+Protein+Binding+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCance%26aufirst%3DW.%2BG.%26atitle%3DFocal%2520Adhesion%2520Kinase%2520Protein%2520Binding%2520Inhibitors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Arold, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoellerer, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, M. E.</span><span> </span><span class="NLM_article-title">The structural basis of localization and signaling by the focal adhesion targeting domain</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=319-327&author=S.+T.+Aroldauthor=M.+K.+Hoellererauthor=M.+E.+Noble&title=The+structural+basis+of+localization+and+signaling+by+the+focal+adhesion+targeting+domain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArold%26aufirst%3DS.%2BT.%26aulast%3DHoellerer%26aufirst%3DM.%2BK.%26aulast%3DNoble%26aufirst%3DM.%2BE.%26atitle%3DThe%2520structural%2520basis%2520of%2520localization%2520and%2520signaling%2520by%2520the%2520focal%2520adhesion%2520targeting%2520domain%26jtitle%3DStructure%26date%3D2002%26volume%3D10%26spage%3D319%26epage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Verdine, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walensky, L. D.</span><span> </span><span class="NLM_article-title">The challenge of drugging undruggable targets in cancer: lessons learned from targeting BCL-2 family members</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">7264</span><span class="NLM_x">–</span> <span class="NLM_lpage">7270</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1158%2F1078-0432.CCR-07-2184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=18094406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVCktr%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=7264-7270&author=G.+L.+Verdineauthor=L.+D.+Walensky&title=The+challenge+of+drugging+undruggable+targets+in+cancer%3A+lessons+learned+from+targeting+BCL-2+family+members"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">The Challenge of Drugging Undruggable Targets in Cancer: Lessons Learned from Targeting BCL-2 Family Members</span></div><div class="casAuthors">Verdine, Gregory L.; Walensky, Loren D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7264-7270</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The genomic and proteomic revolutions have provided us with an ever-increasing no. of mechanistic insights into cancer pathogenesis.  Mutated genes and pathol. protein products have emerged as the basis for modern anticancer drug development.  With the increasing realization of the importance of disrupting oncogenic protein-protein interaction, new challenges have emerged for classical small mol. and protein-based drug modalities, i.e., the crit. need to target flat and extended protein surfaces.  Here, we highlight two distinct technologies that are being used to bridge the pharmacol. gap between small mols. and protein therapeutics.  With the BCL-2 family of survival proteins as their substrate for intracellular targeting, we conclude that peptide stapling and fragment-based drug discovery show promise to traverse the crit. surface features of proteins that drive human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgYQX3c_4_qLVg90H21EOLACvtfcHk0lgltPtiyJx_mA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVCktr%252FK&md5=1b7fcbe41063e04470f7c34b50410a42</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-2184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-2184%26sid%3Dliteratum%253Aachs%26aulast%3DVerdine%26aufirst%3DG.%2BL.%26aulast%3DWalensky%26aufirst%3DL.%2BD.%26atitle%3DThe%2520challenge%2520of%2520drugging%2520undruggable%2520targets%2520in%2520cancer%253A%2520lessons%2520learned%2520from%2520targeting%2520BCL-2%2520family%2520members%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D7264%26epage%3D7270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Arkin, M.</span><span> </span><span class="NLM_article-title">Protein−protein interactions and cancer: small molecules going in for the kill</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1016%2Fj.cbpa.2005.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=15939335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltVaqt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2005&pages=317-324&author=M.+Arkin&title=Protein%E2%88%92protein+interactions+and+cancer%3A+small+molecules+going+in+for+the+kill"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Protein-protein interactions and cancer: small molecules going in for the kill</span></div><div class="casAuthors">Arkin, Michelle</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">317-324</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  There has been much progress in the discovery of small, org. mols. that inhibit protein-protein interactions, particularly in the field of cancer.  Tubulin polymn. represents a classic target whose function can be allosterically modulated by small mols.  Several protein-protein complexes that regulate apoptosis, or programmed cell death, appear to be particularly amenable to inhibition by small mols., and recently described compds. have helped to characterize Bcl-2, MDM2 and XIAP as drug targets.  Addnl., small-mol. antagonists have recently been described for several new targets, including Rac1-Tiam1, β-catenin-T cell factor (Tcf), and Sur-2-ESX.  Not only is the list of protein-protein inhibitors growing, but the inhibitors themselves are moving closer to treating disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHYj6cW2uvz7Vg90H21EOLACvtfcHk0lgltPtiyJx_mA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltVaqt7Y%253D&md5=e816e6db42b22b8950a78e7463d3cc1b</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2005.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2005.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DArkin%26aufirst%3DM.%26atitle%3DProtein%25E2%2588%2592protein%2520interactions%2520and%2520cancer%253A%2520small%2520molecules%2520going%2520in%2520for%2520the%2520kill%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2005%26volume%3D9%26spage%3D317%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Fry, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassilev, L. T.</span><span> </span><span class="NLM_article-title">Targeting protein−protein interactions for cancer therapy</span> <span class="citation_source-journal">J. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">955</span><span class="NLM_x">–</span> <span class="NLM_lpage">963</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1007%2Fs00109-005-0705-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=16283145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Oks7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2005&pages=955-963&author=D.+C.+Fryauthor=L.+T.+Vassilev&title=Targeting+protein%E2%88%92protein+interactions+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein-protein interactions for cancer therapy</span></div><div class="casAuthors">Fry, David C.; Vassilev, Lyubomir T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Medicine (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">955-963</span>CODEN:
                <span class="NLM_cas:coden">JMLME8</span>;
        ISSN:<span class="NLM_cas:issn">0946-2716</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  An increasing no. of protein-protein interactions have been identified as potential intervention points for the development of anticancer agents.  However, such systems have historically been considered high-risk targets due to the relatively large interaction surfaces involved in protein-protein binding.  This characterization has to be reexamd. as progress has been made recently in identifying small-mol. inhibitors of several protein-protein systems in oncol. including the p53-MDM2 interaction.  This review presents a survey of protein-protein interactions that have been identified as potential oncol. targets and evaluates their attractiveness in terms of drug discovery.  The anal. focuses primarily on the structural characteristics of the participating binding sites, particularly the dimensions of the sites.  Known ligands are also examd., esp. with regard to their druglikeness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQWZ6S-9Msl7Vg90H21EOLACvtfcHk0lgltPtiyJx_mA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Oks7%252FM&md5=42c67ff28620061839842acd47c6948e</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2Fs00109-005-0705-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00109-005-0705-x%26sid%3Dliteratum%253Aachs%26aulast%3DFry%26aufirst%3DD.%2BC.%26aulast%3DVassilev%26aufirst%3DL.%2BT.%26atitle%3DTargeting%2520protein%25E2%2588%2592protein%2520interactions%2520for%2520cancer%2520therapy%26jtitle%3DJ.%2520Mol.%2520Med.%26date%3D2005%26volume%3D83%26spage%3D955%26epage%3D963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Vassilev, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carvajal, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podlaski, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filipovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kammlott, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukacs, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotouhi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, E. A.</span><span> </span><span class="NLM_article-title">In vivo activation of the p53 pathway by small-molecule antagonists of MDM2</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">844</span><span class="NLM_x">–</span> <span class="NLM_lpage">848</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1126%2Fscience.1092472" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=14704432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovVKmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2004&pages=844-848&author=L.+T.+Vassilevauthor=B.+T.+Vuauthor=B.+Gravesauthor=D.+Carvajalauthor=F.+Podlaskiauthor=Z.+Filipovicauthor=N.+Kongauthor=U.+Kammlottauthor=C.+Lukacsauthor=C.+Kleinauthor=N.+Fotouhiauthor=E.+A.+Liu&title=In+vivo+activation+of+the+p53+pathway+by+small-molecule+antagonists+of+MDM2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2</span></div><div class="casAuthors">Vassilev, Lyubomir T.; Vu, Binh T.; Graves, Bradford; Carvajal, Daisy; Podlaski, Frank; Filipovic, Zoran; Kong, Norman; Kammlott, Ursula; Lukacs, Christine; Klein, Christian; Fotouhi, Nader; Liu, Emily A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">5659</span>),
    <span class="NLM_cas:pages">844-848</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">MDM2 binds the p53 tumor suppressor protein with high affinity and neg. modulates its transcriptional activity and stability.  Overexpression of MDM2, found in many human tumors, effectively impairs p53 function.  Inhibition of MDM2-p53 interaction can stabilize p53 and may offer a novel strategy for cancer therapy.  Here, we identify potent and selective small-mol. antagonists of MDM2 and confirm their mode of action through the crystal structures of complexes.  These compds. bind MDM2 in the p53-binding pocket and activate the p53 pathway in cancer cells, leading to cell cycle arrest, apoptosis, and growth inhibition of human tumor xenografts in nude mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzumitGD6V4bVg90H21EOLACvtfcHk0lg4eD9_9ldZCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovVKmtA%253D%253D&md5=cf80c399e8eca8766be1023cda438df3</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1126%2Fscience.1092472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1092472%26sid%3Dliteratum%253Aachs%26aulast%3DVassilev%26aufirst%3DL.%2BT.%26aulast%3DVu%26aufirst%3DB.%2BT.%26aulast%3DGraves%26aufirst%3DB.%26aulast%3DCarvajal%26aufirst%3DD.%26aulast%3DPodlaski%26aufirst%3DF.%26aulast%3DFilipovic%26aufirst%3DZ.%26aulast%3DKong%26aufirst%3DN.%26aulast%3DKammlott%26aufirst%3DU.%26aulast%3DLukacs%26aufirst%3DC.%26aulast%3DKlein%26aufirst%3DC.%26aulast%3DFotouhi%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DE.%2BA.%26atitle%3DIn%2520vivo%2520activation%2520of%2520the%2520p53%2520pathway%2520by%2520small-molecule%2520antagonists%2520of%2520MDM2%26jtitle%3DScience%26date%3D2004%26volume%3D303%26spage%3D844%26epage%3D848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Liu, T.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFortune, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohmori, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatakeyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Groot, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yung, W. K. A.</span><span> </span><span class="NLM_article-title">Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1357</span><span class="NLM_x">–</span> <span class="NLM_lpage">1367</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1158%2F1535-7163.MCT-06-0476" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=17431114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktFams7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=1357-1367&author=T.-J.+Liuauthor=T.+LaFortuneauthor=T.+Hondaauthor=O.+Ohmoriauthor=S.+Hatakeyamaauthor=T.+Meyerauthor=D.+Jacksonauthor=J.+de+Grootauthor=W.+K.+A.+Yung&title=Inhibition+of+both+focal+adhesion+kinase+and+insulin-like+growth+factor-I+receptor+kinase+suppresses+glioma+proliferation+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo</span></div><div class="casAuthors">Liu, Ta-Jen; LaFortune, Tiffany; Honda, Toshiyuki; Ohmori, Osamu; Hatakeyama, Shinji; Meyer, Thomas; Jackson, Dowdy; de Groot, John; Yung, W. K. Alfred</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1357-1367</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Multiple genetic aberrations in human gliomas contribute to their highly infiltrative and rapid growth characteristics.  Focal adhesion kinase (FAK) regulates tumor migration and invasion.  Insulin-like growth factor-I receptor (IGF-IR), whose expression correlates with tumor grade, is involved in proliferation and survival.  We hypothesized that inhibiting the phosphorylation of FAK and IGF-IR by NVP-TAE226 (hereafter called TAE226), a novel dual tyrosine kinase inhibitor of FAK and IGF-IR, would suppress the growth and invasion of glioma cells.  In culture, TAE226 inhibited extracellular matrix-induced autophosphorylation of FAK (Tyr397).  TAE226 also inhibited IGF-I-induced phosphorylation of IGF-IR and activity of its downstream target genes such as MAPK and Akt.  TAE226 retarded tumor cell growth as assessed by a cell viability assay and attenuated G2-M cell cycle progression assocd. with a decrease in cyclin B1 and phosphorylated cdc2 (Tyr15) protein expression.  TAE226 treatment inhibited tumor cell invasion by at least 50% compared with the control in an in vitro Matrigel invasion assay.  Interestingly, TAE226 treatment of tumor cells contg. wild-type p53 mainly exhibited G2-M arrest, whereas tumor cells bearing mutant p53 underwent apoptosis.  Induction of apoptosis by TAE226 was substantiated by detection of caspase-3/7 activation and poly(ADP-ribose) polymerase cleavage and by an Annexin V apoptosis assay.  More importantly, TAE226 treatment significantly increased the survival rate of animals in an intracranial glioma xenograft model.  Collectively, these data show that blocking the signaling pathways of FAK and IGF-IR with TAE226 has the potential to be an efficacious treatment for human gliomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQMIquqcQABrVg90H21EOLACvtfcHk0lg4eD9_9ldZCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktFams7o%253D&md5=1659c50e987e8bbb24c998e0aae14861</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0476%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DT.-J.%26aulast%3DLaFortune%26aufirst%3DT.%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DOhmori%26aufirst%3DO.%26aulast%3DHatakeyama%26aufirst%3DS.%26aulast%3DMeyer%26aufirst%3DT.%26aulast%3DJackson%26aufirst%3DD.%26aulast%3Dde%2BGroot%26aufirst%3DJ.%26aulast%3DYung%26aufirst%3DW.%2BK.%2BA.%26atitle%3DInhibition%2520of%2520both%2520focal%2520adhesion%2520kinase%2520and%2520insulin-like%2520growth%2520factor-I%2520receptor%2520kinase%2520suppresses%2520glioma%2520proliferation%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D1357%26epage%3D1367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Kirkin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiele, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazitschek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohde, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fellbrich, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weich, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waltenberger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sleeman, J. P.</span><span> </span><span class="NLM_article-title">MAZ51, an indolinone that inhibits endothelial cell and tumor cell growth in vitro, suppresses tumor growth in vivo</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">986</span><span class="NLM_x">–</span> <span class="NLM_lpage">993</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1002%2Fijc.20509" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=15386354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVSnsLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2004&pages=986-993&author=V.+Kirkinauthor=W.+Thieleauthor=P.+Baumannauthor=R.+Mazitschekauthor=K.+Rohdeauthor=G.+Fellbrichauthor=H.+Weichauthor=J.+Waltenbergerauthor=A.+Giannisauthor=J.+P.+Sleeman&title=MAZ51%2C+an+indolinone+that+inhibits+endothelial+cell+and+tumor+cell+growth+in+vitro%2C+suppresses+tumor+growth+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">MAZ51, an indolinone that inhibits endothelial cell and tumor cell growth in vitro, suppresses tumor growth in vivo</span></div><div class="casAuthors">Kirkin, Vladimir; Thiele, Wilko; Baumann, Petra; Mazitschek, Ralph; Rohde, Katrin; Fellbrich, Guido; Weich, Herbert; Waltenberger, Johannes; Giannis, Athanassios; Sleeman, Jonathan P.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">986-993</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">We have recently described MAZ51, an indolinone that blocks the ligand-induced autophosphorylation of VEGFR-3, a receptor tyrosine kinase that plays a central role in the regulation of lymphangiogenesis.  Here we show that MAZ51 is able to block the proliferation of VEGFR-3-expressing human endothelial cells and is less potently able to induce their apoptosis.  MAZ51 also inhibits the proliferation and induces the apoptosis of a variety of non-VEGFR-3-expressing tumor cell lines.  These data suggest that MAZ51 blocks the activity of tyrosine kinases in addn. to VEGFR-3.  In vivo, MAZ51 significantly inhibits the growth of rat mammary carcinomas.  These data establish MAZ51 as a compd. with antitumor properties that inhibits tumor growth directly and also indirectly by interfering with tumor-host interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp6UBQk1bx8LVg90H21EOLACvtfcHk0lg4eD9_9ldZCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVSnsLnM&md5=c6819375918c41f02febeedc5df384cf</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fijc.20509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.20509%26sid%3Dliteratum%253Aachs%26aulast%3DKirkin%26aufirst%3DV.%26aulast%3DThiele%26aufirst%3DW.%26aulast%3DBaumann%26aufirst%3DP.%26aulast%3DMazitschek%26aufirst%3DR.%26aulast%3DRohde%26aufirst%3DK.%26aulast%3DFellbrich%26aufirst%3DG.%26aulast%3DWeich%26aufirst%3DH.%26aulast%3DWaltenberger%26aufirst%3DJ.%26aulast%3DGiannis%26aufirst%3DA.%26aulast%3DSleeman%26aufirst%3DJ.%2BP.%26atitle%3DMAZ51%252C%2520an%2520indolinone%2520that%2520inhibits%2520endothelial%2520cell%2520and%2520tumor%2520cell%2520growth%2520in%2520vitro%252C%2520suppresses%2520tumor%2520growth%2520in%2520vivo%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2004%26volume%3D112%26spage%3D986%26epage%3D993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Olsson, A.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreuger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claesson-Welsh, L.</span><span> </span><span class="NLM_article-title">VEGF receptor signalling—in control of vascular function</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">371</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1038%2Fnrm1911" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=16633338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD28XjslSktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=359-371&author=A.-K.+Olssonauthor=A.+Dimbergauthor=J.+Kreugerauthor=L.+Claesson-Welsh&title=VEGF+receptor+signalling%E2%80%94in+control+of+vascular+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">VEGF receptor signaling - in control of vascular function</span></div><div class="casAuthors">Olsson, Anna-Karin; Dimberg, Anna; Kreuger, Johan; Claesson-Welsh, Lena</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">359-371</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Vascular endothelial growth-factor receptors (VEGFRs) regulate the cardiovascular system.  VEGFR1 is required for the recruitment of hematopoietic precursors and migration of monocytes and macrophages, whereas VEGFR2 and VEGFR3 are essential for the functions of vascular endothelial and lymphendothelial cells, resp.  Recent insights have shed light onto VEGFR signal transduction and the interplay between different VEGFRs and VEGF co-receptors in development, adult physiol. and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-6sAaLO1e57Vg90H21EOLACvtfcHk0lgSub91o3n8uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjslSktrc%253D&md5=82711ef5c267a382bb2ba22e468d2d68</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fnrm1911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1911%26sid%3Dliteratum%253Aachs%26aulast%3DOlsson%26aufirst%3DA.-K.%26aulast%3DDimberg%26aufirst%3DA.%26aulast%3DKreuger%26aufirst%3DJ.%26aulast%3DClaesson-Welsh%26aufirst%3DL.%26atitle%3DVEGF%2520receptor%2520signalling%25E2%2580%2594in%2520control%2520of%2520vascular%2520function%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2006%26volume%3D7%26spage%3D359%26epage%3D371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Honti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Putnoky, G.</span><span> </span><span class="NLM_article-title">The effect of subcutaneously administered suprastin on ascites tumor strains in mice</span> <span class="citation_source-journal">Z. Gesamte Inn. Med. Ihre Grenzgeb.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1963</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">801</span><span class="NLM_x">–</span> <span class="NLM_lpage">803</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=14095005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A280%3ADyaF2c%252Flt1Krtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1963&pages=801-803&author=G.+Hontiauthor=G.+Putnoky&title=The+effect+of+subcutaneously+administered+suprastin+on+ascites+tumor+strains+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">THE EFFECT OF SUBCUTANEOUSLY ADMINISTERED SUPRASTIN ON ASCITES TUMOR STRAINS IN MICE</span></div><div class="casAuthors">HONTI G; PUTNOKY G</div><div class="citationInfo"><span class="NLM_cas:title">Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete</span>
        (<span class="NLM_cas:date">1963</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">801-3</span>
        ISSN:<span class="NLM_cas:issn">0044-2542</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSgKMtJDCUVW8jl5L8hwNX0fW6udTcc2ebw2GxwQIG3Arntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaF2c%252Flt1Krtg%253D%253D&md5=291b217b55471c1f57f48e176245e0c6</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHonti%26aufirst%3DG.%26aulast%3DPutnoky%26aufirst%3DG.%26atitle%3DThe%2520effect%2520of%2520subcutaneously%2520administered%2520suprastin%2520on%2520ascites%2520tumor%2520strains%2520in%2520mice%26jtitle%3DZ.%2520Gesamte%2520Inn.%2520Med.%2520Ihre%2520Grenzgeb.%26date%3D1963%26volume%3D18%26spage%3D801%26epage%3D803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Kahlson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosengren, E.</span><span> </span><span class="NLM_article-title">New approaches to the physiology of histamine</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1968</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1968&pages=155-196&author=G.+Kahlsonauthor=E.+Rosengren&title=New+approaches+to+the+physiology+of+histamine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKahlson%26aufirst%3DG.%26aulast%3DRosengren%26aufirst%3DE.%26atitle%3DNew%2520approaches%2520to%2520the%2520physiology%2520of%2520histamine%26jtitle%3DPhysiol.%2520Rev.%26date%3D1968%26volume%3D48%26spage%3D155%26epage%3D196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">van Nimwegen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huigsloot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tijdens, I. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Water, B.</span><span> </span><span class="NLM_article-title">Focal adhesion kinase and protein kinase B cooperate to suppress doxorubicin-induced apoptosis of breast tumor cells</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1330</span><span class="NLM_x">–</span> <span class="NLM_lpage">1339</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=1330-1339&author=M.+J.+van+Nimwegenauthor=M.+Huigslootauthor=A.+Camierauthor=I.+B.+Tijdensauthor=B.+van+de+Water&title=Focal+adhesion+kinase+and+protein+kinase+B+cooperate+to+suppress+doxorubicin-induced+apoptosis+of+breast+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BNimwegen%26aufirst%3DM.%2BJ.%26aulast%3DHuigsloot%26aufirst%3DM.%26aulast%3DCamier%26aufirst%3DA.%26aulast%3DTijdens%26aufirst%3DI.%2BB.%26aulast%3Dvan%2Bde%2BWater%26aufirst%3DB.%26atitle%3DFocal%2520adhesion%2520kinase%2520and%2520protein%2520kinase%2520B%2520cooperate%2520to%2520suppress%2520doxorubicin-induced%2520apoptosis%2520of%2520breast%2520tumor%2520cells%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D1330%26epage%3D1339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Sandberg, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostrov, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sayeski, P. P.</span><span> </span><span class="NLM_article-title">Identification of 1,2,3,4,5,6-hexabromocyclohexane as a small molecule inhibitor of jak2 tyrosine kinase autophosphorylation [correction of autophophorylation]</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2526</span><span class="NLM_x">–</span> <span class="NLM_lpage">2533</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049470k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2526-2533&author=E.+M.+Sandbergauthor=X.+Maauthor=K.+Heauthor=S.+J.+Frankauthor=D.+A.+Ostrovauthor=P.+P.+Sayeski&title=Identification+of+1%2C2%2C3%2C4%2C5%2C6-hexabromocyclohexane+as+a+small+molecule+inhibitor+of+jak2+tyrosine+kinase+autophosphorylation+%5Bcorrection+of+autophophorylation%5D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm049470k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049470k%26sid%3Dliteratum%253Aachs%26aulast%3DSandberg%26aufirst%3DE.%2BM.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DK.%26aulast%3DFrank%26aufirst%3DS.%2BJ.%26aulast%3DOstrov%26aufirst%3DD.%2BA.%26aulast%3DSayeski%26aufirst%3DP.%2BP.%26atitle%3DIdentification%2520of%25201%252C2%252C3%252C4%252C5%252C6-hexabromocyclohexane%2520as%2520a%2520small%2520molecule%2520inhibitor%2520of%2520jak2%2520tyrosine%2520kinase%2520autophosphorylation%2520%255Bcorrection%2520of%2520autophophorylation%255D%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2526%26epage%3D2533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Richards, F. M.</span><span> </span><span class="NLM_article-title">Areas, volumes, packing and protein structure</span> <span class="citation_source-journal">Annu. Rev. Biophys. Bioeng.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">176</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1146%2Fannurev.bb.06.060177.001055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=326146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADyaE2sXks1CisrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1977&pages=151-176&author=F.+M.+Richards&title=Areas%2C+volumes%2C+packing+and+protein+structure"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Areas, volumes, packing, and protein structure</span></div><div class="casAuthors">Richards, Frederic M.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biophysics and Bioengineering</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">151-76</span>CODEN:
                <span class="NLM_cas:coden">ABPBBK</span>;
        ISSN:<span class="NLM_cas:issn">0084-6589</span>.
    </div><div class="casAbstract">A review with 148 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvHGphzlx3JbVg90H21EOLACvtfcHk0ljF44U6wyYWXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXks1CisrY%253D&md5=13c917ccbda3f36f1c6390a42c712818</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1146%2Fannurev.bb.06.060177.001055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.bb.06.060177.001055%26sid%3Dliteratum%253Aachs%26aulast%3DRichards%26aufirst%3DF.%2BM.%26atitle%3DAreas%252C%2520volumes%252C%2520packing%2520and%2520protein%2520structure%26jtitle%3DAnnu.%2520Rev.%2520Biophys.%2520Bioeng.%26date%3D1977%26volume%3D6%26spage%3D151%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 43 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yang Lu, <span class="NLM_string-name hlFld-ContribAuthor">Haiying Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Progress in the Development of Small Molecular Inhibitors of Focal Adhesion Kinase (FAK). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (23)
                                     , 14382-14403. <a href="https://doi.org/10.1021/acs.jmedchem.0c01248" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01248</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01248%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DProgress%252Bin%252Bthe%252BDevelopment%252Bof%252BSmall%252BMolecular%252BInhibitors%252Bof%252BFocal%252BAdhesion%252BKinase%252B%252528FAK%252529%26aulast%3DLu%26aufirst%3DYang%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D17072020%26date%3D15102020%26volume%3D63%26issue%3D23%26spage%3D14382%26epage%3D14403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timo  Heinrich</span>, <span class="hlFld-ContribAuthor ">Jeyaprakashnarayanan  Seenisamy</span>, <span class="hlFld-ContribAuthor ">Lourdusamy  Emmanuvel</span>, <span class="hlFld-ContribAuthor ">Santosh S.  Kulkarni</span>, <span class="hlFld-ContribAuthor ">Jörg  Bomke</span>, <span class="hlFld-ContribAuthor ">Felix  Rohdich</span>, <span class="hlFld-ContribAuthor ">Hartmut  Greiner</span>, <span class="hlFld-ContribAuthor ">Christina  Esdar</span>, <span class="hlFld-ContribAuthor ">Mireille  Krier</span>, <span class="hlFld-ContribAuthor ">Ulrich  Grädler</span>, and <span class="hlFld-ContribAuthor ">Djordje  Musil</span>  . </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Discovery of New Highly Substituted 1H-Pyrrolo[2,3-b]- and 3H-Imidazolo[4,5-b]-Pyridines as Focal Adhesion Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (3)
                                     , 1160-1170. <a href="https://doi.org/10.1021/jm3016014" title="DOI URL">https://doi.org/10.1021/jm3016014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3016014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3016014%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFragment-Based%252BDiscovery%252Bof%252BNew%252BHighly%252BSubstituted%252B1H-Pyrrolo%25255B2%25252C3-b%25255D-%252Band%252B3H-Imidazolo%25255B4%25252C5-b%25255D-Pyridines%252Bas%252BFocal%252BAdhesion%252BKinase%252BInhibitors%26aulast%3DHeinrich%26aufirst%3DTimo%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D30102012%26date%3D22012013%26date%3D14022013%26date%3D08012013%26volume%3D56%26issue%3D3%26spage%3D1160%26epage%3D1170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ioanna  Antoniades</span>, <span class="hlFld-ContribAuthor ">Maria  Kyriakou</span>, <span class="hlFld-ContribAuthor ">Anna  Charalambous</span>, <span class="hlFld-ContribAuthor ">Katerina  Kalalidou</span>, <span class="hlFld-ContribAuthor ">Andri  Christodoulou</span>, <span class="hlFld-ContribAuthor ">Maria  Christoforou</span>, <span class="hlFld-ContribAuthor ">Paris A.  Skourides</span>. </span><span class="cited-content_cbyCitation_article-title">FAK displacement from focal adhesions: a promising strategy to target processes implicated in cancer progression and metastasis. </span><span class="cited-content_cbyCitation_journal-name">Cell Communication and Signaling</span><span> <strong>2021,</strong> <em>19 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12964-020-00671-1" title="DOI URL">https://doi.org/10.1186/s12964-020-00671-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12964-020-00671-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12964-020-00671-1%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Communication%2520and%2520Signaling%26atitle%3DFAK%252Bdisplacement%252Bfrom%252Bfocal%252Badhesions%25253A%252Ba%252Bpromising%252Bstrategy%252Bto%252Btarget%252Bprocesses%252Bimplicated%252Bin%252Bcancer%252Bprogression%252Band%252Bmetastasis%26aulast%3DAntoniades%26aufirst%3DIoanna%26date%3D2021%26date%3D2021%26volume%3D19%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antoine  Mousson</span>, <span class="hlFld-ContribAuthor ">Marlène  Legrand</span>, <span class="hlFld-ContribAuthor ">Tania  Steffan</span>, <span class="hlFld-ContribAuthor ">Romain  Vauchelles</span>, <span class="hlFld-ContribAuthor ">Philippe  Carl</span>, <span class="hlFld-ContribAuthor ">Jean-Pierre  Gies</span>, <span class="hlFld-ContribAuthor ">Maxime  Lehmann</span>, <span class="hlFld-ContribAuthor ">Guy  Zuber</span>, <span class="hlFld-ContribAuthor ">Jan  De Mey</span>, <span class="hlFld-ContribAuthor ">Denis  Dujardin</span>, <span class="hlFld-ContribAuthor ">Emilie  Sick</span>, <span class="hlFld-ContribAuthor ">Philippe  Rondé</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibiting FAK–Paxillin Interaction Reduces Migration and Invadopodia-Mediated Matrix Degradation in Metastatic Melanoma Cells. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (8)
                                     , 1871. <a href="https://doi.org/10.3390/cancers13081871" title="DOI URL">https://doi.org/10.3390/cancers13081871</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13081871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13081871%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DInhibiting%252BFAK%2525E2%252580%252593Paxillin%252BInteraction%252BReduces%252BMigration%252Band%252BInvadopodia-Mediated%252BMatrix%252BDegradation%252Bin%252BMetastatic%252BMelanoma%252BCells%26aulast%3DMousson%26aufirst%3DAntoine%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D8%26spage%3D1871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eleni  Michael</span>, <span class="hlFld-ContribAuthor ">Savvas  Polydorides</span>, <span class="hlFld-ContribAuthor ">Vasilis J.  Promponas</span>, <span class="hlFld-ContribAuthor ">Paris  Skourides</span>, <span class="hlFld-ContribAuthor ">Georgios  Archontis</span>. </span><span class="cited-content_cbyCitation_article-title">Recognition of
              LD
              motifs by the focal adhesion targeting domains of focal adhesion kinase and proline‐rich tyrosine kinase 2‐beta: Insights from molecular dynamics simulations. </span><span class="cited-content_cbyCitation_journal-name">Proteins: Structure, Function, and Bioinformatics</span><span> <strong>2021,</strong> <em>89 </em>
                                    (1)
                                     , 29-52. <a href="https://doi.org/10.1002/prot.25992" title="DOI URL">https://doi.org/10.1002/prot.25992</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/prot.25992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fprot.25992%26sid%3Dliteratum%253Aachs%26jtitle%3DProteins%253A%2520Structure%252C%2520Function%252C%2520and%2520Bioinformatics%26atitle%3DRecognition%252Bof%252BLD%252Bmotifs%252Bby%252Bthe%252Bfocal%252Badhesion%252Btargeting%252Bdomains%252Bof%252Bfocal%252Badhesion%252Bkinase%252Band%252Bproline%2525E2%252580%252590rich%252Btyrosine%252Bkinase%252B2%2525E2%252580%252590beta%25253A%252BInsights%252Bfrom%252Bmolecular%252Bdynamics%252Bsimulations%26aulast%3DMichael%26aufirst%3DEleni%26date%3D2021%26date%3D2020%26volume%3D89%26issue%3D1%26spage%3D29%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yumeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Shu  Liu</span>, <span class="hlFld-ContribAuthor ">Shu  Zhou</span>, <span class="hlFld-ContribAuthor ">Dandan  Yu</span>, <span class="hlFld-ContribAuthor ">Junjie  Gu</span>, <span class="hlFld-ContribAuthor ">Qin  Qin</span>, <span class="hlFld-ContribAuthor ">Yu  Cheng</span>, <span class="hlFld-ContribAuthor ">Xinchen  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Focal adhesion kinase: Insight into its roles and therapeutic potential in oesophageal cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancer Letters</span><span> <strong>2021,</strong> <em>496 </em>, 93-103. <a href="https://doi.org/10.1016/j.canlet.2020.10.005" title="DOI URL">https://doi.org/10.1016/j.canlet.2020.10.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.canlet.2020.10.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.canlet.2020.10.005%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Letters%26atitle%3DFocal%252Badhesion%252Bkinase%25253A%252BInsight%252Binto%252Bits%252Broles%252Band%252Btherapeutic%252Bpotential%252Bin%252Boesophageal%252Bcancer%26aulast%3DZhang%26aufirst%3DYumeng%26date%3D2021%26volume%3D496%26spage%3D93%26epage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joshua T.  Burgess</span>, <span class="hlFld-ContribAuthor ">Emma  Bolderson</span>, <span class="hlFld-ContribAuthor ">Mark N.  Adams</span>, <span class="hlFld-ContribAuthor ">Pascal H. G.  Duijf</span>, <span class="hlFld-ContribAuthor ">Shu-Dong  Zhang</span>, <span class="hlFld-ContribAuthor ">Steven G.  Gray</span>, <span class="hlFld-ContribAuthor ">Gavin  Wright</span>, <span class="hlFld-ContribAuthor ">Derek J.  Richard</span>, <span class="hlFld-ContribAuthor ">Kenneth J.  O’Byrne</span>. </span><span class="cited-content_cbyCitation_article-title">SASH1 is a prognostic indicator and potential therapeutic target in non-small cell lung cancer. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-75625-1" title="DOI URL">https://doi.org/10.1038/s41598-020-75625-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-75625-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-75625-1%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DSASH1%252Bis%252Ba%252Bprognostic%252Bindicator%252Band%252Bpotential%252Btherapeutic%252Btarget%252Bin%252Bnon-small%252Bcell%252Blung%252Bcancer%26aulast%3DBurgess%26aufirst%3DJoshua%2BT.%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sahar B.  Kandil</span>, <span class="hlFld-ContribAuthor ">Samuel R.  Jones</span>, <span class="hlFld-ContribAuthor ">Sonia  Smith</span>, <span class="hlFld-ContribAuthor ">Stephen E.  Hiscox</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Westwell</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Virtual Screening, Synthesis and Biological Evaluation of Potential FAK-FAT Domain Inhibitors for Treatment of Metastatic Cancer. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (15)
                                     , 3488. <a href="https://doi.org/10.3390/molecules25153488" title="DOI URL">https://doi.org/10.3390/molecules25153488</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25153488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25153488%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DStructure-Based%252BVirtual%252BScreening%25252C%252BSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BPotential%252BFAK-FAT%252BDomain%252BInhibitors%252Bfor%252BTreatment%252Bof%252BMetastatic%252BCancer%26aulast%3DKandil%26aufirst%3DSahar%2BB.%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D15%26spage%3D3488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Girieca  Lorusso</span>, <span class="hlFld-ContribAuthor ">Curzio  Rüegg</span>, <span class="hlFld-ContribAuthor ">François  Kuonen</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the Extra-Cellular Matrix—Tumor Cell Crosstalk for Anti-Cancer Therapy: Emerging Alternatives to Integrin Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2020,</strong> <em>10 </em><a href="https://doi.org/10.3389/fonc.2020.01231" title="DOI URL">https://doi.org/10.3389/fonc.2020.01231</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2020.01231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2020.01231%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DTargeting%252Bthe%252BExtra-Cellular%252BMatrix%2525E2%252580%252594Tumor%252BCell%252BCrosstalk%252Bfor%252BAnti-Cancer%252BTherapy%25253A%252BEmerging%252BAlternatives%252Bto%252BIntegrin%252BInhibitors%26aulast%3DLorusso%26aufirst%3DGirieca%26date%3D2020%26date%3D2020%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Connor M.  Blair</span>, <span class="hlFld-ContribAuthor ">Nicola M.  Walsh</span>, <span class="hlFld-ContribAuthor ">Bruce H.  Littman</span>, <span class="hlFld-ContribAuthor ">Frank W.  Marcoux</span>, <span class="hlFld-ContribAuthor ">George S.  Baillie</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting B-Raf inhibitor resistant melanoma with novel cell penetrating peptide disrupters of PDE8A – C-Raf. </span><span class="cited-content_cbyCitation_journal-name">BMC Cancer</span><span> <strong>2019,</strong> <em>19 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12885-019-5489-4" title="DOI URL">https://doi.org/10.1186/s12885-019-5489-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12885-019-5489-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12885-019-5489-4%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Cancer%26atitle%3DTargeting%252BB-Raf%252Binhibitor%252Bresistant%252Bmelanoma%252Bwith%252Bnovel%252Bcell%252Bpenetrating%252Bpeptide%252Bdisrupters%252Bof%252BPDE8A%252B%2525E2%252580%252593%252BC-Raf%26aulast%3DBlair%26aufirst%3DConnor%2BM.%26date%3D2019%26date%3D2019%26volume%3D19%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frank  Aboubakar Nana</span>, <span class="hlFld-ContribAuthor ">Marie  Vanderputten</span>, <span class="hlFld-ContribAuthor ">Sebahat  Ocak</span>. </span><span class="cited-content_cbyCitation_article-title">Role of Focal Adhesion Kinase in Small-Cell Lung Cancer and Its Potential as a Therapeutic Target. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2019,</strong> <em>11 </em>
                                    (11)
                                     , 1683. <a href="https://doi.org/10.3390/cancers11111683" title="DOI URL">https://doi.org/10.3390/cancers11111683</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers11111683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers11111683%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DRole%252Bof%252BFocal%252BAdhesion%252BKinase%252Bin%252BSmall-Cell%252BLung%252BCancer%252Band%252BIts%252BPotential%252Bas%252Ba%252BTherapeutic%252BTarget%26aulast%3DAboubakar%2BNana%26aufirst%3DFrank%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D11%26spage%3D1683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frank  Aboubakar Nana</span>, <span class="hlFld-ContribAuthor ">Marylène  Lecocq</span>, <span class="hlFld-ContribAuthor ">Maha Zohra  Ladjemi</span>, <span class="hlFld-ContribAuthor ">Bruno  Detry</span>, <span class="hlFld-ContribAuthor ">Sébastien  Dupasquier</span>, <span class="hlFld-ContribAuthor ">Olivier  Feron</span>, <span class="hlFld-ContribAuthor ">Pierre P.  Massion</span>, <span class="hlFld-ContribAuthor ">Yves  Sibille</span>, <span class="hlFld-ContribAuthor ">Charles  Pilette</span>, <span class="hlFld-ContribAuthor ">Sebahat  Ocak</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic Potential of Focal Adhesion Kinase Inhibition in Small Cell Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2019,</strong> <em>18 </em>
                                    (1)
                                     , 17-27. <a href="https://doi.org/10.1158/1535-7163.MCT-18-0328" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-18-0328</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-18-0328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-18-0328%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DTherapeutic%252BPotential%252Bof%252BFocal%252BAdhesion%252BKinase%252BInhibition%252Bin%252BSmall%252BCell%252BLung%252BCancer%26aulast%3DAboubakar%2BNana%26aufirst%3DFrank%26date%3D2019%26date%3D2018%26volume%3D18%26issue%3D1%26spage%3D17%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elizabeth  Baker</span>, <span class="hlFld-ContribAuthor ">Naomi  Whiteoak</span>, <span class="hlFld-ContribAuthor ">Louise  Hall</span>, <span class="hlFld-ContribAuthor ">James  France</span>, <span class="hlFld-ContribAuthor ">Deborah  Wilson</span>, <span class="hlFld-ContribAuthor ">Pudupalayam  Bhaskar</span>. </span><span class="cited-content_cbyCitation_article-title">Mammaglobin-A, VEGFR3, and Ki67 in Human Breast Cancer Pathology and Five Year Survival. </span><span class="cited-content_cbyCitation_journal-name">Breast Cancer: Basic and Clinical Research</span><span> <strong>2019,</strong> <em>13 </em>, 117822341985895. <a href="https://doi.org/10.1177/1178223419858957" title="DOI URL">https://doi.org/10.1177/1178223419858957</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1178223419858957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1178223419858957%26sid%3Dliteratum%253Aachs%26jtitle%3DBreast%2520Cancer%253A%2520Basic%2520and%2520Clinical%2520Research%26atitle%3DMammaglobin-A%25252C%252BVEGFR3%25252C%252Band%252BKi67%252Bin%252BHuman%252BBreast%252BCancer%252BPathology%252Band%252BFive%252BYear%252BSurvival%26aulast%3DBaker%26aufirst%3DElizabeth%26date%3D2019%26date%3D2019%26volume%3D13%26spage%3D117822341985895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antoine  Mousson</span>, <span class="hlFld-ContribAuthor ">Emilie  Sick</span>, <span class="hlFld-ContribAuthor ">Philippe  Carl</span>, <span class="hlFld-ContribAuthor ">Denis  Dujardin</span>, <span class="hlFld-ContribAuthor ">Jan  De Mey</span>, <span class="hlFld-ContribAuthor ">Philippe  Rondé</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Focal Adhesion Kinase Using Inhibitors of Protein-Protein Interactions. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2018,</strong> <em>10 </em>
                                    (9)
                                     , 278. <a href="https://doi.org/10.3390/cancers10090278" title="DOI URL">https://doi.org/10.3390/cancers10090278</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers10090278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers10090278%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DTargeting%252BFocal%252BAdhesion%252BKinase%252BUsing%252BInhibitors%252Bof%252BProtein-Protein%252BInteractions%26aulast%3DMousson%26aufirst%3DAntoine%26date%3D2018%26date%3D2018%26volume%3D10%26issue%3D9%26spage%3D278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nassim  Khosravi</span>, <span class="hlFld-ContribAuthor ">Heath  Skinner</span>, <span class="hlFld-ContribAuthor ">John  Heymach</span>. </span><span class="cited-content_cbyCitation_article-title">FAK as a Target for Therapy in Head and Neck Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 469-490. <a href="https://doi.org/10.1007/978-3-319-78762-6_17" title="DOI URL">https://doi.org/10.1007/978-3-319-78762-6_17</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-78762-6_17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-78762-6_17%26sid%3Dliteratum%253Aachs%26atitle%3DFAK%252Bas%252Ba%252BTarget%252Bfor%252BTherapy%252Bin%252BHead%252Band%252BNeck%252BCancer%26aulast%3DKhosravi%26aufirst%3DNassim%26date%3D2018%26date%3D2018%26spage%3D469%26epage%3D490%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DMolecular%252BDeterminants%252Bof%252BHead%252Band%252BNeck%252BCancer%26aulast%3DBurtness%26aufirst%3DBarbara%26date%3D2018%26volume%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liyan  Yue</span>, <span class="hlFld-ContribAuthor ">Wei  Wan</span>, <span class="hlFld-ContribAuthor ">Pan  Xu</span>, <span class="hlFld-ContribAuthor ">Linjuan  Li</span>, <span class="hlFld-ContribAuthor ">Chen  Wang</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Heng  Xu</span>, <span class="hlFld-ContribAuthor ">Rukang  Zhang</span>, <span class="hlFld-ContribAuthor ">Junchi  Hu</span>, <span class="hlFld-ContribAuthor ">Wenchao  Lu</span>, <span class="hlFld-ContribAuthor ">Hao  Jiang</span>, <span class="hlFld-ContribAuthor ">Cheng  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Small Molecule Inhibitors Targeting New Targets of Protein-Protein Interactions. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 179-211. <a href="https://doi.org/10.1007/978-981-13-0773-7_7" title="DOI URL">https://doi.org/10.1007/978-981-13-0773-7_7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-13-0773-7_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-13-0773-7_7%26sid%3Dliteratum%253Aachs%26atitle%3DSmall%252BMolecule%252BInhibitors%252BTargeting%252BNew%252BTargets%252Bof%252BProtein-Protein%252BInteractions%26aulast%3DYue%26aufirst%3DLiyan%26date%3D2018%26date%3D2018%26spage%3D179%26epage%3D211%26pub%3DSpringer%2520Singapore%26atitle%3DTargeting%252BProtein-Protein%252BInteractions%252Bby%252BSmall%252BMolecules%26aulast%3DSheng%26aufirst%3DChunquan%26date%3D2018%26volume%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Fang</span>, <span class="hlFld-ContribAuthor ">Dawei  Wang</span>, <span class="hlFld-ContribAuthor ">Xingyu  Xu</span>, <span class="hlFld-ContribAuthor ">Gila  Dava</span>, <span class="hlFld-ContribAuthor ">Jianping  Liu</span>, <span class="hlFld-ContribAuthor ">Xiang  Li</span>, <span class="hlFld-ContribAuthor ">Qianqian  Xue</span>, <span class="hlFld-ContribAuthor ">Huan  Wang</span>, <span class="hlFld-ContribAuthor ">Jiangshan  Zhang</span>, <span class="hlFld-ContribAuthor ">Huabei  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Preparation,
              in vitro
              and
              in vivo
              evaluation, and molecular dynamics (MD) simulation studies of novel F-18 labeled tumor imaging agents targeting focal adhesion kinase (FAK). </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2018,</strong> <em>8 </em>
                                    (19)
                                     , 10333-10345. <a href="https://doi.org/10.1039/C8RA00652K" title="DOI URL">https://doi.org/10.1039/C8RA00652K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8RA00652K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8RA00652K%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DPreparation%25252C%252Bin%252Bvitro%252Band%252Bin%252Bvivo%252Bevaluation%25252C%252Band%252Bmolecular%252Bdynamics%252B%252528MD%252529%252Bsimulation%252Bstudies%252Bof%252Bnovel%252BF-18%252Blabeled%252Btumor%252Bimaging%252Bagents%252Btargeting%252Bfocal%252Badhesion%252Bkinase%252B%252528FAK%252529%26aulast%3DFang%26aufirst%3DYu%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D19%26spage%3D10333%26epage%3D10345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sahar  Kandil</span>, <span class="hlFld-ContribAuthor ">Filippo  Prencipe</span>, <span class="hlFld-ContribAuthor ">Samuel  Jones</span>, <span class="hlFld-ContribAuthor ">Stephen  Hiscox</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Westwell</span>. </span><span class="cited-content_cbyCitation_article-title">The discovery of new and more potent chloropyramine (C4) analogues for the potential treatment of invasive breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2018,</strong> <em>91 </em>
                                    (1)
                                     , 314-321. <a href="https://doi.org/10.1111/cbdd.13083" title="DOI URL">https://doi.org/10.1111/cbdd.13083</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13083%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DThe%252Bdiscovery%252Bof%252Bnew%252Band%252Bmore%252Bpotent%252Bchloropyramine%252B%252528C4%252529%252Banalogues%252Bfor%252Bthe%252Bpotential%252Btreatment%252Bof%252Binvasive%252Bbreast%252Bcancer%26aulast%3DKandil%26aufirst%3DSahar%26date%3D2018%26date%3D2017%26volume%3D91%26issue%3D1%26spage%3D314%26epage%3D321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miodrag  Dragoj</span>, <span class="hlFld-ContribAuthor ">Zorica  Milosevic</span>, <span class="hlFld-ContribAuthor ">Jasna  Bankovic</span>, <span class="hlFld-ContribAuthor ">Nikola  Tanic</span>, <span class="hlFld-ContribAuthor ">Milica  Pesic</span>, <span class="hlFld-ContribAuthor ">Tijana  Stankovic</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting CXCR4 and FAK reverses doxorubicin resistance and suppresses invasion in non-small cell lung carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Cellular Oncology</span><span> <strong>2017,</strong> <em>40 </em>
                                    (1)
                                     , 47-62. <a href="https://doi.org/10.1007/s13402-016-0304-6" title="DOI URL">https://doi.org/10.1007/s13402-016-0304-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13402-016-0304-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13402-016-0304-6%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520Oncology%26atitle%3DTargeting%252BCXCR4%252Band%252BFAK%252Breverses%252Bdoxorubicin%252Bresistance%252Band%252Bsuppresses%252Binvasion%252Bin%252Bnon-small%252Bcell%252Blung%252Bcarcinoma%26aulast%3DDragoj%26aufirst%3DMiodrag%26date%3D2017%26date%3D2016%26volume%3D40%26issue%3D1%26spage%3D47%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Fang</span>, <span class="hlFld-ContribAuthor ">Dawei  Wang</span>, <span class="hlFld-ContribAuthor ">Xingyu  Xu</span>, <span class="hlFld-ContribAuthor ">Jianping  Liu</span>, <span class="hlFld-ContribAuthor ">Aiqin  Wu</span>, <span class="hlFld-ContribAuthor ">Xiang  Li</span>, <span class="hlFld-ContribAuthor ">Qianqian  Xue</span>, <span class="hlFld-ContribAuthor ">Huan  Wang</span>, <span class="hlFld-ContribAuthor ">Hang  Wang</span>, <span class="hlFld-ContribAuthor ">Huabei  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, biological evaluation, and molecular dynamics (MD) simulation studies of three novel F-18 labeled and focal adhesion kinase (FAK) targeted 5-bromo pyrimidines as radiotracers for tumor. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>127 </em>, 493-508. <a href="https://doi.org/10.1016/j.ejmech.2017.01.015" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.01.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.01.015%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Bbiological%252Bevaluation%25252C%252Band%252Bmolecular%252Bdynamics%252B%252528MD%252529%252Bsimulation%252Bstudies%252Bof%252Bthree%252Bnovel%252BF-18%252Blabeled%252Band%252Bfocal%252Badhesion%252Bkinase%252B%252528FAK%252529%252Btargeted%252B5-bromo%252Bpyrimidines%252Bas%252Bradiotracers%252Bfor%252Btumor%26aulast%3DFang%26aufirst%3DYu%26date%3D2017%26volume%3D127%26spage%3D493%26epage%3D508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joshua T.  Burgess</span>, <span class="hlFld-ContribAuthor ">Emma  Bolderson</span>, <span class="hlFld-ContribAuthor ">Jodi M.  Saunus</span>, <span class="hlFld-ContribAuthor ">Shu-Dong  Zhang</span>, <span class="hlFld-ContribAuthor ">Lynne E.  Reid</span>, <span class="hlFld-ContribAuthor ">Anne Marie  McNicol</span>, <span class="hlFld-ContribAuthor ">Sunil R.  Lakhani</span>, <span class="hlFld-ContribAuthor ">Katharine  Cuff</span>, <span class="hlFld-ContribAuthor ">Kerry  Richard</span>, <span class="hlFld-ContribAuthor ">Derek J.  Richard</span>, <span class="hlFld-ContribAuthor ">Kenneth J.  O’Byrne</span>. </span><span class="cited-content_cbyCitation_article-title">SASH1 mediates sensitivity of breast cancer cells to chloropyramine and is associated with prognosis in breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2016,</strong> <em>7 </em>
                                    (45)
                                     , 72807-72818. <a href="https://doi.org/10.18632/oncotarget.12020" title="DOI URL">https://doi.org/10.18632/oncotarget.12020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.12020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.12020%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DSASH1%252Bmediates%252Bsensitivity%252Bof%252Bbreast%252Bcancer%252Bcells%252Bto%252Bchloropyramine%252Band%252Bis%252Bassociated%252Bwith%252Bprognosis%252Bin%252Bbreast%252Bcancer%26aulast%3DBurgess%26aufirst%3DJoshua%2BT.%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D45%26spage%3D72807%26epage%3D72818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Zhang</span>, <span class="hlFld-ContribAuthor ">Huanjie  Shao</span>, <span class="hlFld-ContribAuthor ">Vita M  Golubovskaya</span>, <span class="hlFld-ContribAuthor ">Hongbin  Chen</span>, <span class="hlFld-ContribAuthor ">William  Cance</span>, <span class="hlFld-ContribAuthor ">Alex A  Adjei</span>, <span class="hlFld-ContribAuthor ">Grace K  Dy</span>. </span><span class="cited-content_cbyCitation_article-title">Efficacy of focal adhesion kinase inhibition in non-small cell lung cancer with oncogenically activated MAPK pathways. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Cancer</span><span> <strong>2016,</strong> <em>115 </em>
                                    (2)
                                     , 203-211. <a href="https://doi.org/10.1038/bjc.2016.190" title="DOI URL">https://doi.org/10.1038/bjc.2016.190</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/bjc.2016.190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fbjc.2016.190%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Cancer%26atitle%3DEfficacy%252Bof%252Bfocal%252Badhesion%252Bkinase%252Binhibition%252Bin%252Bnon-small%252Bcell%252Blung%252Bcancer%252Bwith%252Boncogenically%252Bactivated%252BMAPK%252Bpathways%26aulast%3DZhang%26aufirst%3DHao%26date%3D2016%26date%3D2016%26volume%3D115%26issue%3D2%26spage%3D203%26epage%3D211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajani  Kanteti</span>, <span class="hlFld-ContribAuthor ">Surinder K.  Batra</span>, <span class="hlFld-ContribAuthor ">Frances E.  Lennon</span>, <span class="hlFld-ContribAuthor ">Ravi  Salgia</span>. </span><span class="cited-content_cbyCitation_article-title">FAK and paxillin, two potential targets in pancreatic cancer. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2016,</strong> <em>7 </em>
                                    (21)
                                     , 31586-31601. <a href="https://doi.org/10.18632/oncotarget.8040" title="DOI URL">https://doi.org/10.18632/oncotarget.8040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.8040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.8040%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DFAK%252Band%252Bpaxillin%25252C%252Btwo%252Bpotential%252Btargets%252Bin%252Bpancreatic%252Bcancer%26aulast%3DKanteti%26aufirst%3DRajani%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D21%26spage%3D31586%26epage%3D31601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John  Wilton</span>, <span class="hlFld-ContribAuthor ">Elena  Kurenova</span>, <span class="hlFld-ContribAuthor ">Laura  Pitzonka</span>, <span class="hlFld-ContribAuthor ">Allison  Gaudy</span>, <span class="hlFld-ContribAuthor ">Leslie  Curtin</span>, <span class="hlFld-ContribAuthor ">Sandra  Sexton</span>, <span class="hlFld-ContribAuthor ">William  Cance</span>, <span class="hlFld-ContribAuthor ">Gerald  Fetterly</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetic analysis of the FAK scaffold inhibitor C4 in dogs. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Drug Metabolism and Pharmacokinetics</span><span> <strong>2016,</strong> <em>41 </em>
                                    (1)
                                     , 55-67. <a href="https://doi.org/10.1007/s13318-014-0233-6" title="DOI URL">https://doi.org/10.1007/s13318-014-0233-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13318-014-0233-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13318-014-0233-6%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Drug%2520Metabolism%2520and%2520Pharmacokinetics%26atitle%3DPharmacokinetic%252Banalysis%252Bof%252Bthe%252BFAK%252Bscaffold%252Binhibitor%252BC4%252Bin%252Bdogs%26aulast%3DWilton%26aufirst%3DJohn%26date%3D2016%26date%3D2014%26volume%3D41%26issue%3D1%26spage%3D55%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ke  Ren</span>, <span class="hlFld-ContribAuthor ">Xiao  Lu</span>, <span class="hlFld-ContribAuthor ">Nan  Yao</span>, <span class="hlFld-ContribAuthor ">Yong  Chen</span>, <span class="hlFld-ContribAuthor ">Aizhen  Yang</span>, <span class="hlFld-ContribAuthor ">Hui  Chen</span>, <span class="hlFld-ContribAuthor ">Jian  Zhang</span>, <span class="hlFld-ContribAuthor ">Sujia  Wu</span>, <span class="hlFld-ContribAuthor ">Xin  Shi</span>, <span class="hlFld-ContribAuthor ">Chen  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaoliang  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Focal adhesion kinase overexpression and its impact on human osteosarcoma. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2015,</strong> <em>6 </em>
                                    (31)
                                     , 31085-31103. <a href="https://doi.org/10.18632/oncotarget.5044" title="DOI URL">https://doi.org/10.18632/oncotarget.5044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.5044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.5044%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DFocal%252Badhesion%252Bkinase%252Boverexpression%252Band%252Bits%252Bimpact%252Bon%252Bhuman%252Bosteosarcoma%26aulast%3DRen%26aufirst%3DKe%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D31%26spage%3D31085%26epage%3D31103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katarzyna W.  Walkiewicz</span>, <span class="hlFld-ContribAuthor ">Jean-Antoine  Girault</span>, <span class="hlFld-ContribAuthor ">Stefan T.  Arold</span>. </span><span class="cited-content_cbyCitation_article-title">How to awaken your nanomachines: Site-specific activation of focal adhesion kinases through ligand interactions. </span><span class="cited-content_cbyCitation_journal-name">Progress in Biophysics and Molecular Biology</span><span> <strong>2015,</strong> <em>119 </em>
                                    (1)
                                     , 60-71. <a href="https://doi.org/10.1016/j.pbiomolbio.2015.06.001" title="DOI URL">https://doi.org/10.1016/j.pbiomolbio.2015.06.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pbiomolbio.2015.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pbiomolbio.2015.06.001%26sid%3Dliteratum%253Aachs%26jtitle%3DProgress%2520in%2520Biophysics%2520and%2520Molecular%2520Biology%26atitle%3DHow%252Bto%252Bawaken%252Byour%252Bnanomachines%25253A%252BSite-specific%252Bactivation%252Bof%252Bfocal%252Badhesion%252Bkinases%252Bthrough%252Bligand%252Binteractions%26aulast%3DWalkiewicz%26aufirst%3DKatarzyna%2BW.%26date%3D2015%26volume%3D119%26issue%3D1%26spage%3D60%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian Y.  Lee</span>, <span class="hlFld-ContribAuthor ">Paul  Timpson</span>, <span class="hlFld-ContribAuthor ">Lisa G.  Horvath</span>, <span class="hlFld-ContribAuthor ">Roger J.  Daly</span>. </span><span class="cited-content_cbyCitation_article-title">FAK signaling in human cancer as a target for therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2015,</strong> <em>146 </em>, 132-149. <a href="https://doi.org/10.1016/j.pharmthera.2014.10.001" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2014.10.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2014.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2014.10.001%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DFAK%252Bsignaling%252Bin%252Bhuman%252Bcancer%252Bas%252Ba%252Btarget%252Bfor%252Btherapeutics%26aulast%3DLee%26aufirst%3DBrian%2BY.%26date%3D2015%26volume%3D146%26spage%3D132%26epage%3D149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jerry E.  Stewart</span>, <span class="hlFld-ContribAuthor ">Xiaojie  Ma</span>, <span class="hlFld-ContribAuthor ">Michael  Megison</span>, <span class="hlFld-ContribAuthor ">Hugh  Nabers</span>, <span class="hlFld-ContribAuthor ">William G.  Cance</span>, <span class="hlFld-ContribAuthor ">Elena V.  Kurenova</span>, <span class="hlFld-ContribAuthor ">Elizabeth A.  Beierle</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of FAK and VEGFR‐3 binding decreases tumorigenicity in neuroblastoma. </span><span class="cited-content_cbyCitation_journal-name">Molecular Carcinogenesis</span><span> <strong>2015,</strong> <em>54 </em>
                                    (1)
                                     , 9-23. <a href="https://doi.org/10.1002/mc.22070" title="DOI URL">https://doi.org/10.1002/mc.22070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/mc.22070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmc.22070%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Carcinogenesis%26atitle%3DInhibition%252Bof%252BFAK%252Band%252BVEGFR%2525E2%252580%2525903%252Bbinding%252Bdecreases%252Btumorigenicity%252Bin%252Bneuroblastoma%26aulast%3DStewart%26aufirst%3DJerry%2BE.%26date%3D2015%26date%3D2013%26volume%3D54%26issue%3D1%26spage%3D9%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu-Ling  Tai</span>, <span class="hlFld-ContribAuthor ">Lih-Chyang  Chen</span>, <span class="hlFld-ContribAuthor ">Tang-Long  Shen</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging Roles of Focal Adhesion Kinase in Cancer. </span><span class="cited-content_cbyCitation_journal-name">BioMed Research International</span><span> <strong>2015,</strong> <em>2015 </em>, 1-13. <a href="https://doi.org/10.1155/2015/690690" title="DOI URL">https://doi.org/10.1155/2015/690690</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2015/690690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2015%2F690690%26sid%3Dliteratum%253Aachs%26jtitle%3DBioMed%2520Research%2520International%26atitle%3DEmerging%252BRoles%252Bof%252BFocal%252BAdhesion%252BKinase%252Bin%252BCancer%26aulast%3DTai%26aufirst%3DYu-Ling%26date%3D2015%26volume%3D2015%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Song  Chen</span>, <span class="hlFld-ContribAuthor ">Michael  Haas</span>, <span class="hlFld-ContribAuthor ">Shaogang  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Disrupting the scaffold, an alternative approach to inhibiting FAK. </span><span class="cited-content_cbyCitation_journal-name">Cell Cycle</span><span> <strong>2014,</strong> <em>13 </em>
                                    (24)
                                     , 3794-3795. <a href="https://doi.org/10.4161/15384101.2014.986629" title="DOI URL">https://doi.org/10.4161/15384101.2014.986629</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4161/15384101.2014.986629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4161%2F15384101.2014.986629%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Cycle%26atitle%3DDisrupting%252Bthe%252Bscaffold%25252C%252Ban%252Balternative%252Bapproach%252Bto%252Binhibiting%252BFAK%26aulast%3DChen%26aufirst%3DSong%26date%3D2014%26date%3D2015%26volume%3D13%26issue%3D24%26spage%3D3794%26epage%3D3795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Priyanka N.  Gogate</span>, <span class="hlFld-ContribAuthor ">Manivannan  Ethirajan</span>, <span class="hlFld-ContribAuthor ">Elena V.  Kurenova</span>, <span class="hlFld-ContribAuthor ">Andrew T.  Magis</span>, <span class="hlFld-ContribAuthor ">Ravindra K.  Pandey</span>, <span class="hlFld-ContribAuthor ">William G.  Cance</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of novel FAK scaffold inhibitors targeting the FAK–VEGFR3 protein–protein interaction. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>80 </em>, 154-166. <a href="https://doi.org/10.1016/j.ejmech.2014.04.041" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.04.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.04.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.04.041%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252BFAK%252Bscaffold%252Binhibitors%252Btargeting%252Bthe%252BFAK%2525E2%252580%252593VEGFR3%252Bprotein%2525E2%252580%252593protein%252Binteraction%26aulast%3DGogate%26aufirst%3DPriyanka%2BN.%26date%3D2014%26volume%3D80%26spage%3D154%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianliang  Zhang</span>, <span class="hlFld-ContribAuthor ">Steven N.  Hochwald</span>. </span><span class="cited-content_cbyCitation_article-title">The role of FAK in tumor metabolism and therapy. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2014,</strong> <em>142 </em>
                                    (2)
                                     , 154-163. <a href="https://doi.org/10.1016/j.pharmthera.2013.12.003" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2013.12.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2013.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2013.12.003%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DThe%252Brole%252Bof%252BFAK%252Bin%252Btumor%252Bmetabolism%252Band%252Btherapy%26aulast%3DZhang%26aufirst%3DJianliang%26date%3D2014%26volume%3D142%26issue%3D2%26spage%3D154%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xia  Lu</span>, <span class="hlFld-ContribAuthor ">Lingzhou  Zhao</span>, <span class="hlFld-ContribAuthor ">Tian  Xue</span>, <span class="hlFld-ContribAuthor ">Huabei  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design of novel focal adhesion kinase inhibitors using 3D-QSAR and molecular docking. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2014,</strong> <em>23 </em>
                                    (4)
                                     , 1976-1997. <a href="https://doi.org/10.1007/s00044-013-0768-0" title="DOI URL">https://doi.org/10.1007/s00044-013-0768-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-013-0768-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-013-0768-0%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DDesign%252Bof%252Bnovel%252Bfocal%252Badhesion%252Bkinase%252Binhibitors%252Busing%252B3D-QSAR%252Band%252Bmolecular%252Bdocking%26aulast%3DLu%26aufirst%3DXia%26date%3D2014%26date%3D2013%26volume%3D23%26issue%3D4%26spage%3D1976%26epage%3D1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thérèse B.  Deramaudt</span>, <span class="hlFld-ContribAuthor ">Denis  Dujardin</span>, <span class="hlFld-ContribAuthor ">Fanny  Noulet</span>, <span class="hlFld-ContribAuthor ">Sophie  Martin</span>, <span class="hlFld-ContribAuthor ">Romain  Vauchelles</span>, <span class="hlFld-ContribAuthor ">Ken  Takeda</span>, <span class="hlFld-ContribAuthor ">Philippe  Rondé</span>, . </span><span class="cited-content_cbyCitation_article-title">Altering FAK-Paxillin Interactions Reduces Adhesion, Migration and Invasion Processes. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2014,</strong> <em>9 </em>
                                    (3)
                                     , e92059. <a href="https://doi.org/10.1371/journal.pone.0092059" title="DOI URL">https://doi.org/10.1371/journal.pone.0092059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0092059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0092059%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DAltering%252BFAK-Paxillin%252BInteractions%252BReduces%252BAdhesion%25252C%252BMigration%252Band%252BInvasion%252BProcesses%26aulast%3DDeramaudt%26aufirst%3DTh%25C3%25A9r%25C3%25A8se%2BB.%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D3%26spage%3De92059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elizabeth A.  Beierle</span>, <span class="hlFld-ContribAuthor ">Xiaojie  Ma</span>, <span class="hlFld-ContribAuthor ">Jerry E.  Stewart</span>, <span class="hlFld-ContribAuthor ">Michael  Megison</span>, <span class="hlFld-ContribAuthor ">William G.  Cance</span>, <span class="hlFld-ContribAuthor ">Elena V.  Kurenova</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of the focal adhesion kinase and vascular endothelial growth factor receptor-3 interaction leads to decreased survival in human neuroblastoma cell lines. </span><span class="cited-content_cbyCitation_journal-name">Molecular Carcinogenesis</span><span> <strong>2014,</strong> <em>53 </em>
                                    (3)
                                     , 230-242. <a href="https://doi.org/10.1002/mc.21969" title="DOI URL">https://doi.org/10.1002/mc.21969</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/mc.21969&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmc.21969%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Carcinogenesis%26atitle%3DInhibition%252Bof%252Bthe%252Bfocal%252Badhesion%252Bkinase%252Band%252Bvascular%252Bendothelial%252Bgrowth%252Bfactor%252Breceptor-3%252Binteraction%252Bleads%252Bto%252Bdecreased%252Bsurvival%252Bin%252Bhuman%252Bneuroblastoma%252Bcell%252Blines%26aulast%3DBeierle%26aufirst%3DElizabeth%2BA.%26date%3D2014%26date%3D2012%26volume%3D53%26issue%3D3%26spage%3D230%26epage%3D242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elena  Kurenova</span>, <span class="hlFld-ContribAuthor ">Jianqun  Liao</span>, <span class="hlFld-ContribAuthor ">Di-Hua  He</span>, <span class="hlFld-ContribAuthor ">Darrell  Hunt</span>, <span class="hlFld-ContribAuthor ">Michael  Yemma</span>, <span class="hlFld-ContribAuthor ">Wiam  Bshara</span>, <span class="hlFld-ContribAuthor ">Mukund  Seshadri</span>, <span class="hlFld-ContribAuthor ">William G.  Cance</span>. </span><span class="cited-content_cbyCitation_article-title">The FAK scaffold inhibitor C4 disrupts FAK-VEGFR-3 signaling and inhibits pancreatic cancer growth. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2013,</strong> <em>4 </em>
                                    (10)
                                     , 1632-1646. <a href="https://doi.org/10.18632/oncotarget.1365" title="DOI URL">https://doi.org/10.18632/oncotarget.1365</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.1365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.1365%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DThe%252BFAK%252Bscaffold%252Binhibitor%252BC4%252Bdisrupts%252BFAK-VEGFR-3%252Bsignaling%252Band%252Binhibits%252Bpancreatic%252Bcancer%252Bgrowth%26aulast%3DKurenova%26aufirst%3DElena%26date%3D2013%26date%3D2013%26volume%3D4%26issue%3D10%26spage%3D1632%26epage%3D1646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vita M.  Golubovskaya</span>, <span class="hlFld-ContribAuthor ">William G.  Cance</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the p53 Pathway. </span><span class="cited-content_cbyCitation_journal-name">Surgical Oncology Clinics of North America</span><span> <strong>2013,</strong> <em>22 </em>
                                    (4)
                                     , 747-764. <a href="https://doi.org/10.1016/j.soc.2013.06.003" title="DOI URL">https://doi.org/10.1016/j.soc.2013.06.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.soc.2013.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.soc.2013.06.003%26sid%3Dliteratum%253Aachs%26jtitle%3DSurgical%2520Oncology%2520Clinics%2520of%2520North%2520America%26atitle%3DTargeting%252Bthe%252Bp53%252BPathway%26aulast%3DGolubovskaya%26aufirst%3DVita%2BM.%26date%3D2013%26volume%3D22%26issue%3D4%26spage%3D747%26epage%3D764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hwan  Kim</span>, <span class="hlFld-ContribAuthor ">Nam Doo  Kim</span>, <span class="hlFld-ContribAuthor ">Jiyeon  Lee</span>, <span class="hlFld-ContribAuthor ">Gyoonhee  Han</span>, <span class="hlFld-ContribAuthor ">Taebo  Sim</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of methyl violet 2B as a novel blocker of focal adhesion kinase signaling pathway in cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Biochemical and Biophysical Research Communications</span><span> <strong>2013,</strong> <em>437 </em>
                                    (2)
                                     , 319-324. <a href="https://doi.org/10.1016/j.bbrc.2013.06.078" title="DOI URL">https://doi.org/10.1016/j.bbrc.2013.06.078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbrc.2013.06.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbrc.2013.06.078%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520and%2520Biophysical%2520Research%2520Communications%26atitle%3DIdentification%252Bof%252Bmethyl%252Bviolet%252B2B%252Bas%252Ba%252Bnovel%252Bblocker%252Bof%252Bfocal%252Badhesion%252Bkinase%252Bsignaling%252Bpathway%252Bin%252Bcancer%252Bcells%26aulast%3DKim%26aufirst%3DHwan%26date%3D2013%26volume%3D437%26issue%3D2%26spage%3D319%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">W. G.  Cance</span>, <span class="hlFld-ContribAuthor ">E.  Kurenova</span>, <span class="hlFld-ContribAuthor ">T.  Marlowe</span>, <span class="hlFld-ContribAuthor ">V.  Golubovskaya</span>. </span><span class="cited-content_cbyCitation_article-title">Disrupting the Scaffold to Improve Focal Adhesion Kinase-Targeted Cancer Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Science Signaling</span><span> <strong>2013,</strong> <em>6 </em>
                                    (268)
                                     , pe10-pe10. <a href="https://doi.org/10.1126/scisignal.2004021" title="DOI URL">https://doi.org/10.1126/scisignal.2004021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/scisignal.2004021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fscisignal.2004021%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%2520Signaling%26atitle%3DDisrupting%252Bthe%252BScaffold%252Bto%252BImprove%252BFocal%252BAdhesion%252BKinase-Targeted%252BCancer%252BTherapeutics%26aulast%3DCance%26aufirst%3DW.%2BG.%26date%3D2013%26date%3D2013%26volume%3D6%26issue%3D268%26spage%3Dpe10%26epage%3Dpe10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Deniz A.  Ucar</span>, <span class="hlFld-ContribAuthor ">Elena  Kurenova</span>, <span class="hlFld-ContribAuthor ">Timothy J.  Garrett</span>, <span class="hlFld-ContribAuthor ">William G.  Cance</span>, <span class="hlFld-ContribAuthor ">Carl  Nyberg</span>, <span class="hlFld-ContribAuthor ">Audrey  Cox</span>, <span class="hlFld-ContribAuthor ">Nicole  Massoll</span>, <span class="hlFld-ContribAuthor ">David A.  Ostrov</span>, <span class="hlFld-ContribAuthor ">Nicholas  Lawrence</span>, <span class="hlFld-ContribAuthor ">Saïd M.  Sebti</span>, <span class="hlFld-ContribAuthor ">Maria  Zajac-Kaye</span>, <span class="hlFld-ContribAuthor ">Steven N.  Hochwald</span>. </span><span class="cited-content_cbyCitation_article-title">Disruption of the protein interaction between FAK and IGF-1R inhibits melanoma tumor growth. </span><span class="cited-content_cbyCitation_journal-name">Cell Cycle</span><span> <strong>2012,</strong> <em>11 </em>
                                    (17)
                                     , 3250-3259. <a href="https://doi.org/10.4161/cc.21611" title="DOI URL">https://doi.org/10.4161/cc.21611</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4161/cc.21611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4161%2Fcc.21611%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Cycle%26atitle%3DDisruption%252Bof%252Bthe%252Bprotein%252Binteraction%252Bbetween%252BFAK%252Band%252BIGF-1R%252Binhibits%252Bmelanoma%252Btumor%252Bgrowth%26aulast%3DUcar%26aufirst%3DDeniz%2BA.%26date%3D2012%26date%3D2014%26volume%3D11%26issue%3D17%26spage%3D3250%26epage%3D3259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Article withdrawal: Disruption of the protein interaction between FAK and IGF-1R inhibits melanoma tumor growth. </span><span class="cited-content_cbyCitation_journal-name">Carcinogenesis</span><span> <strong>2012,</strong>,, 473-473. <a href="https://doi.org/10.1093/carcin/bgr115" title="DOI URL">https://doi.org/10.1093/carcin/bgr115</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/carcin/bgr115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fcarcin%2Fbgr115%26sid%3Dliteratum%253Aachs%26jtitle%3DCarcinogenesis%26atitle%3DArticle%252Bwithdrawal%25253A%252BDisruption%252Bof%252Bthe%252Bprotein%252Binteraction%252Bbetween%252BFAK%252Band%252BIGF-1R%252Binhibits%252Bmelanoma%252Btumor%252Bgrowth%26date%3D2012%26date%3D2011%26volume%3D33%26issue%3D2%26spage%3D473%26epage%3D473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jessica E.  Hall</span>, <span class="hlFld-ContribAuthor ">Wei  Fu</span>, <span class="hlFld-ContribAuthor ">Michael D.  Schaller</span>. </span><span class="cited-content_cbyCitation_article-title">Focal Adhesion Kinase. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2011,</strong>,, 185-225. <a href="https://doi.org/10.1016/B978-0-12-386041-5.00005-4" title="DOI URL">https://doi.org/10.1016/B978-0-12-386041-5.00005-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-386041-5.00005-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-386041-5.00005-4%26sid%3Dliteratum%253Aachs%26atitle%3DFocal%252BAdhesion%252BKinase%26aulast%3DHall%26aufirst%3DJessica%2BE.%26date%3D2011%26spage%3D185%26epage%3D225%26pub%3DElsevier%26date%3D2011%26volume%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vita M.  Golubovskaya</span>, <span class="hlFld-ContribAuthor ">Elizabeth A.  Beierle</span>, <span class="hlFld-ContribAuthor ">Steven N.  Hochwald</span>, <span class="hlFld-ContribAuthor ">Elena V.  Kurenova</span>, <span class="hlFld-ContribAuthor ">William G.  Cance</span>. </span><span class="cited-content_cbyCitation_article-title">Focal Adhesion Kinase with the Interacting Proteins and Signaling in Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2010,</strong>,, 275-305. <a href="https://doi.org/10.1007/978-1-4419-0814-8_12" title="DOI URL">https://doi.org/10.1007/978-1-4419-0814-8_12</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4419-0814-8_12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4419-0814-8_12%26sid%3Dliteratum%253Aachs%26atitle%3DFocal%252BAdhesion%252BKinase%252Bwith%252Bthe%252BInteracting%252BProteins%252Band%252BSignaling%252Bin%252BCancer%26aulast%3DGolubovskaya%26aufirst%3DVita%2BM.%26date%3D2010%26date%3D2009%26spage%3D275%26epage%3D305%26pub%3DSpringer%2520New%2520York%26atitle%3DCell-Extracellular%252BMatrix%252BInteractions%252Bin%252BCancer%26aulast%3DZent%26aufirst%3DRoy%26date%3D2010%26volume%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/medium/jm-2009-00159g_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/large/jm-2009-00159g_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900159g&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/medium/jm-2009-00159g_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/large/jm-2009-00159g_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure-based development of small molecules that targeted the binding of FAK and VEGFR-3. (A) Site selection for high throughout virtual screening of druglike compounds to develop small molecule FAK inhibitors. The crystal structure of the focal adhesion targeting (FAT) domain of FAK was obtained from the Protein Data Bank (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1K04">1K04</a>) and prepared for computational docking. The 140 000 small molecules from the NCI’s Development Therapeutics Program were each positioned in the structural pocket and scored for electrostatic and van der Waals interactions as implemented in DOCKv5.2 package9 (UCSF). The crystal structure is shown in cyan and salmon, and residues that undergo shifts upon peptide binding in NMR studies are shown in magenta. The catalytic tyrosine is shown in green. Red spheres indicate the site defined by the program SPHGEN (UCSF) with chemical and geometric features appropriate for specific small molecule binding. Gray bars demarcate the scoring grid utilized to calculate interactions between potential ligands and the targeted structural pocket. (B) Predicted binding site of <b>1</b> to focal adhesion targeting domain of FAK. Histidine 1025 shown in magenta with surrounding residues. Black dashed lines indicate hydrogen bonds between proline 906 and <b>1</b> N2, aspartic acid 1030 hydroxyl group and <b>1</b> N1, and also hydroxyl group of threonin1022 and Cl of <b>1</b>. (C) Compound <b>1</b> (chlorpyramin hydrochloride) structure. (D) <b>1</b> treatment decreased the viability of a diverse set of cancer cell types. MTS assay was performed on selected cell lines. Cells were treated with the increased concentration of <b>1</b> for 72 h and analyzed with Cell Titer Proliferation Assay. Error bars represent ± SEM, <i>P < </i>0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/large/jm-2009-00159g_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900159g&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/medium/jm-2009-00159g_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/large/jm-2009-00159g_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. <b>1</b> specifically decreased the viability and proliferation and caused apoptosis in breast cancer cells that expressed VEGFR-3. BT474 breast cancer cells with endogenous high VEGFR-3 expression and stable clones of MCF7 breast cancer cells with undetectable VEGFR-3 expression, transfected with either control vector pcDNA3 or VEGFR-3, were treated with the marked concentration of <b>1</b>. (A) <b>1</b> caused a dose-dependent cytotoxicity of VEGFR-3 expressing cells. The viability was measured in MTS assays after 48 h of treatment: (∗) <i>P</i> < 0.01; (∗∗) <i>P</i> < 0.001. (B) <b>1</b> caused a dose-dependent and a time-dependent decrease in proliferation of VEGFR-3 expressing cells: BrdU incorporation assay, (∗) <i>P</i> < 0.05, (∗∗) <i>P</i> < 0.001. (C) <b>1</b> treatment caused dose-dependent apoptosis, and proapoptotic effect of <b>1</b> is specific for cells expressing VEGFR3: TUNEL assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/large/jm-2009-00159g_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900159g&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/medium/jm-2009-00159g_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/large/jm-2009-00159g_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. <b>1</b> treatment affected colocalization and led to redistribution and decrease of FAK−VEGFR-3 complexes. Cells were treated with DMSO (CTL, all panels a and b) or 10 μM <b>1</b> (all panels c and d) for 24 h, immunostained for FAK (green, Alexa Fluor 488) in combination with VEGFR-3 or paxillin (red, Alexa Fluor 546). Colocalization in treated and untreated cells was assessed by confocal microscopy and scatter plot analysis (e). (A) Treatment with small molecule <b>1</b> caused decrease in colocalization of FAK and VEGFR-3 in BT474 cells: (a) merged image, control cells; (b) colocalization, control cells; (c) merged image, <b>1</b> treated cells; (d) colocalization, <b>1</b> treated cells; (e) percentage of colocalized FAK and VEGFR-3 molecules in control and <b>1</b> treated cells. (B) FAK−paxillin complexes were not affected by treatment with small molecule <b>1</b>. (a−e) Percentage of colocalized FAK and paxillin molecules in control and <b>1</b> treated BT474 cells. (C) <b>1</b> caused decrease in colocalization of VEGFR-3 and FAK in MCF7 cells that overexpressed VEGFR-3. (a−e) Percentage of colocalized FAK and VEGFR-3 molecules in control and <b>1</b> treated MCF7−VEGFR-3 cells. (D) <b>1</b> disrupted binding of the FAK and VEGFR-3 proteins. Immunoprecipitation with VEGFR-3 antibody after treatment for 24 h with increasing concentrations of compound <b>1</b> revealed a decreased amount of FAK protein coprecipitated with VEGFR-3.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/large/jm-2009-00159g_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900159g&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/medium/jm-2009-00159g_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/large/jm-2009-00159g_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. <b>1</b> treatment caused dose-dependent dephosphorylation of VEGFR-3 and decreased phosphorylation of FAK. (A, B) Western blot analysis of MCF7−VEGFR-3 breast cancer cells and BT474 breast cancer cells after 24 h of treatment with increasing doses of <b>1</b>. VEGFR-3 phosphorylation was analyzed. (C, D) Immunoprecipitation of FAK and Western blot analysis with antiphosphotyrosine antibody 4G10 of MCF7−VEGFR-3 and BT474 cells treated for 24 h with 10 μM or 1 μM <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/large/jm-2009-00159g_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900159g&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/medium/jm-2009-00159g_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/large/jm-2009-00159g_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. <b>1</b> reduced tumor growth in mouse xenograft models. BT474 (A) or MCF7−VEGFR-3 (B) cells were inoculated into mice subcutaneously. Treatment with 60 mg/kg <b>1</b> or vehicle (PBS) was started the day after cell inoculation. Mice were sacrificed 21 days later, and tumors were measured for size and weight (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Figure S6). BT474 and MCF7−VEGFR-3 <b>1</b>-treated tumor volumes were significantly smaller than vehicle treated tumors after day 14: (∗) <i>P</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/large/jm-2009-00159g_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900159g&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/medium/jm-2009-00159g_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/large/jm-2009-00159g_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. The <b>1</b> antitumor effect is not related to its antihistamine properties, and it sensitizes tumors to chemotherapy treatment with doxorubicin at low concentration. (A) MCF7−VEGFR-3 cells were inoculated into mice subcutaneously. Treatment with 60 mg/kg <b>1</b>, 30 mg/kg <b>2</b> (diphenhydramine), or vehicle (PBS) daily was started the next day. (B) BT474 cells were inoculated into mice subcutaneously. Treatment with 10 mg/kg <b>1</b> daily or doxorubicin 0.3 mg/kg weekly or the combination of both drugs was started the next day after cell inoculation. Experiments were terminated after 14 days when tumor size of single treatment reached protocol end point. Statistically significant difference (∗, <i>P</i> < 0.01) with vehicle treated tumors was seen from day 9.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900159g/production/images/large/jm-2009-00159g_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900159g&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i21">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07130" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07130" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 46 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Chatzizacharias, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouraklis, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theocharis, S. E.</span><span> </span><span class="NLM_article-title">Focal adhesion kinase: a promising target for anticancer therapy</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1315</span><span class="NLM_x">–</span> <span class="NLM_lpage">1328</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1517%2F14728222.11.10.1315" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=17907961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSgsbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=1315-1328&author=N.+A.+Chatzizachariasauthor=G.+P.+Kouraklisauthor=S.+E.+Theocharis&title=Focal+adhesion+kinase%3A+a+promising+target+for+anticancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Focal adhesion kinase: a promising target for anticancer therapy</span></div><div class="casAuthors">Chatzizacharias, Nikolaos A.; Kouraklis, Gregory P.; Theocharis, Stamatios E.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1315-1328</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Focal adhesion kinase (FAK) is a protein tyrosine kinase acting as an early modulator of the integrin signalling cascade, thus regulating various basic cellular functions.  In transformed cells, upregulation of FAK protein expression and uncontroled signalling were held responsible for the promotion of malignant phenotypic characteristics, as well as resistance to chemotherapy and radiotherapy.  Direct FAK targeting resulted in the inhibition of the malignant phenotype of cancer cells, whereas increased apoptotic rates of cancer cells, either used alone or in combination with conventional chemotherapeutic agents, radiotherapy or hormonal therapy.  Furthermore, drugs used in cancer chemotherapy, besides their basic mode of action, were also shown to act through altering FAK signalling.  Finally, pos. results were noted by the transfection of cancer cells with fak mutants or genes that suppress FAK expression or activity, such as phosphatase and tensin homolog deleted on chromosome Ten (PTEN), ribonucleotide reductase M1 polypeptide (RRM1) and melanoma differentiation-assocd. gene-7 (mda-7).  The purpose of this article is a comprehensive review of the existing data on the possible use of FAK targeting in anticancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGOvqvFdDrFrVg90H21EOLACvtfcHk0lg-oGt8cP7VCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSgsbvE&md5=d875e2641fa7f0e622d2b764c2233c7b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1517%2F14728222.11.10.1315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.11.10.1315%26sid%3Dliteratum%253Aachs%26aulast%3DChatzizacharias%26aufirst%3DN.%2BA.%26aulast%3DKouraklis%26aufirst%3DG.%2BP.%26aulast%3DTheocharis%26aufirst%3DS.%2BE.%26atitle%3DFocal%2520adhesion%2520kinase%253A%2520a%2520promising%2520target%2520for%2520anticancer%2520therapy%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2007%26volume%3D11%26spage%3D1315%26epage%3D1328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Tammela, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarkada, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallgard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murtomaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suchting, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirzenius, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waltari, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellstrom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schomber, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peltonen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freitas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duarte, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isoniemi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laakkonen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christofori, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yla-Herttuala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibuya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pytowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eichmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betsholtz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alitalo, K.</span><span> </span><span class="NLM_article-title">Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">454</span><span class="NLM_x">, </span> <span class="NLM_fpage">656</span><span class="NLM_x">–</span> <span class="NLM_lpage">660</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=454&publication_year=2008&pages=656-660&author=T.+Tammelaauthor=G.+Zarkadaauthor=E.+Wallgardauthor=A.+Murtomakiauthor=S.+Suchtingauthor=M.+Wirzeniusauthor=M.+Waltariauthor=M.+Hellstromauthor=T.+Schomberauthor=R.+Peltonenauthor=C.+Freitasauthor=A.+Duarteauthor=H.+Isoniemiauthor=P.+Laakkonenauthor=G.+Christoforiauthor=S.+Yla-Herttualaauthor=M.+Shibuyaauthor=B.+Pytowskiauthor=A.+Eichmannauthor=C.+Betsholtzauthor=K.+Alitalo&title=Blocking+VEGFR-3+suppresses+angiogenic+sprouting+and+vascular+network+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTammela%26aufirst%3DT.%26aulast%3DZarkada%26aufirst%3DG.%26aulast%3DWallgard%26aufirst%3DE.%26aulast%3DMurtomaki%26aufirst%3DA.%26aulast%3DSuchting%26aufirst%3DS.%26aulast%3DWirzenius%26aufirst%3DM.%26aulast%3DWaltari%26aufirst%3DM.%26aulast%3DHellstrom%26aufirst%3DM.%26aulast%3DSchomber%26aufirst%3DT.%26aulast%3DPeltonen%26aufirst%3DR.%26aulast%3DFreitas%26aufirst%3DC.%26aulast%3DDuarte%26aufirst%3DA.%26aulast%3DIsoniemi%26aufirst%3DH.%26aulast%3DLaakkonen%26aufirst%3DP.%26aulast%3DChristofori%26aufirst%3DG.%26aulast%3DYla-Herttuala%26aufirst%3DS.%26aulast%3DShibuya%26aufirst%3DM.%26aulast%3DPytowski%26aufirst%3DB.%26aulast%3DEichmann%26aufirst%3DA.%26aulast%3DBetsholtz%26aufirst%3DC.%26aulast%3DAlitalo%26aufirst%3DK.%26atitle%3DBlocking%2520VEGFR-3%2520suppresses%2520angiogenic%2520sprouting%2520and%2520vascular%2520network%2520formation%26jtitle%3DNature%26date%3D2008%26volume%3D454%26spage%3D656%26epage%3D660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Cox, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natarajan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stettner, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gladson, C. L.</span><span> </span><span class="NLM_article-title">New concepts regarding focal adhesion kinase promotion of cell migration and proliferation</span> <span class="citation_source-journal">J. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1002%2Fjcb.20956" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=16823799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A280%3ADC%252BD28rhtFGgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2006&pages=35-52&author=B.+D.+Coxauthor=M.+Natarajanauthor=M.+R.+Stettnerauthor=C.+L.+Gladson&title=New+concepts+regarding+focal+adhesion+kinase+promotion+of+cell+migration+and+proliferation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">New concepts regarding focal adhesion kinase promotion of cell migration and proliferation</span></div><div class="casAuthors">Cox Braden D; Natarajan Meera; Stettner Michelle R; Gladson Candece L</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cellular biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-52</span>
        ISSN:<span class="NLM_cas:issn">0730-2312</span>.
    </div><div class="casAbstract">Focal adhesion kinase (FAK) is a non-receptor cytoplasmic tyrosine kinase that plays a key role in the regulation of proliferation and migration of normal and tumor cells.  FAK associates with integrin receptors and recruits other molecules to the site of this interaction thus forming a signaling complex that transmits signals from the extracellular matrix to the cell cytoskeleton.  Crk-associated substrate (CAS) family members appear to play a pivotal role in FAK regulation of cell migration.  Cellular Src bound to FAK phosphorylates CAS proteins leading to the recruitment of a Crk family adaptor molecule and activation of a small GTPase and c-Jun N-terminal kinase (JNK) promoting membrane protrusion and cell migration.  The relocalization of CAS and signaling through specific CAS family members appears to determine the outcome of this pathway.  FAK also plays an important role in regulating cell cycle progression through transcriptional control of the cyclin D1 promoter by the Ets B and Kruppel-like factor 8 (KLF8) transcription factors.  FAK regulation of cell cycle progression in tumor cells requires Erk activity, cyclin D1 transcription, and the cyclin-dependent kinase (cdk) inhibitor p27Kip1.  The ability of FAK to integrate integrin and growth factor signals resulting in synergistic promotion of cell migration and proliferation, and its potential regulation by nuclear factor kappa B (NFkappaB) and p53 and a ubiquitously expressed inhibitory protein, suggest that it is remarkable in its capacity to integrate multiple extracellular and intracellular stimuli.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTJXl7Nm0CVcjAEfvC7EH1LfW6udTcc2ebWzpyujxM7aLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28rhtFGgug%253D%253D&md5=418bfd01c7dacb9607c4c591973b30b5</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fjcb.20956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.20956%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DB.%2BD.%26aulast%3DNatarajan%26aufirst%3DM.%26aulast%3DStettner%26aufirst%3DM.%2BR.%26aulast%3DGladson%26aufirst%3DC.%2BL.%26atitle%3DNew%2520concepts%2520regarding%2520focal%2520adhesion%2520kinase%2520promotion%2520of%2520cell%2520migration%2520and%2520proliferation%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2006%26volume%3D99%26spage%3D35%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Frisch, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruoslahti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan-Hui, P. Y.</span><span> </span><span class="NLM_article-title">Control of adhesion-dependent cell survival by focal adhesion kinase</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">793</span><span class="NLM_x">–</span> <span class="NLM_lpage">799</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=1996&pages=793-799&author=S.+M.+Frischauthor=K.+Vuoriauthor=E.+Ruoslahtiauthor=P.+Y.+Chan-Hui&title=Control+of+adhesion-dependent+cell+survival+by+focal+adhesion+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrisch%26aufirst%3DS.%2BM.%26aulast%3DVuori%26aufirst%3DK.%26aulast%3DRuoslahti%26aufirst%3DE.%26aulast%3DChan-Hui%26aufirst%3DP.%2BY.%26atitle%3DControl%2520of%2520adhesion-dependent%2520cell%2520survival%2520by%2520focal%2520adhesion%2520kinase%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D1996%26volume%3D134%26spage%3D793%26epage%3D799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Schlaepfer, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitra, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ilic, D.</span><span> </span><span class="NLM_article-title">Control of motile and invasive cell phenotypes by focal adhesion kinase</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1692</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1692&publication_year=2004&pages=77-102&author=D.+D.+Schlaepferauthor=S.+K.+Mitraauthor=D.+Ilic&title=Control+of+motile+and+invasive+cell+phenotypes+by+focal+adhesion+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchlaepfer%26aufirst%3DD.%2BD.%26aulast%3DMitra%26aufirst%3DS.%2BK.%26aulast%3DIlic%26aufirst%3DD.%26atitle%3DControl%2520of%2520motile%2520and%2520invasive%2520cell%2520phenotypes%2520by%2520focal%2520adhesion%2520kinase%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2004%26volume%3D1692%26spage%3D77%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Chen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y.</span><span> </span><span class="NLM_article-title">Regulation of the PH-domain-containing tyrosine kinase Etk by focal adhesion kinase through the FERM domain</span> <span class="citation_source-journal">Nat. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">444</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1038%2F35074500" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=11331870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjsFClu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2001&pages=439-444&author=R.+Chenauthor=O.+Kimauthor=M.+Liauthor=X.+Xiongauthor=J.+L.+Guanauthor=H.+J.+Kungauthor=H.+Chenauthor=Y.+Shimizuauthor=Y.+Qiu&title=Regulation+of+the+PH-domain-containing+tyrosine+kinase+Etk+by+focal+adhesion+kinase+through+the+FERM+domain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of the PH-domain-containing tyrosine kinase Etk by focal adhesion kinase through the FERM domain</span></div><div class="casAuthors">Chen, Riyan; Kim, Oekyung; Li, Ming; Xiong, Xinsheng; Guan, Jun-Lin; Kung, Hsing-Jien; Chen, Hegang; Shimizu, Yoji; Qiu, Yun</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">439-444</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Etk/BMX, a member of the Btk family of tyrosine kinases, is highly expressed in cells with great migratory potential, including endothelial cells and metastatic carcinoma cell lines.  Here, we present evidence that Etk is involved in integrin signalling and promotes cell migration.  The activation of Etk by extracellular matrix proteins is regulated by focal adhesion kinase (FAK) through an interaction between the PH domain of Etk and the FERM domain of FAK.  The lack of Etk activation by extracellular matrix in FAK-null cells could be restored by co-transfection with wild-type FAK.  Disrupting the interaction between Etk and FAK diminished the cell migration promoted by either kinase.  Furthermore, inhibiting Etk expression in metastatic carcinoma cell lines with an antisense oligonucleotide blocks integrin-mediated migration of these cells.  Taken together, our data indicate the essential role of the interaction of the PH domain of Etk and the FERM domain of FAK in integrin signalling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXbI88x44Jo7Vg90H21EOLACvtfcHk0lhM5mdSEaLkAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjsFClu7c%253D&md5=937a54d06ef57978840f8a16100b0058</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2F35074500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35074500%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DO.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DXiong%26aufirst%3DX.%26aulast%3DGuan%26aufirst%3DJ.%2BL.%26aulast%3DKung%26aufirst%3DH.%2BJ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DShimizu%26aufirst%3DY.%26aulast%3DQiu%26aufirst%3DY.%26atitle%3DRegulation%2520of%2520the%2520PH-domain-containing%2520tyrosine%2520kinase%2520Etk%2520by%2520focal%2520adhesion%2520kinase%2520through%2520the%2520FERM%2520domain%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2001%26volume%3D3%26spage%3D439%26epage%3D444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Garces, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurenova, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golubovskaya, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cance, W. G.</span><span> </span><span class="NLM_article-title">Vascular endothelial growth factor receptor-3 and focal adhesion kinase bind and suppress apoptosis in breast cancer cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">1446</span><span class="NLM_x">–</span> <span class="NLM_lpage">1454</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1158%2F0008-5472.CAN-05-1661" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=16452200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsVehug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=1446-1454&author=C.+A.+Garcesauthor=E.+V.+Kurenovaauthor=V.+M.+Golubovskayaauthor=W.+G.+Cance&title=Vascular+endothelial+growth+factor+receptor-3+and+focal+adhesion+kinase+bind+and+suppress+apoptosis+in+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular Endothelial Growth Factor Receptor-3 and Focal Adhesion Kinase Bind and Suppress Apoptosis in Breast Cancer Cells</span></div><div class="casAuthors">Garces, Christopher A.; Kurenova, Elena V.; Golubovskaya, Vita M.; Cance, William G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1446-1454</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Focal adhesion kinase (FAK) and vascular endothelial growth factor receptor-3 (VEGFR-3) are protein tyrosine kinases that are overexpressed in human cancer and play an important role in survival signaling.  In addn. to its involvement with cell survival, VEGFR-3 is a primary factor in lymphatic angiogenesis.  Because FAK function is regulated by its COOH terminus (FAK-CD), we used FAK-CD as a target to identify binding partners.  We isolated a peptide from a phage library that bound to FAK-CD, specifically the focal adhesion targeting domain of FAK and was homologous to VEGFR-3, suggesting these two tyrosine kinases phys. interact.  We have also shown that VEGFR-3 is overexpressed in human breast tumors and cancer cell lines.  For the first time, we have shown the phys. assocn. of FAK and VEGFR-3.  The assocn. between the NH2 terminus of VEGFR-3, contg. the peptide identified by phage display, and the COOH terminus of FAK was detected by in vitro and in vivo binding studies.  We then coupled a 12-amino-acid VEGFR-3 peptide, AV3, to a TAT cellular penetration sequence and showed that AV3 and not control-scrambled peptide caused specific displacement of FAK from the focal adhesions and affected colocalization of FAK and VEGFR-3.  In addn., AV3 peptide decreased proliferation and caused cell detachment and apoptosis in breast cancer cell lines but not in normal breast cells.  Thus, the FAK/VEGFR-3 interaction may have a potential use to develop novel mol. therapeutics to target the signaling between FAK and VEGFR-3 in human tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod9mUYmoenhrVg90H21EOLACvtfcHk0lhM5mdSEaLkAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsVehug%253D%253D&md5=889ef9ed6935fe6ebe4b1ec6933369b6</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-1661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-1661%26sid%3Dliteratum%253Aachs%26aulast%3DGarces%26aufirst%3DC.%2BA.%26aulast%3DKurenova%26aufirst%3DE.%2BV.%26aulast%3DGolubovskaya%26aufirst%3DV.%2BM.%26aulast%3DCance%26aufirst%3DW.%2BG.%26atitle%3DVascular%2520endothelial%2520growth%2520factor%2520receptor-3%2520and%2520focal%2520adhesion%2520kinase%2520bind%2520and%2520suppress%2520apoptosis%2520in%2520breast%2520cancer%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D1446%26epage%3D1454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Mamali, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapodistria, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lampropoulou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marmaras, V. J.</span><span> </span><span class="NLM_article-title">Elk-1 is a novel protein-binding partner for FAK, regulating phagocytosis in medfly hemocytes</span> <span class="citation_source-journal">J. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">1895</span><span class="NLM_x">–</span> <span class="NLM_lpage">1911</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2008&pages=1895-1911&author=I.+Mamaliauthor=K.+Kapodistriaauthor=M.+Lampropoulouauthor=V.+J.+Marmaras&title=Elk-1+is+a+novel+protein-binding+partner+for+FAK%2C+regulating+phagocytosis+in+medfly+hemocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMamali%26aufirst%3DI.%26aulast%3DKapodistria%26aufirst%3DK.%26aulast%3DLampropoulou%26aufirst%3DM.%26aulast%3DMarmaras%26aufirst%3DV.%2BJ.%26atitle%3DElk-1%2520is%2520a%2520novel%2520protein-binding%2520partner%2520for%2520FAK%252C%2520regulating%2520phagocytosis%2520in%2520medfly%2520hemocytes%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2008%26volume%3D103%26spage%3D1895%26epage%3D1911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Kurenova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, A. S., ,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craven, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanks, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.-g.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cance, W. G.</span><span> </span><span class="NLM_article-title">Focal adhesion kinase suppresses apoptosis by binding to the death domain of receptor-interacting protein</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">4361</span><span class="NLM_x">–</span> <span class="NLM_lpage">4371</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1128%2FMCB.24.10.4361-4371.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=15121855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvFChtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=4361-4371&author=E.+Kurenovaauthor=L.-H.+Xuauthor=X.+Yangauthor=A.+S.%2C++Baldwinauthor=R.+J.+Cravenauthor=S.+K.+Hanksauthor=Z.-g.+Liuauthor=W.+G.+Cance&title=Focal+adhesion+kinase+suppresses+apoptosis+by+binding+to+the+death+domain+of+receptor-interacting+protein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Focal adhesion kinase suppresses apoptosis by binding to the death domain of receptor-interacting protein</span></div><div class="casAuthors">Kurenova, Elena; Xu, Li-Hui; Yang, Xihui; Baldwin, Albert S., Jr.; Craven, Rolf J.; Hanks, Steven K.; Liu, Zheng-gang; Cance, William G.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4361-4371</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Tumor cells resist the apoptotic stimuli assocd. with invasion and metastasis by activating survival signals that suppress apoptosis.  Focal adhesion kinase (FAK), a tyrosine kinase that is overexpressed in a variety of human tumors, mediates one of these survival signals.  Attenuation of FAK expression in tumor cells results in apoptosis that is mediated by caspase 8- and FADD-dependent pathways, suggesting that death receptor pathways are involved in the process.  Here, we report a functional link between FAK and death receptors.  We have demonstrated that FAK binds to the death domain of kinase receptor-interacting protein (RIP).  RIP is a major component of the death receptor complex and has been shown to interact with Fas and tumor necrosis factor receptor 1 through its binding to adapter proteins.  We have shown that RIP provides proapoptotic signals that are suppressed by its binding to FAK.  We thus propose that FAK overexpression in human tumors provides a survival signal function by binding to RIP and inhibiting its interaction with the death receptor complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1a2jd8fnDFLVg90H21EOLACvtfcHk0liB63ZVRu7hoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvFChtLs%253D&md5=5ab911dd0a17eb990cda9806b6ef054b</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1128%2FMCB.24.10.4361-4371.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.24.10.4361-4371.2004%26sid%3Dliteratum%253Aachs%26aulast%3DKurenova%26aufirst%3DE.%26aulast%3DXu%26aufirst%3DL.-H.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DBaldwin%26aufirst%3DA.%2BS.%252C%26aulast%3DCraven%26aufirst%3DR.%2BJ.%26aulast%3DHanks%26aufirst%3DS.%2BK.%26aulast%3DLiu%26aufirst%3DZ.-g.%26aulast%3DCance%26aufirst%3DW.%2BG.%26atitle%3DFocal%2520adhesion%2520kinase%2520suppresses%2520apoptosis%2520by%2520binding%2520to%2520the%2520death%2520domain%2520of%2520receptor-interacting%2520protein%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2004%26volume%3D24%26spage%3D4361%26epage%3D4371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Golubovskaya, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cance, W. G.</span><span> </span><span class="NLM_article-title">Focal adhesion kinase and p53 signaling in cancer cells</span> <span class="citation_source-journal">Int. Rev. Cytol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">263</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">153</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1016%2FS0074-7696%2807%2963003-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=17725966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1ajt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=263&publication_year=2007&pages=103-153&author=V.+M.+Golubovskayaauthor=W.+G.+Cance&title=Focal+adhesion+kinase+and+p53+signaling+in+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Focal adhesion kinase and p53 signaling in cancer cells</span></div><div class="casAuthors">Golubovskaya, Vita M.; Cance, William G.</div><div class="citationInfo"><span class="NLM_cas:title">International Review of Cytology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">263</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103-153</span>CODEN:
                <span class="NLM_cas:coden">IRCYAJ</span>;
        ISSN:<span class="NLM_cas:issn">0074-7696</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The progression of human cancer is characterized by a process of tumor cell motility, invasion, and metastasis to distant sites, requiring the cancer cells to be able to survive the apoptotic pressures of anchorage-independent conditions.  One of the crit. tyrosine kinases linked to these processes of tumor invasion and survival is the focal adhesion kinase (FAK).  FAK was first isolated from human tumors, and FAK mRNA was found to be upregulated in invasive and metastatic human breast and colon cancer samples.  Recently, the FAK promoter was cloned, and it has been found to contain p53-binding sites.  P53 inhibits FAK transcription, and recent data show direct binding of FAK and P53 proteins in vitro and in vivo.  The structure of FAK and P53, proteins interacting with FAK, and the role of FAK in tumorigenesis and FAK-p53-related therapy are reviewed.  This review focuses on FAK signal transduction pathways, particularly on FAK and P53 signaling, revealing a new paradigm in cell biol., linking signaling from the extracellular matrix to the nucleus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY7XzbcgJKfrVg90H21EOLACvtfcHk0liB63ZVRu7hoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1ajt70%253D&md5=a16ab3013b215e4f74ef16b4187cdca4</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0074-7696%2807%2963003-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0074-7696%252807%252963003-4%26sid%3Dliteratum%253Aachs%26aulast%3DGolubovskaya%26aufirst%3DV.%2BM.%26aulast%3DCance%26aufirst%3DW.%2BG.%26atitle%3DFocal%2520adhesion%2520kinase%2520and%2520p53%2520signaling%2520in%2520cancer%2520cells%26jtitle%3DInt.%2520Rev.%2520Cytol.%26date%3D2007%26volume%3D263%26spage%3D103%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Hungerford, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Compton, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matter, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffstrom, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otey, C. A.</span><span> </span><span class="NLM_article-title">Inhibition of pp125FAK in cultured fibroblasts results in apoptosis</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">1383</span><span class="NLM_x">–</span> <span class="NLM_lpage">1390</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=1996&pages=1383-1390&author=J.+E.+Hungerfordauthor=M.+T.+Comptonauthor=M.+L.+Matterauthor=B.+G.+Hoffstromauthor=C.+A.+Otey&title=Inhibition+of+pp125FAK+in+cultured+fibroblasts+results+in+apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHungerford%26aufirst%3DJ.%2BE.%26aulast%3DCompton%26aufirst%3DM.%2BT.%26aulast%3DMatter%26aufirst%3DM.%2BL.%26aulast%3DHoffstrom%26aufirst%3DB.%2BG.%26aulast%3DOtey%26aufirst%3DC.%2BA.%26atitle%3DInhibition%2520of%2520pp125FAK%2520in%2520cultured%2520fibroblasts%2520results%2520in%2520apoptosis%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D1996%26volume%3D135%26spage%3D1383%26epage%3D1390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Liu, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiang, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. P.</span><span> </span><span class="NLM_article-title">Apoptosis of rat hepatic stellate cells induced by anti-focal adhesion kinase antibody</span> <span class="citation_source-journal">World J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">734</span><span class="NLM_x">–</span> <span class="NLM_lpage">738</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=12174388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD38XntFeqt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=734-738&author=X.+J.+Liuauthor=L.+Yangauthor=H.+B.+Wuauthor=O.+Qiangauthor=M.+H.+Huangauthor=Y.+P.+Wang&title=Apoptosis+of+rat+hepatic+stellate+cells+induced+by+anti-focal+adhesion+kinase+antibody"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis of rat hepatic stellate cells induced by anti-focal adhesion kinase antibody</span></div><div class="casAuthors">Liu, Xiao-Jing; Yang, Li; Wu, Hong-Bin; Ou, Qiang; Huang, Ming-Hui; Wang, Ying-Ping</div><div class="citationInfo"><span class="NLM_cas:title">World Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">734-738</span>CODEN:
                <span class="NLM_cas:coden">WJGAF2</span>;
        ISSN:<span class="NLM_cas:issn">1007-9327</span>.
    
            (<span class="NLM_cas:orgname">World Journal of Gastroenterology</span>)
        </div><div class="casAbstract">AIM: To explore the role of focal adhesion kinase (FAK) in the apoptosis in culture-activated rat hepatic stellate cells (HSCs) using a specific anti-FAK antibody.  METHODS: Rat HSCs were prepd. from Wistar rats by in situ perfusion of collagenase and pronase and single-step d. Nycodenze gradient.  Culture-activated HSCs were serum-starved and treated with the anti-FAK antibodies for 24, 48 or 72 h.  The apoptosis of HSC was detected by DNA-fragment assay, flow cytometry and caspase-3 activity detn.  The expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) mRNA was assessed by reverse transcription polymerase chain reaction (RT-PCR).  RESULTS: The expt. showed that anti-FAK antibodies induced apoptosis of culture-activated rat HSCs.  This phenomenon displayed the classical features of apoptotic cell death (DNA fragmentation, cell cycle anal.) after treated with 30 mg·L-1 FAK antibody for 72 h, and accompanied by a significant increase of caspase-3 activity (1208+76) vs (309±28) nmol·min-1·g-1, t=208.5, P<0.05.  Meanwhile, treatment with the FAK antibody in HSCs could markedly decrease the TIMP-1 mRNA expression (0.07±0.01 vs 0.38±0.03, t = 2.72, P<0.05).  CONCLUSION: FAK plays an important role in the survival of HSCs and the specific anti-FAK antibody could induce the apoptosis in rat HSCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj2rTZ3910OrVg90H21EOLACvtfcHk0lgLx26akk_3GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntFeqt7Y%253D&md5=93c9ec709fa5443896b4fd110407ab76</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%2BJ.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DH.%2BB.%26aulast%3DQiang%26aufirst%3DO.%26aulast%3DHuang%26aufirst%3DM.%2BH.%26aulast%3DWang%26aufirst%3DY.%2BP.%26atitle%3DApoptosis%2520of%2520rat%2520hepatic%2520stellate%2520cells%2520induced%2520by%2520anti-focal%2520adhesion%2520kinase%2520antibody%26jtitle%3DWorld%2520J.%2520Gastroenterol.%26date%3D2002%26volume%3D8%26spage%3D734%26epage%3D738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Heidkamp, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayer, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalina, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eble, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samarel, A. M.</span><span> </span><span class="NLM_article-title">GFP-FRNK disrupts focal adhesions and induces anoikis in neonatal rat ventricular myocytes</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">1282</span><span class="NLM_x">–</span> <span class="NLM_lpage">1289</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2002&pages=1282-1289&author=M.+C.+Heidkampauthor=A.+L.+Bayerauthor=J.+A.+Kalinaauthor=D.+M.+Ebleauthor=A.+M.+Samarel&title=GFP-FRNK+disrupts+focal+adhesions+and+induces+anoikis+in+neonatal+rat+ventricular+myocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeidkamp%26aufirst%3DM.%2BC.%26aulast%3DBayer%26aufirst%3DA.%2BL.%26aulast%3DKalina%26aufirst%3DJ.%2BA.%26aulast%3DEble%26aufirst%3DD.%2BM.%26aulast%3DSamarel%26aufirst%3DA.%2BM.%26atitle%3DGFP-FRNK%2520disrupts%2520focal%2520adhesions%2520and%2520induces%2520anoikis%2520in%2520neonatal%2520rat%2520ventricular%2520myocytes%26jtitle%3DCirc.%2520Res.%26date%3D2002%26volume%3D90%26spage%3D1282%26epage%3D1289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Xu, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturge, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craven, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cance, W. G.</span><span> </span><span class="NLM_article-title">Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells</span> <span class="citation_source-journal">Cell Growth Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">418</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=9052982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADyaK28XitFegt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1996&pages=413-418&author=L.+H.+Xuauthor=L.+V.+Owensauthor=G.+C.+Sturgeauthor=X.+Yangauthor=E.+T.+Liuauthor=R.+J.+Cravenauthor=W.+G.+Cance&title=Attenuation+of+the+expression+of+the+focal+adhesion+kinase+induces+apoptosis+in+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells</span></div><div class="casAuthors">Xu, Li-hui; Owens, Lewis V.; Sturge, Glenn C.; Yang, Xihui; Liu, Edison T.; Craven, Rolf J.; Cance, William G.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Growth & Differentiation</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">413-18</span>CODEN:
                <span class="NLM_cas:coden">CGDIE7</span>;
        ISSN:<span class="NLM_cas:issn">1044-9523</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The focal adhesion kinase (FAK) is a non-receptor protein tyrosine kinase implicated in integrin-mediated signal transduction pathways, oncogenic transformation by v-src, and the invasion of human tumors.  The overexpression of p125FAK in a variety of human tumors and tumor cell lines in comparison to their non-transformed counterparts suggested that attenuation of p125FaK expression might have an effect on tumor cell proliferation.  In this study, the authors have treated tumor cell lines that expressed high levels of p125FAK with different antisense oligonucleotides to FAK, and have specifically attenuated p125FAK expression.  The cells treated with antisense oligonucleotides not only lost their attachment, but also underwent apoptosis.  Extensive control oligonucleotide expts. suggested that this attenuation was highly FAK specific.  Furthermore, normal human fibroblasts, which did not express high levels of p125FaK, did not lose their attachment or become apoptotic with FAK antisense treatment.  These results suggested that FAK is involved in adhesion-mediated growth in tumor cells and that FAK may be a rational gene-directed target for disrupting tumor cell growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGYz8mKAEF_LVg90H21EOLACvtfcHk0lgLx26akk_3GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XitFegt78%253D&md5=ea65ebdce50a369ce454259f072a320d</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DL.%2BH.%26aulast%3DOwens%26aufirst%3DL.%2BV.%26aulast%3DSturge%26aufirst%3DG.%2BC.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DE.%2BT.%26aulast%3DCraven%26aufirst%3DR.%2BJ.%26aulast%3DCance%26aufirst%3DW.%2BG.%26atitle%3DAttenuation%2520of%2520the%2520expression%2520of%2520the%2520focal%2520adhesion%2520kinase%2520induces%2520apoptosis%2520in%2520tumor%2520cells%26jtitle%3DCell%2520Growth%2520Differ.%26date%3D1996%26volume%3D7%26spage%3D413%26epage%3D418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Halder, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamat, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landen, C. N., ,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutgendorf, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merritt, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavez-Reyes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gershenson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmandt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Berestein, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sood, A. K.</span><span> </span><span class="NLM_article-title">Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">4916</span><span class="NLM_x">–</span> <span class="NLM_lpage">4924</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1158%2F1078-0432.CCR-06-0021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=16914580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD28XotFKgt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=4916-4924&author=J.+Halderauthor=A.+A.+Kamatauthor=C.+N.%2C++Landenauthor=L.+Y.+Hanauthor=S.+K.+Lutgendorfauthor=Y.+G.+Linauthor=W.+M.+Merrittauthor=N.+B.+Jenningsauthor=A.+Chavez-Reyesauthor=R.+L.+Colemanauthor=D.+M.+Gershensonauthor=R.+Schmandtauthor=S.+W.+Coleauthor=G.+Lopez-Beresteinauthor=A.+K.+Sood&title=Focal+adhesion+kinase+targeting+using+in+vivo+short+interfering+RNA+delivery+in+neutral+liposomes+for+ovarian+carcinoma+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Focal Adhesion Kinase Targeting Using In vivo Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma Therapy</span></div><div class="casAuthors">Halder, Jyotsnabaran; Kamat, Aparna A.; Landen, Charles N., Jr.; Han, Liz Y.; Lutgendorf, Susan K.; Lin, Yvonne G.; Merritt, William M.; Jennings, Nicholas B.; Chavez-Reyes, Arturo; Coleman, Robert L.; Gershenson, David M.; Schmandt, Rosemarie; Cole, Steven W.; Lopez-Berestein, Gabriel; Sood, Anil K.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4916-4924</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Focal adhesion kinase (FAK) plays a crit. role in ovarian cancer cell survival and in various steps in the metastatic cascade.  Based on encouraging in vitro results with FAK silencing, the authors examd. the in vivo therapeutic potential of this approach using short interfering RNA (siRNA) in the neutral liposome 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine (DOPC).  Exptl. Design: Therapy expts. of FAK siRNA with or without docetaxel were done using human ovarian cancer cell lines SKOV3i.p.1, HeyA8, and HeyA8MDR in nude mice.  Addnl. expts. with a cisplatin-resistant cell line (A2780-CP20) were also done.  Assessments of angiogenesis (CD31), cell proliferation (proliferating cell nuclear antigen), and apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling) were done using immunohistochem. anal.  RESULTS: A single dose of FAK siRNA-DOPC was highly effective in reducing in vivo FAK expression for up to 4 days as assayed by Western blot and immunohistochem. anal.  Therapy expts. were started 1 wk after injection of the ovarian cancer cells.  Treatment with FAK siRNA-DOPC (150 μg/kg twice weekly) reduced mean tumor wt. by 44% to 72% in the three cell lines compared with the control group (Ps < 0.05 for HeyA8, A2780-CP20, and SKOV3i.p.1).  When FAK siRNA-DOPC was combined with docetaxel, there was even greater redn. in mean tumor wt. in all models (all Ps < 0.05).  Similar results were obsd. in combination with cisplatin.  Treatment with FAK siRNA-DOPC plus docetaxel resulted in decreased microvessel d., decreased expression of vascular endothelial growth factor and matrix metalloproteinase-9, and increased apoptosis of tumor-assocd. endothelial cells and tumor cells.  CONCLUSIONS: Taken together, these findings suggest that FAK siRNA-DOPC plus docetaxel or platinum might be a novel therapeutic approach against ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-vlGdBWWR07Vg90H21EOLACvtfcHk0lgLx26akk_3GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotFKgt7Y%253D&md5=5792171e4e7d89bb4ce2c3f9d3697b5e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-0021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-0021%26sid%3Dliteratum%253Aachs%26aulast%3DHalder%26aufirst%3DJ.%26aulast%3DKamat%26aufirst%3DA.%2BA.%26aulast%3DLanden%26aufirst%3DC.%2BN.%252C%26aulast%3DHan%26aufirst%3DL.%2BY.%26aulast%3DLutgendorf%26aufirst%3DS.%2BK.%26aulast%3DLin%26aufirst%3DY.%2BG.%26aulast%3DMerritt%26aufirst%3DW.%2BM.%26aulast%3DJennings%26aufirst%3DN.%2BB.%26aulast%3DChavez-Reyes%26aufirst%3DA.%26aulast%3DColeman%26aufirst%3DR.%2BL.%26aulast%3DGershenson%26aufirst%3DD.%2BM.%26aulast%3DSchmandt%26aufirst%3DR.%26aulast%3DCole%26aufirst%3DS.%2BW.%26aulast%3DLopez-Berestein%26aufirst%3DG.%26aulast%3DSood%26aufirst%3DA.%2BK.%26atitle%3DFocal%2520adhesion%2520kinase%2520targeting%2520using%2520in%2520vivo%2520short%2520interfering%2520RNA%2520delivery%2520in%2520neutral%2520liposomes%2520for%2520ovarian%2520carcinoma%2520therapy%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2006%26volume%3D12%26spage%3D4916%26epage%3D4924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Jin, Y.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jindra, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rozengurt, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, E. F.</span><span> </span><span class="NLM_article-title">RNA interference elucidates the role of focal adhesion kinase in HLA class I-mediated focal adhesion complex formation and proliferation in human endothelial cells</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">178</span><span class="NLM_x">, </span> <span class="NLM_fpage">7911</span><span class="NLM_x">–</span> <span class="NLM_lpage">7922</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2007&pages=7911-7922&author=Y.-P.+Jinauthor=Y.+Korinauthor=X.+Zhangauthor=P.+T.+Jindraauthor=E.+Rozengurtauthor=E.+F.+Reed&title=RNA+interference+elucidates+the+role+of+focal+adhesion+kinase+in+HLA+class+I-mediated+focal+adhesion+complex+formation+and+proliferation+in+human+endothelial+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DY.-P.%26aulast%3DKorin%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DJindra%26aufirst%3DP.%2BT.%26aulast%3DRozengurt%26aufirst%3DE.%26aulast%3DReed%26aufirst%3DE.%2BF.%26atitle%3DRNA%2520interference%2520elucidates%2520the%2520role%2520of%2520focal%2520adhesion%2520kinase%2520in%2520HLA%2520class%2520I-mediated%2520focal%2520adhesion%2520complex%2520formation%2520and%2520proliferation%2520in%2520human%2520endothelial%2520cells%26jtitle%3DJ.%2520Immunol.%26date%3D2007%26volume%3D178%26spage%3D7911%26epage%3D7922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Huang, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. T.</span><span> </span><span class="NLM_article-title">Targeting of focal adhesion kinase by flavonoids and small-interfering RNAs reduces tumor cell migration ability</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">2017</span><span class="NLM_x">–</span> <span class="NLM_lpage">2025</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=16158939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtl2htLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=2017-2025&author=Y.+T.+Huangauthor=L.+T.+Leeauthor=P.+P.+Leeauthor=Y.+S.+Linauthor=M.+T.+Lee&title=Targeting+of+focal+adhesion+kinase+by+flavonoids+and+small-interfering+RNAs+reduces+tumor+cell+migration+ability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting of focal adhesion kinase by flavonoids and small-interfering RNAs reduces tumor cell migration ability</span></div><div class="casAuthors">Huang, Ying-Tang; Lee, Lung-Ta; Lee, Ping-Ping; Lin, Yung-Sheng; Lee, Ming-Ting</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3B</span>),
    <span class="NLM_cas:pages">2017-2025</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Focal adhesion kinase (FAK), a member of a growing family of structurally distinct protein tyrosine kinases (PTK), has been linked to specific phosphorylation events, and the elevation of FAK activity in human carcinoma cells is assocd. with increased invasive potential.  In the present study, therefore, we developed two expts. to test the hypothesis that FAK is a determinant of, and plays an important role in, regulating tumor cell migration.  In the first, the biol. functions of FAK were examd. using flavonoid inhibition.  MiaPaCa-2 cells, treated with luteolin (Lu) and quercetin (Qu), were used to dampen FAK phosphorylation and protein expression by parallel suppression of cell migration ability.  The second expt. involved suppression of FAK expression using small-interfering RNAs (siRNA) specific to FAK.  While not affecting cellular proliferation or apoptosis, the siRNA targeting FAK almost completely inhibited FAK protein expression in MiaPaCa-2 cells and potently blocked the cell migration mediated by FAK.  Our results show that FAK functions as a key regulator of cell migration, and that FAK activity can be suppressed by specific FAK siRNA, and by luteolin and quercetin.  It appears reasonable to conclude, therefore, that suppression of FAK protein has a significant impact on tumor cell invasiveness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc-mkf_c_XXbVg90H21EOLACvtfcHk0lgYyxLS10WKeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtl2htLk%253D&md5=ac103b157e667456af301a8bcab91476</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%2BT.%26aulast%3DLee%26aufirst%3DL.%2BT.%26aulast%3DLee%26aufirst%3DP.%2BP.%26aulast%3DLin%26aufirst%3DY.%2BS.%26aulast%3DLee%26aufirst%3DM.%2BT.%26atitle%3DTargeting%2520of%2520focal%2520adhesion%2520kinase%2520by%2520flavonoids%2520and%2520small-interfering%2520RNAs%2520reduces%2520tumor%2520cell%2520migration%2520ability%26jtitle%3DAnticancer%2520Res.%26date%3D2005%26volume%3D25%26spage%3D2017%26epage%3D2025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Cance, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iacocca, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roche, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simkins, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span> </span><span class="NLM_article-title">Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">2417</span><span class="NLM_x">–</span> <span class="NLM_lpage">2423</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=10873094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD3cXksVGhsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=2417-2423&author=W.+G.+Canceauthor=J.+E.+Harrisauthor=M.+V.+Iacoccaauthor=E.+Rocheauthor=X.+Yangauthor=J.+Changauthor=S.+Simkinsauthor=L.+Xu&title=Immunohistochemical+analyses+of+focal+adhesion+kinase+expression+in+benign+and+malignant+human+breast+and+colon+tissues%3A+correlation+with+preinvasive+and+invasive+phenotypes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues. Correlation with preinvasive and invasive phenotypes</span></div><div class="casAuthors">Cance, William G.; Harris, Janet E.; Iacocca, Mary V.; Roche, Elizabeth; Yang, XiHui; Chang, Jinli; Simkins, Stephen; Xu, LiHui</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2417-2423</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The focal adhesion kinase (FAK) is a protein Tyr kinase linked to signaling events between cells and the extracellular matrix.  Studies at the Western blot level have demonstrated up-regulation of FAK expression in invasive breast and colon cancers.  To assess p125FAK expression at the cellular level, the authors developed monoclonal antibodies that specifically detected FAK in formalin-fixed, paraffin-embedded tissue sections and analyzed the levels of FAK expression in human breast and colon tissues.  Monoclonal antibody 4.47 demonstrated FAK-specific focal adhesion staining by immunofluorescence assays on BT-474 breast cancer cells and detected a Mr 125,000 protein by both Western blotting and immunopptn. analyses.  Using immunohistochem. techniques, the expression of p125FAK was analyzed in 36 normal and 43 preinvasive or invasive human breast and colon tissues from individual patients.  FAK was weakly expressed in most benign breast epithelium but was up-regulated at moderate or strong levels in 14 of 18 invasive breast carcinomas.  In 7 samples of ductal carcinoma-in situ, FAK was overexpressed.  Borderline-to-weak expression of FAK was detected in the normal colonic epithelium.  In the invasive colon cancers, FAK was overexpressed at moderate or strong levels in 13 of 15 tumors.  Furthermore, FAK expression was up-regulated in areas of dysplastic, premalignant colon epithelium.  These results provide the 1st evidence at the cellular level that FAK expression is variably overexpressed in breast and colon cancer and suggest that up-regulation occurs at an early stage of tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2hXSzIeZTIrVg90H21EOLACvtfcHk0lgYyxLS10WKeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXksVGhsLY%253D&md5=832dfa56cb894eadd8835c82d7d39f46</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCance%26aufirst%3DW.%2BG.%26aulast%3DHarris%26aufirst%3DJ.%2BE.%26aulast%3DIacocca%26aufirst%3DM.%2BV.%26aulast%3DRoche%26aufirst%3DE.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DSimkins%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DL.%26atitle%3DImmunohistochemical%2520analyses%2520of%2520focal%2520adhesion%2520kinase%2520expression%2520in%2520benign%2520and%2520malignant%2520human%2520breast%2520and%2520colon%2520tissues%253A%2520correlation%2520with%2520preinvasive%2520and%2520invasive%2520phenotypes%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2000%26volume%3D6%26spage%3D2417%26epage%3D2423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Carelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zadra, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaira, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falleni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottiglieri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nosotti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Giulio, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosari, S.</span><span> </span><span class="NLM_article-title">Up-regulation of focal adhesion kinase in non-small cell lung cancer</span> <span class="citation_source-journal">Lung Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">271</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2006&pages=263-271&author=S.+Carelliauthor=G.+Zadraauthor=V.+Vairaauthor=M.+Falleniauthor=L.+Bottiglieriauthor=M.+Nosottiauthor=A.+M.+Di+Giulioauthor=A.+Gorioauthor=S.+Bosari&title=Up-regulation+of+focal+adhesion+kinase+in+non-small+cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarelli%26aufirst%3DS.%26aulast%3DZadra%26aufirst%3DG.%26aulast%3DVaira%26aufirst%3DV.%26aulast%3DFalleni%26aufirst%3DM.%26aulast%3DBottiglieri%26aufirst%3DL.%26aulast%3DNosotti%26aufirst%3DM.%26aulast%3DDi%2BGiulio%26aufirst%3DA.%2BM.%26aulast%3DGorio%26aufirst%3DA.%26aulast%3DBosari%26aufirst%3DS.%26atitle%3DUp-regulation%2520of%2520focal%2520adhesion%2520kinase%2520in%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DLung%2520Cancer%26date%3D2006%26volume%3D53%26spage%3D263%26epage%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">McLean, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carragher, N. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avizienyte, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunton, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frame, M. C.</span><span> </span><span class="NLM_article-title">The role of focal-adhesion kinase in cancer—a new therapeutic opportunity</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">505</span><span class="NLM_x">–</span> <span class="NLM_lpage">515</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1038%2Fnrc1647" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=16069815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtFOns7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=505-515&author=G.+W.+McLeanauthor=N.+O.+Carragherauthor=E.+Avizienyteauthor=J.+Evansauthor=V.+G.+Bruntonauthor=M.+C.+Frame&title=The+role+of+focal-adhesion+kinase+in+cancer%E2%80%94a+new+therapeutic+opportunity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The role of focal-adhesion kinase in cancer - A new therapeutic opportunity</span></div><div class="casAuthors">McLean, Gordon W.; Carragher, Neil O.; Avizienyte, Egle; Evans, Jeff; Brunton, Valerie G.; Frame, Margaret C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">505-515</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  I Focal-adhesion kinase (FAK) is an important mediator of growth-factor signaling, cell proliferation, cell survival and cell migration.  Given that the development of malignancy is often assocd. with perturbations in these processes, it is not surprising that FAK activity is altered in cancer cells.  Mouse models have shown that FAK is involved in tumor formation and progression, and other studies showing that FAK expression is increased in human tumors make FAK a potentially important new therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplqluP90LTaLVg90H21EOLACvtfcHk0ljg2yXLRqfH2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtFOns7k%253D&md5=805ddeb142a8d73e111cf8211dbcdfa9</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnrc1647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1647%26sid%3Dliteratum%253Aachs%26aulast%3DMcLean%26aufirst%3DG.%2BW.%26aulast%3DCarragher%26aufirst%3DN.%2BO.%26aulast%3DAvizienyte%26aufirst%3DE.%26aulast%3DEvans%26aufirst%3DJ.%26aulast%3DBrunton%26aufirst%3DV.%2BG.%26aulast%3DFrame%26aufirst%3DM.%2BC.%26atitle%3DThe%2520role%2520of%2520focal-adhesion%2520kinase%2520in%2520cancer%25E2%2580%2594a%2520new%2520therapeutic%2520opportunity%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2005%26volume%3D5%26spage%3D505%26epage%3D515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">van Nimwegen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Water, B.</span><span> </span><span class="NLM_article-title">Focal adhesion kinase: a potential target in cancer therapy</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">609</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=597-609&author=M.+J.+van+Nimwegenauthor=B.+van+de+Water&title=Focal+adhesion+kinase%3A+a+potential+target+in+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BNimwegen%26aufirst%3DM.%2BJ.%26aulast%3Dvan%2Bde%2BWater%26aufirst%3DB.%26atitle%3DFocal%2520adhesion%2520kinase%253A%2520a%2520potential%2520target%2520in%2520cancer%2520therapy%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2006%26spage%3D597%26epage%3D609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Shi, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hjelmeland, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keir, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohmori, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigner, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, J. N.</span><span> </span><span class="NLM_article-title">A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth</span> <span class="citation_source-journal">Mol. Carcinog.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">488</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1002%2Fmc.20297" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=17219439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD2sXms1Olsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=488-496&author=Q.+Shiauthor=A.+B.+Hjelmelandauthor=S.+T.+Keirauthor=L.+Songauthor=S.+Wickmanauthor=D.+Jacksonauthor=O.+Ohmoriauthor=D.+D.+Bignerauthor=H.+S.+Friedmanauthor=J.+N.+Rich&title=A+novel+low-molecular+weight+inhibitor+of+focal+adhesion+kinase%2C+TAE226%2C+inhibits+glioma+growth"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth</span></div><div class="casAuthors">Shi, Qing; Hjelmeland, Anita B.; Keir, Stephen T.; Song, Linhua; Wickman, Sarah; Jackson, Dowdy; Ohmori, Osamu; Bigner, Darell D.; Friedman, Henry S.; Rich, Jeremy N.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Carcinogenesis</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">488-496</span>CODEN:
                <span class="NLM_cas:coden">MOCAE8</span>;
        ISSN:<span class="NLM_cas:issn">0899-1987</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Glioblastomas are highly lethal cancers that resist current therapies.  Novel therapies under development target mol. mechanisms that promote glioblastoma growth.  In glioblastoma patient specimens, the non-receptor tyrosine kinase focal adhesion kinase (FAK) is overexpressed.  Upon growth factor receptor stimulation or integrin engagement, FAK is activated by phosphorylation on crit. tyrosine residues.  Activated FAK initiates a signal transduction cascade which promotes glioma growth and invasion by increasing cellular adhesion, migration, invasion, and proliferation.  We find that human glioma cell lines express different levels of total FAK protein and activating phosphorylation of tyrosine residues Tyr397, Tyr861, and Tyr925.  As all glioma cell lines examd. expressed phosphorylated FAK, we examd. the efficacy of a novel low-mol. wt. inhibitor of FAK, TAE226, against human glioma cell lines.  TAE226 inhibited the phosphorylation of FAK as well as the downstream effectors AKT, extracellular signal-related kinase, and S6 ribosomal protein in multiple glioma cell lines.  TAE226 induced a concn.-dependent decrease in cellular proliferation with an assocd. G2 cell cycle arrest in every cell line and an increase in apoptosis in a cell-line-specific manner.  TAE226 also decreased glioma cell adhesion, migration, and invasion through an artificial extracellular matrix.  Together, these data demonstrate the potential benefit of TAE226 for glioma therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXL0wEDuHo9bVg90H21EOLACvtfcHk0ljg2yXLRqfH2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXms1Olsrg%253D&md5=83711a44fe2472eae4baf568ee4332a4</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fmc.20297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmc.20297%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DQ.%26aulast%3DHjelmeland%26aufirst%3DA.%2BB.%26aulast%3DKeir%26aufirst%3DS.%2BT.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DWickman%26aufirst%3DS.%26aulast%3DJackson%26aufirst%3DD.%26aulast%3DOhmori%26aufirst%3DO.%26aulast%3DBigner%26aufirst%3DD.%2BD.%26aulast%3DFriedman%26aufirst%3DH.%2BS.%26aulast%3DRich%26aufirst%3DJ.%2BN.%26atitle%3DA%2520novel%2520low-molecular%2520weight%2520inhibitor%2520of%2520focal%2520adhesion%2520kinase%252C%2520TAE226%252C%2520inhibits%2520glioma%2520growth%26jtitle%3DMol.%2520Carcinog.%26date%3D2007%26volume%3D46%26spage%3D488%26epage%3D496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Slack-Davis, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilghman, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwanicki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ung, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Autry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luzzio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kath, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, J. T.</span><span> </span><span class="NLM_article-title">Cellular characterization of a novel focal adhesion kinase inhibitor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">14845</span><span class="NLM_x">–</span> <span class="NLM_lpage">14852</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1074%2Fjbc.M606695200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=17395594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltFemtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=14845-14852&author=J.+K.+Slack-Davisauthor=K.+H.+Martinauthor=R.+W.+Tilghmanauthor=M.+Iwanickiauthor=E.+J.+Ungauthor=C.+Autryauthor=M.+J.+Luzzioauthor=B.+Cooperauthor=J.+C.+Kathauthor=W.+G.+Robertsauthor=J.+T.+Parsons&title=Cellular+characterization+of+a+novel+focal+adhesion+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular Characterization of a Novel Focal Adhesion Kinase Inhibitor</span></div><div class="casAuthors">Slack-Davis, Jill K.; Martin, Karen H.; Tilghman, Robert W.; Iwanicki, Marcin; Ung, Ethan J.; Autry, Christopher; Luzzio, Michael J.; Cooper, Beth; Kath, John C.; Roberts, W. Gregory; Parsons, J. Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">14845-14852</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Focal adhesion kinase (FAK) is a member of a family of non-receptor protein-tyrosine kinases that regulates integrin and growth factor signaling pathways involved in cell migration, proliferation, and survival.  FAK expression is increased in many cancers, including breast and prostate cancer.  Here we describe perturbation of adhesion-mediated signaling with a FAK inhibitor, PF-573,228.  In vitro, this compd. inhibited purified recombinant catalytic fragment of FAK with an IC50 of 4 nM.  In cultured cells, PF-573,228 inhibited FAK phosphorylation on Tyr397 with an IC50 of 30-100 nM.  Treatment of cells with concns. of PF-573,228 that significantly decreased FAK Tyr397 phosphorylation failed to inhibit cell growth or induce apoptosis.  In contrast, treatment with PF-573,228 inhibited both chemotactic and haptotactic migration concomitant with the inhibition of focal adhesion turnover.  These studies show that PF-573,228 serves as a useful tool to dissect the functions of FAK in integrin-dependent signaling pathways in normal and cancer cells and forms the basis for the generation of compds. amenable for preclin. and patient trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_48hzQ-vWhrVg90H21EOLACvtfcHk0ljg2yXLRqfH2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltFemtbY%253D&md5=38e97c67d37fbcbde006e6937ae4e360</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M606695200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M606695200%26sid%3Dliteratum%253Aachs%26aulast%3DSlack-Davis%26aufirst%3DJ.%2BK.%26aulast%3DMartin%26aufirst%3DK.%2BH.%26aulast%3DTilghman%26aufirst%3DR.%2BW.%26aulast%3DIwanicki%26aufirst%3DM.%26aulast%3DUng%26aufirst%3DE.%2BJ.%26aulast%3DAutry%26aufirst%3DC.%26aulast%3DLuzzio%26aufirst%3DM.%2BJ.%26aulast%3DCooper%26aufirst%3DB.%26aulast%3DKath%26aufirst%3DJ.%2BC.%26aulast%3DRoberts%26aufirst%3DW.%2BG.%26aulast%3DParsons%26aufirst%3DJ.%2BT.%26atitle%3DCellular%2520characterization%2520of%2520a%2520novel%2520focal%2520adhesion%2520kinase%2520inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D14845%26epage%3D14852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Roberts, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whalen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulford, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Autry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emerson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kath, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Alsina, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorenzen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berliner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luzzio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaGreca, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jani, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wessel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marr, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vajdos, F.</span><span> </span><span class="NLM_article-title">Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">1935</span><span class="NLM_x">–</span> <span class="NLM_lpage">1944</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=1935-1944&author=W.+G.+Robertsauthor=E.+Ungauthor=P.+Whalenauthor=B.+Cooperauthor=C.+Hulfordauthor=C.+Autryauthor=D.+Richterauthor=E.+Emersonauthor=J.+Linauthor=J.+Kathauthor=K.+Colemanauthor=L.+Yaoauthor=L.+Martinez-Alsinaauthor=M.+Lorenzenauthor=M.+Berlinerauthor=M.+Luzzioauthor=N.+Patelauthor=E.+Schmittauthor=S.+LaGrecaauthor=J.+Janiauthor=M.+Wesselauthor=E.+Marrauthor=M.+Grifforauthor=F.+Vajdos&title=Antitumor+activity+and+pharmacology+of+a+selective+focal+adhesion+kinase+inhibitor%2C+PF-562%2C271"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DW.%2BG.%26aulast%3DUng%26aufirst%3DE.%26aulast%3DWhalen%26aufirst%3DP.%26aulast%3DCooper%26aufirst%3DB.%26aulast%3DHulford%26aufirst%3DC.%26aulast%3DAutry%26aufirst%3DC.%26aulast%3DRichter%26aufirst%3DD.%26aulast%3DEmerson%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DKath%26aufirst%3DJ.%26aulast%3DColeman%26aufirst%3DK.%26aulast%3DYao%26aufirst%3DL.%26aulast%3DMartinez-Alsina%26aufirst%3DL.%26aulast%3DLorenzen%26aufirst%3DM.%26aulast%3DBerliner%26aufirst%3DM.%26aulast%3DLuzzio%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DN.%26aulast%3DSchmitt%26aufirst%3DE.%26aulast%3DLaGreca%26aufirst%3DS.%26aulast%3DJani%26aufirst%3DJ.%26aulast%3DWessel%26aufirst%3DM.%26aulast%3DMarr%26aufirst%3DE.%26aulast%3DGriffor%26aufirst%3DM.%26aulast%3DVajdos%26aufirst%3DF.%26atitle%3DAntitumor%2520activity%2520and%2520pharmacology%2520of%2520a%2520selective%2520focal%2520adhesion%2520kinase%2520inhibitor%252C%2520PF-562%252C271%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D1935%26epage%3D1944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Alitalo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmeliet, P.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of lymphangiogenesis in health and disease</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">227</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=219-227&author=K.+Alitaloauthor=P.+Carmeliet&title=Molecular+mechanisms+of+lymphangiogenesis+in+health+and+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlitalo%26aufirst%3DK.%26aulast%3DCarmeliet%26aufirst%3DP.%26atitle%3DMolecular%2520mechanisms%2520of%2520lymphangiogenesis%2520in%2520health%2520and%2520disease%26jtitle%3DCancer%2520Cell%26date%3D2002%26volume%3D1%26spage%3D219%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Skobe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawighorst, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prevo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janes, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velasco, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccardi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alitalo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claffey, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Detmar, M.</span><span> </span><span class="NLM_article-title">Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">192</span><span class="NLM_x">–</span> <span class="NLM_lpage">198</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1038%2F84643" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=11175850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhtVylu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=192-198&author=M.+Skobeauthor=T.+Hawighorstauthor=D.+G.+Jacksonauthor=R.+Prevoauthor=L.+Janesauthor=P.+Velascoauthor=L.+Riccardiauthor=K.+Alitaloauthor=K.+Claffeyauthor=M.+Detmar&title=Induction+of+tumor+lymphangiogenesis+by+VEGF-C+promotes+breast+cancer+metastasis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis</span></div><div class="casAuthors">Skobe, Mihaela; Hawighorsti, Thomas; Jackson, David G.; Prevo, Remko; Janes, Lauren; Velasco, Paula; Riccardii, Lucia; Alitalo, Kari; Claffey, Kevin; Detmar, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">192-198</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Metastasis of breast cancer occurs primarily through the lymphatic system, and the extent of lymph node involvement is a key prognostic factor for the disease.  Whereas the significance of angiogenesis for tumor progression has been well documented, the ability of tumor cells to induce the growth of lymphatic vessels (lymphangiogenesis) and the presence of intratumoral lymphatic vessels have been controversial.  Using a novel marker for lymphatic endothelium, LYVE-1, the authors demonstrate here the occurrence of intratumoral lymphangiogenesis within human breast cancers after orthotropic transplantation onto nude mice.  Vascular endothelial growth factor (VEGF)-C overexpression in breast cancer cells potently increased intratumoral lymphangiogenesis, resulting in significantly enhanced metastasis to regional lymph nodes and to lungs.  The degree of tumor lymphangiogenesis was highly correlated with the extent of lymph node and lung metastases.  These results establish the occurrence and biol. significance of intratumoral lymphangiogenesis in breast cancer and identify VEGF-C as a mol. link between tumor lymphangiogenesis and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgrUUm-FXuuLVg90H21EOLACvtfcHk0lh9U-iKG-IjGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhtVylu7s%253D&md5=ecb4286d89dc5a32b8cee8a52396420b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2F84643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F84643%26sid%3Dliteratum%253Aachs%26aulast%3DSkobe%26aufirst%3DM.%26aulast%3DHawighorst%26aufirst%3DT.%26aulast%3DJackson%26aufirst%3DD.%2BG.%26aulast%3DPrevo%26aufirst%3DR.%26aulast%3DJanes%26aufirst%3DL.%26aulast%3DVelasco%26aufirst%3DP.%26aulast%3DRiccardi%26aufirst%3DL.%26aulast%3DAlitalo%26aufirst%3DK.%26aulast%3DClaffey%26aufirst%3DK.%26aulast%3DDetmar%26aufirst%3DM.%26atitle%3DInduction%2520of%2520tumor%2520lymphangiogenesis%2520by%2520VEGF-C%2520promotes%2520breast%2520cancer%2520metastasis%26jtitle%3DNat.%2520Med.%26date%3D2001%26volume%3D7%26spage%3D192%26epage%3D198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Su, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, L.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeng, Y.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, K.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, M.-L.</span><span> </span><span class="NLM_article-title">The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">223</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=209-223&author=J.-L.+Suauthor=P.-C.+Yangauthor=J.-Y.+Shihauthor=C.-Y.+Yangauthor=L.-H.+Weiauthor=C.-Y.+Hsiehauthor=C.-H.+Chouauthor=Y.-M.+Jengauthor=M.-Y.+Wangauthor=K.-J.+Changauthor=M.-C.+Hungauthor=M.-L.+Kuo&title=The+VEGF-C%2FFlt-4+axis+promotes+invasion+and+metastasis+of+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DJ.-L.%26aulast%3DYang%26aufirst%3DP.-C.%26aulast%3DShih%26aufirst%3DJ.-Y.%26aulast%3DYang%26aufirst%3DC.-Y.%26aulast%3DWei%26aufirst%3DL.-H.%26aulast%3DHsieh%26aufirst%3DC.-Y.%26aulast%3DChou%26aufirst%3DC.-H.%26aulast%3DJeng%26aufirst%3DY.-M.%26aulast%3DWang%26aufirst%3DM.-Y.%26aulast%3DChang%26aufirst%3DK.-J.%26aulast%3DHung%26aufirst%3DM.-C.%26aulast%3DKuo%26aufirst%3DM.-L.%26atitle%3DThe%2520VEGF-C%252FFlt-4%2520axis%2520promotes%2520invasion%2520and%2520metastasis%2520of%2520cancer%2520cells%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D9%26spage%3D209%26epage%3D223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Thiele, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sleeman, J. P.</span><span> </span><span class="NLM_article-title">Tumor-induced lymphangiogenesis: a target for cancer therapy?</span> <span class="citation_source-journal">J. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">224</span><span class="NLM_x">–</span> <span class="NLM_lpage">241</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1016%2Fj.jbiotec.2006.01.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=16497404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD28Xltl2isb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2006&pages=224-241&author=W.+Thieleauthor=J.+P.+Sleeman&title=Tumor-induced+lymphangiogenesis%3A+a+target+for+cancer+therapy%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor-induced lymphangiogenesis: A target for cancer therapy?</span></div><div class="casAuthors">Thiele, Wilko; Sleeman, Jonathan P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biotechnology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">224-241</span>CODEN:
                <span class="NLM_cas:coden">JBITD4</span>;
        ISSN:<span class="NLM_cas:issn">0168-1656</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Recent advances in understanding the biol. of lymphangiogenesis, the new growth of lymphatic vessels, have cast new light on the mol. basis of metastasis to regional lymph nodes.  The receptor tyrosine kinase VEGFR-3 is virtually exclusively expressed on lymphatic but not blood endothelium in the adult, and activation of VEGFR-3 by its ligands VEGF-C and VEGF-D is sufficient to induce lymphangiogenesis.  Correlative studies with human tumors and functional studies using animal tumor models show that increased levels of VEGF-C or VEGF-D in tumors lead to enhanced nos. of lymphatic vessels in the vicinity of tumors, which in turn promotes metastasis to regional lymph nodes by providing a greater no. of entry sites into the lymphatic system for invading tumor cells.  These findings have prompted studies to investigate whether inhibitors of VEGFR-3 activation might represent novel therapeutic agents for the suppression of metastasis.  However, a no. of points regarding the therapeutic potential of anti-lymphangiogenic treatments in the context of cancer remain to be addressed.  The spectrum and relative importance of mols. that induce lymphangiogenesis and the regulation of their expression during tumor progression, the reversibility of tumor-induced lymphangiogenesis, and possible side-effects of anti-lymphangiogenesis-based therapies all need to be investigated.  Most importantly, the extent to which lymph node metastases contribute to the formation of metastases in other organs remains to be elucidated.  These aspects are the focus of this review, and their investigation should serve as a roadmap to possible translational application.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9rMBypIU9KbVg90H21EOLACvtfcHk0lh_h7v_ksIdzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xltl2isb8%253D&md5=57fcd518b694182b92295e8d3c2a2a8d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.jbiotec.2006.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jbiotec.2006.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DThiele%26aufirst%3DW.%26aulast%3DSleeman%26aufirst%3DJ.%2BP.%26atitle%3DTumor-induced%2520lymphangiogenesis%253A%2520a%2520target%2520for%2520cancer%2520therapy%253F%26jtitle%3DJ.%2520Biotechnol.%26date%3D2006%26volume%3D124%26spage%3D224%26epage%3D241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Valtola, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salven, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heikkila, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taipale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joensuu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rehn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pihlajaniemi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weich, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">deWaal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alitalo, K.</span><span> </span><span class="NLM_article-title">VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">1381</span><span class="NLM_x">–</span> <span class="NLM_lpage">1390</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=10329591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A280%3ADyaK1M3mtlektg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=1999&pages=1381-1390&author=R.+Valtolaauthor=P.+Salvenauthor=P.+Heikkilaauthor=J.+Taipaleauthor=H.+Joensuuauthor=M.+Rehnauthor=T.+Pihlajaniemiauthor=H.+Weichauthor=R.+deWaalauthor=K.+Alitalo&title=VEGFR-3+and+its+ligand+VEGF-C+are+associated+with+angiogenesis+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer</span></div><div class="casAuthors">Valtola R; Salven P; Heikkila P; Taipale J; Joensuu H; Rehn M; Pihlajaniemi T; Weich H; deWaal R; Alitalo K</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of pathology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1381-90</span>
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    </div><div class="casAbstract">Recently, monoclonal antibodies against the human vascular endothelial growth factor receptor VEGFR-3 were shown to provide a specific antigenic marker for lymphatic endothelium in various normal tissues.  In this study we have investigated the expression of VEGFR-3 and its ligand VEGF-C in normal breast tissue and in breast tumors by immunohistochemistry.  VEGFR-3 was weakly expressed in capillaries of normal breast tissue and in fibroadenomas.  In intraductal breast carcinomas, VEGFR-3 was prominent in the "necklace" vessels adjacent to the basal lamina of the tumor-filled ducts.  VEGF receptor 1 and 2 as well as blood vessel endothelial and basal lamina markers were colocalized with VEGFR-3 in many of these vessels.  Antibodies against smooth muscle alpha-actin gave a weak staining of the necklace vessels, suggesting that they were incompletely covered by pericytes/smooth muscle cells.  A highly elevated number of VEGFR-3 positive vessels was found in invasive breast cancer in comparison with histologically normal breast tissue (P < 0.0001, the Mann-Whitney test).  VEGF-C was located in the cytoplasm of intraductal and invasive cancer cells.  The results demonstrate that the expression of VEGFR-3 becomes up-regulated in the endothelium of angiogenic blood vessels in breast cancer.  The results also suggest that VEGF-C secreted by the intraductal carcinoma cells acts predominantly as an angiogenic growth factor for blood vessels, although this paracrine signaling network between the cancer cells and the endothelium may also be involved in modifying the permeabilities of both blood and lymphatic vessels and metastasis formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRqsKqXdODnb-98rul4nhSdfW6udTcc2ebhdrZfIoKT-rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M3mtlektg%253D%253D&md5=de09976eb9f8045f4709956e03e34d60</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DValtola%26aufirst%3DR.%26aulast%3DSalven%26aufirst%3DP.%26aulast%3DHeikkila%26aufirst%3DP.%26aulast%3DTaipale%26aufirst%3DJ.%26aulast%3DJoensuu%26aufirst%3DH.%26aulast%3DRehn%26aufirst%3DM.%26aulast%3DPihlajaniemi%26aufirst%3DT.%26aulast%3DWeich%26aufirst%3DH.%26aulast%3DdeWaal%26aufirst%3DR.%26aulast%3DAlitalo%26aufirst%3DK.%26atitle%3DVEGFR-3%2520and%2520its%2520ligand%2520VEGF-C%2520are%2520associated%2520with%2520angiogenesis%2520in%2520breast%2520cancer%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D1999%26volume%3D154%26spage%3D1381%26epage%3D1390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Paavonen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puolakkainen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jussila, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jahkola, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alitalo, K.</span><span> </span><span class="NLM_article-title">Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">156</span><span class="NLM_x">, </span> <span class="NLM_fpage">1499</span><span class="NLM_x">–</span> <span class="NLM_lpage">1504</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1016%2FS0002-9440%2810%2965021-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=10793061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjslKltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2000&pages=1499-1504&author=K.+Paavonenauthor=P.+Puolakkainenauthor=L.+Jussilaauthor=T.+Jahkolaauthor=K.+Alitalo&title=Vascular+endothelial+growth+factor+receptor-3+in+lymphangiogenesis+in+wound+healing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing</span></div><div class="casAuthors">Paavonen, Karri; Puolakkainen, Pauli; Jussila, Lotta; Jahkola, Tiina; Alitalo, Kari</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1499-1504</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Vascular endothelial growth factor receptor-3 (VEGFR-3) is essential for embryonic cardiovascular development, but thereafter becomes confined to the lymphatic endothelium in adult tissues.  We have here studied VEGFR-3 expression in exptl. wounds of pigs and chronic inflammatory wounds of humans.  In healing incisional and punch biopsy wounds made in the dorsal skin of pigs, angiogenic blood vessels, identified by use of the blood vascular endothelial markers vWF and PAL-E and the basal lamina protein laminin, developed into the granulation tissue stroma from day 4 onward, being most abundant on days 5 and 6 and regressing thereafter.  VEGFR-3-pos. vessels were obsd. in the granulation tissue from day 5 onward.  These vessels were distinct from the PAL-E/laminin/vWF-pos. vessels and fewer in no., and they appeared to sprout from pre-existing VEGFR-3-pos. lymphatic vessels at the wound edge.  Unlike the blood vessels, very few VEGFR-3-pos. lymphatic vessels persisted on day 9 and none on day 14.  In chronic wounds such as ulcers and decubitus wounds of the lower extremity of humans, VEGFR-3 was also weakly expressed in the vascular endothelium.  Our results suggest that transient lymphangiogenesis occurs in parallel with angiogenesis in healing wounds and that VEGFR-3 becomes up-regulated in blood vessel endothelium in chronic inflammatory wounds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJqxyWjHM1-bVg90H21EOLACvtfcHk0lh_h7v_ksIdzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjslKltL8%253D&md5=47ea2671a4261d08c45d7acd2adb749a</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2965021-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252965021-3%26sid%3Dliteratum%253Aachs%26aulast%3DPaavonen%26aufirst%3DK.%26aulast%3DPuolakkainen%26aufirst%3DP.%26aulast%3DJussila%26aufirst%3DL.%26aulast%3DJahkola%26aufirst%3DT.%26aulast%3DAlitalo%26aufirst%3DK.%26atitle%3DVascular%2520endothelial%2520growth%2520factor%2520receptor-3%2520in%2520lymphangiogenesis%2520in%2520wound%2520healing%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2000%26volume%3D156%26spage%3D1499%26epage%3D1504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Petrova, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bono, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holnthoner, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesnes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pytowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sihto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laakkonen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heikkilä, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joensuu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alitalo, K.</span><span> </span><span class="NLM_article-title">VEGFR-3 expression is restricted to blood and lymphatic vessels in solid tumors</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">554</span><span class="NLM_x">–</span> <span class="NLM_lpage">556</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=554-556&author=T.+V.+Petrovaauthor=P.+Bonoauthor=W.+Holnthonerauthor=J.+Chesnesauthor=B.+Pytowskiauthor=H.+Sihtoauthor=P.+Laakkonenauthor=P.+Heikkil%C3%A4author=H.+Joensuuauthor=K.+Alitalo&title=VEGFR-3+expression+is+restricted+to+blood+and+lymphatic+vessels+in+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPetrova%26aufirst%3DT.%2BV.%26aulast%3DBono%26aufirst%3DP.%26aulast%3DHolnthoner%26aufirst%3DW.%26aulast%3DChesnes%26aufirst%3DJ.%26aulast%3DPytowski%26aufirst%3DB.%26aulast%3DSihto%26aufirst%3DH.%26aulast%3DLaakkonen%26aufirst%3DP.%26aulast%3DHeikkil%25C3%25A4%26aufirst%3DP.%26aulast%3DJoensuu%26aufirst%3DH.%26aulast%3DAlitalo%26aufirst%3DK.%26atitle%3DVEGFR-3%2520expression%2520is%2520restricted%2520to%2520blood%2520and%2520lymphatic%2520vessels%2520in%2520solid%2520tumors%26jtitle%3DCancer%2520Cell%26date%3D2008%26volume%3D13%26spage%3D554%26epage%3D556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Su, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, M.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, M.-L.</span><span> </span><span class="NLM_article-title">Further evidence for expression and function of the VEGF-C/VEGFR-3 axis in cancer cells</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">557</span><span class="NLM_x">–</span> <span class="NLM_lpage">560</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=557-560&author=J.-L.+Suauthor=P.-S.+Chenauthor=M.-H.+Chienauthor=P.+B.+Chenauthor=Y.-H.+Chenauthor=C.-C.+Laiauthor=M.-C.+Hungauthor=M.-L.+Kuo&title=Further+evidence+for+expression+and+function+of+the+VEGF-C%2FVEGFR-3+axis+in+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DJ.-L.%26aulast%3DChen%26aufirst%3DP.-S.%26aulast%3DChien%26aufirst%3DM.-H.%26aulast%3DChen%26aufirst%3DP.%2BB.%26aulast%3DChen%26aufirst%3DY.-H.%26aulast%3DLai%26aufirst%3DC.-C.%26aulast%3DHung%26aufirst%3DM.-C.%26aulast%3DKuo%26aufirst%3DM.-L.%26atitle%3DFurther%2520evidence%2520for%2520expression%2520and%2520function%2520of%2520the%2520VEGF-C%252FVEGFR-3%2520axis%2520in%2520cancer%2520cells%26jtitle%3DCancer%2520Cell%26date%3D2008%26volume%3D13%26spage%3D557%26epage%3D560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Cance, W. G.; Golubovskaia, V. M.; Kurenova, E. V.; Ostrov, D. A.</span><span> </span><span class="NLM_article-title">Focal Adhesion Kinase Protein Binding Inhibitors</span>. Provisional Patent 61/192,192, September 15,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=W.+G.+Cance&author=V.+M.+Golubovskaia&author=E.+V.+Kurenova&author=D.+A.+Ostrov&title=Focal+Adhesion+Kinase+Protein+Binding+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCance%26aufirst%3DW.%2BG.%26atitle%3DFocal%2520Adhesion%2520Kinase%2520Protein%2520Binding%2520Inhibitors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Arold, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoellerer, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, M. E.</span><span> </span><span class="NLM_article-title">The structural basis of localization and signaling by the focal adhesion targeting domain</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=319-327&author=S.+T.+Aroldauthor=M.+K.+Hoellererauthor=M.+E.+Noble&title=The+structural+basis+of+localization+and+signaling+by+the+focal+adhesion+targeting+domain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArold%26aufirst%3DS.%2BT.%26aulast%3DHoellerer%26aufirst%3DM.%2BK.%26aulast%3DNoble%26aufirst%3DM.%2BE.%26atitle%3DThe%2520structural%2520basis%2520of%2520localization%2520and%2520signaling%2520by%2520the%2520focal%2520adhesion%2520targeting%2520domain%26jtitle%3DStructure%26date%3D2002%26volume%3D10%26spage%3D319%26epage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Verdine, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walensky, L. D.</span><span> </span><span class="NLM_article-title">The challenge of drugging undruggable targets in cancer: lessons learned from targeting BCL-2 family members</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">7264</span><span class="NLM_x">–</span> <span class="NLM_lpage">7270</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1158%2F1078-0432.CCR-07-2184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=18094406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVCktr%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=7264-7270&author=G.+L.+Verdineauthor=L.+D.+Walensky&title=The+challenge+of+drugging+undruggable+targets+in+cancer%3A+lessons+learned+from+targeting+BCL-2+family+members"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">The Challenge of Drugging Undruggable Targets in Cancer: Lessons Learned from Targeting BCL-2 Family Members</span></div><div class="casAuthors">Verdine, Gregory L.; Walensky, Loren D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7264-7270</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The genomic and proteomic revolutions have provided us with an ever-increasing no. of mechanistic insights into cancer pathogenesis.  Mutated genes and pathol. protein products have emerged as the basis for modern anticancer drug development.  With the increasing realization of the importance of disrupting oncogenic protein-protein interaction, new challenges have emerged for classical small mol. and protein-based drug modalities, i.e., the crit. need to target flat and extended protein surfaces.  Here, we highlight two distinct technologies that are being used to bridge the pharmacol. gap between small mols. and protein therapeutics.  With the BCL-2 family of survival proteins as their substrate for intracellular targeting, we conclude that peptide stapling and fragment-based drug discovery show promise to traverse the crit. surface features of proteins that drive human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgYQX3c_4_qLVg90H21EOLACvtfcHk0lj8U0VpND0EHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVCktr%252FK&md5=1b7fcbe41063e04470f7c34b50410a42</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-2184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-2184%26sid%3Dliteratum%253Aachs%26aulast%3DVerdine%26aufirst%3DG.%2BL.%26aulast%3DWalensky%26aufirst%3DL.%2BD.%26atitle%3DThe%2520challenge%2520of%2520drugging%2520undruggable%2520targets%2520in%2520cancer%253A%2520lessons%2520learned%2520from%2520targeting%2520BCL-2%2520family%2520members%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D7264%26epage%3D7270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Arkin, M.</span><span> </span><span class="NLM_article-title">Protein−protein interactions and cancer: small molecules going in for the kill</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1016%2Fj.cbpa.2005.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=15939335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltVaqt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2005&pages=317-324&author=M.+Arkin&title=Protein%E2%88%92protein+interactions+and+cancer%3A+small+molecules+going+in+for+the+kill"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Protein-protein interactions and cancer: small molecules going in for the kill</span></div><div class="casAuthors">Arkin, Michelle</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">317-324</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  There has been much progress in the discovery of small, org. mols. that inhibit protein-protein interactions, particularly in the field of cancer.  Tubulin polymn. represents a classic target whose function can be allosterically modulated by small mols.  Several protein-protein complexes that regulate apoptosis, or programmed cell death, appear to be particularly amenable to inhibition by small mols., and recently described compds. have helped to characterize Bcl-2, MDM2 and XIAP as drug targets.  Addnl., small-mol. antagonists have recently been described for several new targets, including Rac1-Tiam1, β-catenin-T cell factor (Tcf), and Sur-2-ESX.  Not only is the list of protein-protein inhibitors growing, but the inhibitors themselves are moving closer to treating disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHYj6cW2uvz7Vg90H21EOLACvtfcHk0lj8U0VpND0EHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltVaqt7Y%253D&md5=e816e6db42b22b8950a78e7463d3cc1b</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2005.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2005.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DArkin%26aufirst%3DM.%26atitle%3DProtein%25E2%2588%2592protein%2520interactions%2520and%2520cancer%253A%2520small%2520molecules%2520going%2520in%2520for%2520the%2520kill%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2005%26volume%3D9%26spage%3D317%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Fry, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassilev, L. T.</span><span> </span><span class="NLM_article-title">Targeting protein−protein interactions for cancer therapy</span> <span class="citation_source-journal">J. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">955</span><span class="NLM_x">–</span> <span class="NLM_lpage">963</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1007%2Fs00109-005-0705-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=16283145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Oks7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2005&pages=955-963&author=D.+C.+Fryauthor=L.+T.+Vassilev&title=Targeting+protein%E2%88%92protein+interactions+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein-protein interactions for cancer therapy</span></div><div class="casAuthors">Fry, David C.; Vassilev, Lyubomir T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Medicine (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">955-963</span>CODEN:
                <span class="NLM_cas:coden">JMLME8</span>;
        ISSN:<span class="NLM_cas:issn">0946-2716</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  An increasing no. of protein-protein interactions have been identified as potential intervention points for the development of anticancer agents.  However, such systems have historically been considered high-risk targets due to the relatively large interaction surfaces involved in protein-protein binding.  This characterization has to be reexamd. as progress has been made recently in identifying small-mol. inhibitors of several protein-protein systems in oncol. including the p53-MDM2 interaction.  This review presents a survey of protein-protein interactions that have been identified as potential oncol. targets and evaluates their attractiveness in terms of drug discovery.  The anal. focuses primarily on the structural characteristics of the participating binding sites, particularly the dimensions of the sites.  Known ligands are also examd., esp. with regard to their druglikeness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQWZ6S-9Msl7Vg90H21EOLACvtfcHk0lj8U0VpND0EHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Oks7%252FM&md5=42c67ff28620061839842acd47c6948e</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2Fs00109-005-0705-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00109-005-0705-x%26sid%3Dliteratum%253Aachs%26aulast%3DFry%26aufirst%3DD.%2BC.%26aulast%3DVassilev%26aufirst%3DL.%2BT.%26atitle%3DTargeting%2520protein%25E2%2588%2592protein%2520interactions%2520for%2520cancer%2520therapy%26jtitle%3DJ.%2520Mol.%2520Med.%26date%3D2005%26volume%3D83%26spage%3D955%26epage%3D963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Vassilev, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carvajal, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podlaski, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filipovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kammlott, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukacs, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotouhi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, E. A.</span><span> </span><span class="NLM_article-title">In vivo activation of the p53 pathway by small-molecule antagonists of MDM2</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">844</span><span class="NLM_x">–</span> <span class="NLM_lpage">848</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1126%2Fscience.1092472" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=14704432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovVKmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2004&pages=844-848&author=L.+T.+Vassilevauthor=B.+T.+Vuauthor=B.+Gravesauthor=D.+Carvajalauthor=F.+Podlaskiauthor=Z.+Filipovicauthor=N.+Kongauthor=U.+Kammlottauthor=C.+Lukacsauthor=C.+Kleinauthor=N.+Fotouhiauthor=E.+A.+Liu&title=In+vivo+activation+of+the+p53+pathway+by+small-molecule+antagonists+of+MDM2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2</span></div><div class="casAuthors">Vassilev, Lyubomir T.; Vu, Binh T.; Graves, Bradford; Carvajal, Daisy; Podlaski, Frank; Filipovic, Zoran; Kong, Norman; Kammlott, Ursula; Lukacs, Christine; Klein, Christian; Fotouhi, Nader; Liu, Emily A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">5659</span>),
    <span class="NLM_cas:pages">844-848</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">MDM2 binds the p53 tumor suppressor protein with high affinity and neg. modulates its transcriptional activity and stability.  Overexpression of MDM2, found in many human tumors, effectively impairs p53 function.  Inhibition of MDM2-p53 interaction can stabilize p53 and may offer a novel strategy for cancer therapy.  Here, we identify potent and selective small-mol. antagonists of MDM2 and confirm their mode of action through the crystal structures of complexes.  These compds. bind MDM2 in the p53-binding pocket and activate the p53 pathway in cancer cells, leading to cell cycle arrest, apoptosis, and growth inhibition of human tumor xenografts in nude mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzumitGD6V4bVg90H21EOLACvtfcHk0ljN4CDn1z2PXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovVKmtA%253D%253D&md5=cf80c399e8eca8766be1023cda438df3</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1126%2Fscience.1092472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1092472%26sid%3Dliteratum%253Aachs%26aulast%3DVassilev%26aufirst%3DL.%2BT.%26aulast%3DVu%26aufirst%3DB.%2BT.%26aulast%3DGraves%26aufirst%3DB.%26aulast%3DCarvajal%26aufirst%3DD.%26aulast%3DPodlaski%26aufirst%3DF.%26aulast%3DFilipovic%26aufirst%3DZ.%26aulast%3DKong%26aufirst%3DN.%26aulast%3DKammlott%26aufirst%3DU.%26aulast%3DLukacs%26aufirst%3DC.%26aulast%3DKlein%26aufirst%3DC.%26aulast%3DFotouhi%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DE.%2BA.%26atitle%3DIn%2520vivo%2520activation%2520of%2520the%2520p53%2520pathway%2520by%2520small-molecule%2520antagonists%2520of%2520MDM2%26jtitle%3DScience%26date%3D2004%26volume%3D303%26spage%3D844%26epage%3D848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Liu, T.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFortune, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohmori, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatakeyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Groot, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yung, W. K. A.</span><span> </span><span class="NLM_article-title">Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1357</span><span class="NLM_x">–</span> <span class="NLM_lpage">1367</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1158%2F1535-7163.MCT-06-0476" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=17431114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktFams7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=1357-1367&author=T.-J.+Liuauthor=T.+LaFortuneauthor=T.+Hondaauthor=O.+Ohmoriauthor=S.+Hatakeyamaauthor=T.+Meyerauthor=D.+Jacksonauthor=J.+de+Grootauthor=W.+K.+A.+Yung&title=Inhibition+of+both+focal+adhesion+kinase+and+insulin-like+growth+factor-I+receptor+kinase+suppresses+glioma+proliferation+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo</span></div><div class="casAuthors">Liu, Ta-Jen; LaFortune, Tiffany; Honda, Toshiyuki; Ohmori, Osamu; Hatakeyama, Shinji; Meyer, Thomas; Jackson, Dowdy; de Groot, John; Yung, W. K. Alfred</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1357-1367</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Multiple genetic aberrations in human gliomas contribute to their highly infiltrative and rapid growth characteristics.  Focal adhesion kinase (FAK) regulates tumor migration and invasion.  Insulin-like growth factor-I receptor (IGF-IR), whose expression correlates with tumor grade, is involved in proliferation and survival.  We hypothesized that inhibiting the phosphorylation of FAK and IGF-IR by NVP-TAE226 (hereafter called TAE226), a novel dual tyrosine kinase inhibitor of FAK and IGF-IR, would suppress the growth and invasion of glioma cells.  In culture, TAE226 inhibited extracellular matrix-induced autophosphorylation of FAK (Tyr397).  TAE226 also inhibited IGF-I-induced phosphorylation of IGF-IR and activity of its downstream target genes such as MAPK and Akt.  TAE226 retarded tumor cell growth as assessed by a cell viability assay and attenuated G2-M cell cycle progression assocd. with a decrease in cyclin B1 and phosphorylated cdc2 (Tyr15) protein expression.  TAE226 treatment inhibited tumor cell invasion by at least 50% compared with the control in an in vitro Matrigel invasion assay.  Interestingly, TAE226 treatment of tumor cells contg. wild-type p53 mainly exhibited G2-M arrest, whereas tumor cells bearing mutant p53 underwent apoptosis.  Induction of apoptosis by TAE226 was substantiated by detection of caspase-3/7 activation and poly(ADP-ribose) polymerase cleavage and by an Annexin V apoptosis assay.  More importantly, TAE226 treatment significantly increased the survival rate of animals in an intracranial glioma xenograft model.  Collectively, these data show that blocking the signaling pathways of FAK and IGF-IR with TAE226 has the potential to be an efficacious treatment for human gliomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQMIquqcQABrVg90H21EOLACvtfcHk0ljN4CDn1z2PXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktFams7o%253D&md5=1659c50e987e8bbb24c998e0aae14861</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0476%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DT.-J.%26aulast%3DLaFortune%26aufirst%3DT.%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DOhmori%26aufirst%3DO.%26aulast%3DHatakeyama%26aufirst%3DS.%26aulast%3DMeyer%26aufirst%3DT.%26aulast%3DJackson%26aufirst%3DD.%26aulast%3Dde%2BGroot%26aufirst%3DJ.%26aulast%3DYung%26aufirst%3DW.%2BK.%2BA.%26atitle%3DInhibition%2520of%2520both%2520focal%2520adhesion%2520kinase%2520and%2520insulin-like%2520growth%2520factor-I%2520receptor%2520kinase%2520suppresses%2520glioma%2520proliferation%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D1357%26epage%3D1367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Kirkin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiele, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazitschek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohde, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fellbrich, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weich, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waltenberger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sleeman, J. P.</span><span> </span><span class="NLM_article-title">MAZ51, an indolinone that inhibits endothelial cell and tumor cell growth in vitro, suppresses tumor growth in vivo</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">986</span><span class="NLM_x">–</span> <span class="NLM_lpage">993</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1002%2Fijc.20509" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=15386354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVSnsLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2004&pages=986-993&author=V.+Kirkinauthor=W.+Thieleauthor=P.+Baumannauthor=R.+Mazitschekauthor=K.+Rohdeauthor=G.+Fellbrichauthor=H.+Weichauthor=J.+Waltenbergerauthor=A.+Giannisauthor=J.+P.+Sleeman&title=MAZ51%2C+an+indolinone+that+inhibits+endothelial+cell+and+tumor+cell+growth+in+vitro%2C+suppresses+tumor+growth+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">MAZ51, an indolinone that inhibits endothelial cell and tumor cell growth in vitro, suppresses tumor growth in vivo</span></div><div class="casAuthors">Kirkin, Vladimir; Thiele, Wilko; Baumann, Petra; Mazitschek, Ralph; Rohde, Katrin; Fellbrich, Guido; Weich, Herbert; Waltenberger, Johannes; Giannis, Athanassios; Sleeman, Jonathan P.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">986-993</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">We have recently described MAZ51, an indolinone that blocks the ligand-induced autophosphorylation of VEGFR-3, a receptor tyrosine kinase that plays a central role in the regulation of lymphangiogenesis.  Here we show that MAZ51 is able to block the proliferation of VEGFR-3-expressing human endothelial cells and is less potently able to induce their apoptosis.  MAZ51 also inhibits the proliferation and induces the apoptosis of a variety of non-VEGFR-3-expressing tumor cell lines.  These data suggest that MAZ51 blocks the activity of tyrosine kinases in addn. to VEGFR-3.  In vivo, MAZ51 significantly inhibits the growth of rat mammary carcinomas.  These data establish MAZ51 as a compd. with antitumor properties that inhibits tumor growth directly and also indirectly by interfering with tumor-host interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp6UBQk1bx8LVg90H21EOLACvtfcHk0ljN4CDn1z2PXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVSnsLnM&md5=c6819375918c41f02febeedc5df384cf</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fijc.20509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.20509%26sid%3Dliteratum%253Aachs%26aulast%3DKirkin%26aufirst%3DV.%26aulast%3DThiele%26aufirst%3DW.%26aulast%3DBaumann%26aufirst%3DP.%26aulast%3DMazitschek%26aufirst%3DR.%26aulast%3DRohde%26aufirst%3DK.%26aulast%3DFellbrich%26aufirst%3DG.%26aulast%3DWeich%26aufirst%3DH.%26aulast%3DWaltenberger%26aufirst%3DJ.%26aulast%3DGiannis%26aufirst%3DA.%26aulast%3DSleeman%26aufirst%3DJ.%2BP.%26atitle%3DMAZ51%252C%2520an%2520indolinone%2520that%2520inhibits%2520endothelial%2520cell%2520and%2520tumor%2520cell%2520growth%2520in%2520vitro%252C%2520suppresses%2520tumor%2520growth%2520in%2520vivo%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2004%26volume%3D112%26spage%3D986%26epage%3D993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Olsson, A.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreuger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claesson-Welsh, L.</span><span> </span><span class="NLM_article-title">VEGF receptor signalling—in control of vascular function</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">371</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1038%2Fnrm1911" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=16633338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADC%252BD28XjslSktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=359-371&author=A.-K.+Olssonauthor=A.+Dimbergauthor=J.+Kreugerauthor=L.+Claesson-Welsh&title=VEGF+receptor+signalling%E2%80%94in+control+of+vascular+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">VEGF receptor signaling - in control of vascular function</span></div><div class="casAuthors">Olsson, Anna-Karin; Dimberg, Anna; Kreuger, Johan; Claesson-Welsh, Lena</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">359-371</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Vascular endothelial growth-factor receptors (VEGFRs) regulate the cardiovascular system.  VEGFR1 is required for the recruitment of hematopoietic precursors and migration of monocytes and macrophages, whereas VEGFR2 and VEGFR3 are essential for the functions of vascular endothelial and lymphendothelial cells, resp.  Recent insights have shed light onto VEGFR signal transduction and the interplay between different VEGFRs and VEGF co-receptors in development, adult physiol. and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-6sAaLO1e57Vg90H21EOLACvtfcHk0lgJHUhoaQ5vIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjslSktrc%253D&md5=82711ef5c267a382bb2ba22e468d2d68</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fnrm1911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1911%26sid%3Dliteratum%253Aachs%26aulast%3DOlsson%26aufirst%3DA.-K.%26aulast%3DDimberg%26aufirst%3DA.%26aulast%3DKreuger%26aufirst%3DJ.%26aulast%3DClaesson-Welsh%26aufirst%3DL.%26atitle%3DVEGF%2520receptor%2520signalling%25E2%2580%2594in%2520control%2520of%2520vascular%2520function%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2006%26volume%3D7%26spage%3D359%26epage%3D371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Honti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Putnoky, G.</span><span> </span><span class="NLM_article-title">The effect of subcutaneously administered suprastin on ascites tumor strains in mice</span> <span class="citation_source-journal">Z. Gesamte Inn. Med. Ihre Grenzgeb.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1963</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">801</span><span class="NLM_x">–</span> <span class="NLM_lpage">803</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=14095005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A280%3ADyaF2c%252Flt1Krtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1963&pages=801-803&author=G.+Hontiauthor=G.+Putnoky&title=The+effect+of+subcutaneously+administered+suprastin+on+ascites+tumor+strains+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">THE EFFECT OF SUBCUTANEOUSLY ADMINISTERED SUPRASTIN ON ASCITES TUMOR STRAINS IN MICE</span></div><div class="casAuthors">HONTI G; PUTNOKY G</div><div class="citationInfo"><span class="NLM_cas:title">Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete</span>
        (<span class="NLM_cas:date">1963</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">801-3</span>
        ISSN:<span class="NLM_cas:issn">0044-2542</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSgKMtJDCUVW8jl5L8hwNX0fW6udTcc2ebFNJMuZxsgmLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaF2c%252Flt1Krtg%253D%253D&md5=291b217b55471c1f57f48e176245e0c6</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHonti%26aufirst%3DG.%26aulast%3DPutnoky%26aufirst%3DG.%26atitle%3DThe%2520effect%2520of%2520subcutaneously%2520administered%2520suprastin%2520on%2520ascites%2520tumor%2520strains%2520in%2520mice%26jtitle%3DZ.%2520Gesamte%2520Inn.%2520Med.%2520Ihre%2520Grenzgeb.%26date%3D1963%26volume%3D18%26spage%3D801%26epage%3D803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Kahlson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosengren, E.</span><span> </span><span class="NLM_article-title">New approaches to the physiology of histamine</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1968</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1968&pages=155-196&author=G.+Kahlsonauthor=E.+Rosengren&title=New+approaches+to+the+physiology+of+histamine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKahlson%26aufirst%3DG.%26aulast%3DRosengren%26aufirst%3DE.%26atitle%3DNew%2520approaches%2520to%2520the%2520physiology%2520of%2520histamine%26jtitle%3DPhysiol.%2520Rev.%26date%3D1968%26volume%3D48%26spage%3D155%26epage%3D196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">van Nimwegen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huigsloot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tijdens, I. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Water, B.</span><span> </span><span class="NLM_article-title">Focal adhesion kinase and protein kinase B cooperate to suppress doxorubicin-induced apoptosis of breast tumor cells</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1330</span><span class="NLM_x">–</span> <span class="NLM_lpage">1339</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=1330-1339&author=M.+J.+van+Nimwegenauthor=M.+Huigslootauthor=A.+Camierauthor=I.+B.+Tijdensauthor=B.+van+de+Water&title=Focal+adhesion+kinase+and+protein+kinase+B+cooperate+to+suppress+doxorubicin-induced+apoptosis+of+breast+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BNimwegen%26aufirst%3DM.%2BJ.%26aulast%3DHuigsloot%26aufirst%3DM.%26aulast%3DCamier%26aufirst%3DA.%26aulast%3DTijdens%26aufirst%3DI.%2BB.%26aulast%3Dvan%2Bde%2BWater%26aufirst%3DB.%26atitle%3DFocal%2520adhesion%2520kinase%2520and%2520protein%2520kinase%2520B%2520cooperate%2520to%2520suppress%2520doxorubicin-induced%2520apoptosis%2520of%2520breast%2520tumor%2520cells%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D1330%26epage%3D1339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Sandberg, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostrov, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sayeski, P. P.</span><span> </span><span class="NLM_article-title">Identification of 1,2,3,4,5,6-hexabromocyclohexane as a small molecule inhibitor of jak2 tyrosine kinase autophosphorylation [correction of autophophorylation]</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2526</span><span class="NLM_x">–</span> <span class="NLM_lpage">2533</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049470k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2526-2533&author=E.+M.+Sandbergauthor=X.+Maauthor=K.+Heauthor=S.+J.+Frankauthor=D.+A.+Ostrovauthor=P.+P.+Sayeski&title=Identification+of+1%2C2%2C3%2C4%2C5%2C6-hexabromocyclohexane+as+a+small+molecule+inhibitor+of+jak2+tyrosine+kinase+autophosphorylation+%5Bcorrection+of+autophophorylation%5D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm049470k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049470k%26sid%3Dliteratum%253Aachs%26aulast%3DSandberg%26aufirst%3DE.%2BM.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DK.%26aulast%3DFrank%26aufirst%3DS.%2BJ.%26aulast%3DOstrov%26aufirst%3DD.%2BA.%26aulast%3DSayeski%26aufirst%3DP.%2BP.%26atitle%3DIdentification%2520of%25201%252C2%252C3%252C4%252C5%252C6-hexabromocyclohexane%2520as%2520a%2520small%2520molecule%2520inhibitor%2520of%2520jak2%2520tyrosine%2520kinase%2520autophosphorylation%2520%255Bcorrection%2520of%2520autophophorylation%255D%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2526%26epage%3D2533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Richards, F. M.</span><span> </span><span class="NLM_article-title">Areas, volumes, packing and protein structure</span> <span class="citation_source-journal">Annu. Rev. Biophys. Bioeng.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">176</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm900159g&amp;key=10.1146%2Fannurev.bb.06.060177.001055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm900159g&amp;key=326146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm900159g&amp;key=1%3ACAS%3A528%3ADyaE2sXks1CisrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1977&pages=151-176&author=F.+M.+Richards&title=Areas%2C+volumes%2C+packing+and+protein+structure"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Areas, volumes, packing, and protein structure</span></div><div class="casAuthors">Richards, Frederic M.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biophysics and Bioengineering</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">151-76</span>CODEN:
                <span class="NLM_cas:coden">ABPBBK</span>;
        ISSN:<span class="NLM_cas:issn">0084-6589</span>.
    </div><div class="casAbstract">A review with 148 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvHGphzlx3JbVg90H21EOLACvtfcHk0lgpQKCEEMcJOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXks1CisrY%253D&md5=13c917ccbda3f36f1c6390a42c712818</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1146%2Fannurev.bb.06.060177.001055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.bb.06.060177.001055%26sid%3Dliteratum%253Aachs%26aulast%3DRichards%26aufirst%3DF.%2BM.%26atitle%3DAreas%252C%2520volumes%252C%2520packing%2520and%2520protein%2520structure%26jtitle%3DAnnu.%2520Rev.%2520Biophys.%2520Bioeng.%26date%3D1977%26volume%3D6%26spage%3D151%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1K04" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1K04','PDB','1K04'); return false;">PDB: 1K04</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i20"><a href="/doi/suppl/10.1021/jm900159g">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_56003"></div></div></div></div></div><hr /></hr><p class="last">Experimental procedures and additional biochemical evaluation of compound <b>1</b> effect in vitro and in vivo. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm900159g/suppl_file/jm900159g_si_001.pdf">jm900159g_si_001.pdf (1.69 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm900159g&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm900159g%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2009.52.issue-15%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm900159g" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b0b8d9acb3d8e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
